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iUMMARY
Anclronen Metabolism in the Human Prostate Glaf.J
1© Testosterone 5 a-reductase, the enzyme responsible for the 
production of dihydrotestosterone, was partially characterised in 
human benign hyperplastic prostatic tissue removeo at surgery* 
Biochemical experiments were carried out with fresh tissue or with 
tissue frozen in liquid nitrogen and stored for a limited period 
at -70°Co
2e Reductase activity was located in microsomal and nuclear
fractions isolated from human hyperplastic prostatic tissue©
In both these fractions, and in prostatic homogenatesj activity 
increased linearly with time for 40min under the experimental 
conditions used® from then on the enzyme lost its activity 
rapidly and became inactive within BOrnin© This inactivation
could not oe explained by lack of cofantor or substrate nor by 
dénaturation by some proteolytic enzymes# In homogenates, and
in nuclear and microsomal fractions, NAÛH was unable to replace 
NADPH as cofactor®
3. The 5 a-rcductasG activity in nuclear and microsomal
fractions was sensitive to thiol group blocking agents* The 
most effective was p-chloromercuribenzoate which caused total 
inhibition at. a concentration of 5 x 10 “M* lodoacetamide, 
iodoacetic acid, and N-ethylmaleimide also inhibited but higher
1X<
—2concentrations (10 M) were needed* Reductase activity 
inhibited by p-chloromercuribenzoats could be reactivated by 
the addition of dithiothreitol»
4# In both nuclear and microsomal fractions divalent cations 
inhibited testosterone reduction at low concentrations (5 x 10 ^M) 
in the following order of effectiveness;-
S3 >  Zn^^ « ^
7‘VStimulation of reduction by low concentrations of Zn ' , observed 
by other researchers, could not be confirmed in either human 
hyperplastic or rat prostatic nuclear fractions* Inhibition of 
5 a-rodijctase activity by the addition of zinc to both nuclear and 
microsomal fractions could be reversed by dithiothreitol, EDTA and 
o-phenanthroline#
S* Lineweaver-Burk analysis of the kinetics of zinc inhibition 
indicated that in both nuclear and microsomal fractions, zinc 
inhibited in a competitive manner with respect to cofactor but in 
a non-competitive manner with respect to substrate®
6# EDTA caused slight stimulation, o-phenanthroline slight
inhibition and citrate nad no effect on Sa-reductase activity of 
both nuclear and microsomal fractions®
7® A high zinc content was detected in the hyperplastic
prostate and wide variations in concentration occurred within 
any one gland® Much lower levels ware detected in well 
differentiated adenocarcinomatous samples and wide variations in
concentration were again detected within any one gland#
Zinc in the human hyperplastic prostate was found to be 
concentrated in the extracellular, nuclear and cytosol fractions®
80 Zinc added in increasing concentrations to homogenate
incubations was found to inhibit 5# -reductase activity© The 
extent of inhibition was similar to that observed when zinc was 
added to incubations of nuclear and microsomal fractions®
9® The results of a comparison of the zinc content and
5 «‘-■"reductase activity in human hyperplastic prostatic. tissus 
homogenates indicated that a significant inverse relationship 
existed between zinc and 5(% -reductase activity* In one 
prostatic sample which was infiltrated with an anaplastic malignancy 
no such relationship was observed*
10® Addition of reagents (EDTA, o-phonanthrolinc and
dithiothreitol) known to rovers© zinc inhibition of 5« -reductase 
in nuclear and microsomal incubations did not stimulate reduction 
in prostatic homogenates to a marked extent®
11* Prostatic cytoplasm, which was shown to contain a high
proportion of the intracellular zinc, did not inhibit 5. «-reduction 
when it was added to microsomal incubations® Heated cytosol 
fraction, however, was capable of inhibiting 5 a-rsductase activity® 
The inhibitory factor present in heated cytosol could be removed 
by passage through a cation exchange column, a process known to 
remove zinc®
XI,
12o An hypothesis is presented which involves zinc in a 
possible control of the accumulation of prostatic secretion by 
blocking the conversion of testosterone to dihydrotestosterone* 
Evidence for and against this hypothesis is discussed©
Xll.
ABBREVIATIONS
Abbreviations used are those recommended by the Eoitorial Board 
of the Biochemical Journal (1975) with the addition of the 
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A* INTRODUCTION
1, The Prostate as an Accessory Reproductive Gland
The prostate is.one of the male accessory reproductive 
glands# These organs function as exocrine glands, manufacturing, 
storing and excreting the materials which at ejaculation form 
seminal plasma, the suspension medium for spermatozoa#
The accessory reproductive glands have many characteristics 
in common; each possesses a secretory epithelium with an underlying 
laysr of connective tissue and smooth muscle fibres# There are 
marked dissimilarities, however, in gross structure and in the 
character the epithelium, and the chemical nature of the 
excretions, both between different glands within a species, and. 
within the same gland between different species# In man, 
seminal plasma is made up of the excretory fluids produced in the 
epididymis, vas deferens, ampullae, seminal vesicloa, prostata, 
bulbourethral (Cowper's) and urethral (Littre's) glands# In 
the dog and cat a relatively large prostate is present but seminal 
vesicles are absent# The bull, on the other hand, has a small 
prostate but very large seminal vesicles (Mann, 1964)#
The accessory glands are target tissues for androgens#
This was first shown by the classical studies of John Hunter (1792), 
who laid the foundation for an understanding of the relation between 
the presence of the testes and the functional state of the accessory 
reproductive glandss- "the prostate, Cowper's gland and the glands 
along the urethra — —  are in the perfect male large and pulpy,
secreting a considerable quantity of slimy mucus which is salt 
to the taste —  while in the castrated aniical those are 
small, flabby, tough and ligamentous and have little secretion." 
Although this implied a messenger travelling from the testes to 
the accessory reproductive glands it took a further hundred years 
for the concept of a hormone to evolve* It was in 1902 that 
Bayliss and Starling defined a hormone as a chemical substance 
which is produced in one part of the body, enters the circulation, 
and is carried to distant organs and tissues to modify their 
structure® It is now known that testosterone, which is produced 
in the testes, is the male sex hormone* This hormone acts on 
the seminiferous tubules and the accessory reproductive glands 
at the same time, thus allowing the simultaneous production of 
seminal plasma and sperm®
A major difference between the prostate and other accessory 
reproductive glands is its susceptibility to hyperplas? a and 
neoplasia in ageing men® The need to understand the biochemical 
nature of these diseases and the hope for medical relief of their 
symptoms has created much interest in and financial support for 
prostatic research® Much research to date, however, has 
focused on experiments with animal tissue, which constitutes an 
unsatisfactory model for the human gland® This study examines 
some aspects of androgen metabolism and its control, in the human 
prostate gland®
2® The Human Prostate % Hyperplasia and Neoplasia
In the normal adult man the prostate gland surrounds the
urethra immediately beneath the neck of the bladder, it is about 
the size of a chestnut and weighs approximately 20g© It has a 
tubulo-alveolar epithelium which is connected to multiple ducts 
used for the discharge of prostatic secretion into the urethra®
This discharge is under the control of the sympathetic nervous 
system which, upon stimulation, causes contraction of smooth 
muscle fibres embedded in connective tissue surrounding the 
epithelium (Price, 1963)©
Anatomically the prostate can be divided into five lobes; 
posterior, middle, anterior and two lateral lobes (Figure 1 )#
These divisions are related to the structures which pass through 
the gland. The posterior lobe lies behind the urethra and the 
ejaculatory ducts; the middle lobe lies between the urethra and- 
ejaculatory ducts; the anterior lobe is in front of the urethra; 
and the lateral lobes, which in many glands are by far the largest, 
lie on either side of the urethra (Franks, 1954)® These 
divisions have no functional or histological basis©
The gland can be more clearly divided into an inner 
periurethral area and an outer or "true" prostate (Figure 1 )#
The periurethral tissue consists of prostatic acin;, mucosal 
glands, the prostatic utricle, and the prostatic urethra itself 
(Franks, 1954)© In some (but not all) glands the inner and 
outer regions are separated by a recognisable fibrous capsule 
(Oacoby, 1923),
The inner and outer regions may be under different endocrine 
controls© The inner gland, for example, is derived from the
F i g u r e  1. D I V I S I O N S  OF THE H U M A N  PROSTATE.
ANATOMI  C AL  ( K e r r  e t  al 1 9 6 0  )
Anterior 
Lo be
T R A N S V E R S E
S L I C ER i g h tL a t e r a
L o b e
^  Le f t  
La te ra l  
► Lobe
F^osteri  o r  (Dor soli
E j a c u l n t o r y  D u c tsU r e t h r a
A n t e r i o r  Lobe
S A GI T TAL
SLICE
Median 
v L o b e  ^
P o s t e r i o r  Lo be
H I S T O L O G I C A L  ( F r o n k s J 9 5 4 )
U r e t h r a l  Glands
P r o s t a t i c  
Glands 
P r o p e r
S u b m u c o s a l  G l a n d s
Inner
Peri  u r e t h r a  
A r e a
O u t e r  
. . . V ^ T r u e
P r o s t a t e
U r e t h r a
2 *
Mullerian duct system (Lousleyj, 1912) and is estrogen sensitive.
At birth this area of the gland is enlarged, probably due to the 
presence of maternal estrogens (Franks* 1954), Also, in 
pseudohermaphrodites the prostate is dependent on the sox of the 
gonad. If there are ovaries present, the prostate is represented 
only by the middle and lateral lobes; when both testes are present, 
the entire male prostate, including the posterior lobe, surrourtdc 
the urethra (Moszkowicz, 1935; Andrews, 1951),
Benign hyperplasia of the prostata affects most males over 
sixty years of age and causes enlargement of the inner gland.
When the urethra becomes constricted surgical removal is required 
to relieve the kidneys and circulatory system of the damaging 
effects of back pressure. Surgical approaches tn the prostate 
gland are shown in Figure 2o During progression of the disease 
the outer region of the gland is compressed into a hard fibrous 
capsule which usually remains after surgery, A diseased prostate 
gland may cieigh up to 200g^a weight increase of 1000^, The 
disease is confined to a limited range of species and has been 
detected to date only in man, dog and lion. The histological 
appearance of diseased glands in these species is^ however, 
dissimilar.
Epidemiological studies have supnlied no important clues 
to tha etiology of benign hyperplasia except that they revealed 
some minor differences in racial and genetic frequencies (Caller, 1974), 
Cellar (1974) has also made a study of clinical literature on 
medical treatment of benign hyperplasia by a variety of steroidal
I" I g u r  e 2.  6.
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compounds* The only effective agents of this type appear to 
be the progestational anti-androgens* These., ho suggests, 
are a very helpful prototype for the ultimate medical treatment 
of human benign prostatic hyperplasia*
Prostatic carcinoma is the most prevalent male cancer, 
and causes approximately 1% 8% of all deaths duo to tumours
in men over fifty years of age in the United Kingdom (Franks, 
1974)* Carcinoma of the prostate is found in the androgen 
sensitive outer region of the gland and ia similar to carcinomas 
arising in other glandular organs* It is usually recognised 
by scirrhus and adenocarcinomatous growths* The incidence 
of carcinoma of the prostate, unlike that of benign hyperplasia, 
appears to be subject to remarkable racial and geographic 
differences(Franks, 1974)* It is interesting that a familial 
association between breast cancer and both prostatic and uterine 
malignancies has recently been demonstrated (Thiesscn, 1974), 
Conservative treatment (hormonal or radiation) of prostatic 
carcinoma is the standard form of therapy* The discovery of 
the androgen dependent nature of the disease (Huggins and Hodges, 
1941) led to the widespread clinical use of estrogens (Huggins, 
1941)* Administration of pharmacological amounts of estrogen 
lowers testicular secretion cf tostosteione probably through 
suppression of pituitary gonadotrophin reluase. Unpleasant 
side effects include breast enlargement * Although estrogen 
treatment causes shrinkage of the primary lesion in the prostate 
this is not a cure for prostatic carcinoma but only delays 
the fatal conséquences of the disease*
6 ,
This account emphasises a connection between steroid 
hormones and the diseases of benign hyperplasia and adenocarcinoma 
of the human prostate gland* Much research has therefore been 
based on the assumption that these diseases are caused by an 
upset in steroid hormone action*
3®. Hormonal Metabolism and Mechanism of Action
By the early 1960s a large volume of information had 
accumulated on the effects, often dramatic, of steroid hormones 
on target tissues* These studies have bean reviewed by Grant 
(1959) and by Dorfman and Ungar (1965)* More recent research 
has been directed towards finding out how steroid hormones induce 
effects on target tissues* The most promising approach, 
instigated by Densen ot al* (1968) and Gorski and Morgan (1967), 
was to follow the progress of a steroid within the target cell* 
Initial experiments showed that when estradiol*™'! 7 p entered its 
target tissue (in this case rat uterus) it bound to two distinct 
types of protein* Proteins to which the steroid bound with low 
capacity but high affinity were called specific receptors and 
these proteins were responsible for the transportation of bound 
steroid from the cytoplasm to the nucleus* Proteins, on the 
other hand, to which the steroid bound with high capacity but low 
affinity ware called storage receptors (Wurtman and Gensen, 1968)* 
These findings stimulated much interest and a general 
picture has now emerged for the mechanism of action of all 
st^^oid hormones* (See Gorski et al*, 1968; Smellie, 1971;
Rasps", 1971; Densen and De Sombre, 1972; OMMalley and Mearns, 1974;
S'.
Liao, 1974; and King and Mainwaring, 1974 for reviews*) After 
a steroid hormone enters the cell of a target tissue, a large 
proportion of this hormone becomes bound to storage receptors*
A smaller proportion becomes bound to specific receptors, which 
upon centrifugation sediment at about 8F* During binding of 
steroid to specific receptors the receptor protein undergoes a 
conformational change to a form that sediments at 45 - 55, 
permitting or causing its translocation to the nucleus* The 
overall process has been shown to be energy dependent* Once 
in the nucleus, an extremely low concentration of hormone, 
receptor, or hormone-receptor complex initiates the passage of 
a large amount of information stored within the double-helical 
structure of DMA back to the cytoplasm* This amplified message 
leaves the nucleus as messenger RNA and is translated into 
proteins by the ribosomes* These steroid induced proteins 
mediate many of the cellular processes in steroid-sensitive 
tissues* This picture is, however, an oversimplification#
The synthesis of tyrosine aminotransferase, for example, may be 
controlled by corticosteroids acting at a translational level 
(Tomkins, 1969)* There are, in addition, no well substantiated 
reports that high affinity receptors exist in the cytoplasm of 
skeletal muscle, an androgen responsive tissue (King and 
Mainwaring, 1974)*
Estradiol-17 p , which is' not extensively metabolised 
within target cells, has bean widely used in studying the mechanism 
of 8ceroid hormone action* The mechanism of action of androgens
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is less readily understood, however, since these hormones may be 
extensively metabolised iidthin target cells© In vitro 
incubations of radioactive testosterone with slices, minces, or 
homogenates of human hyperplastic prostatic tissue nave produced 
a multiplicity of products© Chamberlain et al© (1959), for example,
identified ten metabolites during incubations of human prostatic
14homogsnates with SOnll testosterone-^^ C. These may have 
been produced by at least five steroid transforming enzymess 
3cc -, 3(3 -, and 17p -hydroxysteroid dehydrogenases and 5a *=• and 
5p «reductases® The design of this experiment, in which a high 
substrate concentration was incubated for a long time (2h), 
allowed measurement of the total catabolic potential of the 
prostatic homogenatsc
The 3a « and 3(3 -hydroxysteroid dehydrogenases were found 
predominantly in the cytosol fraction, whereas the 17p -hydroxystoroid 
dehydrogenase was located in the mitochondrial fraction® The 
5cx «reductase was located in the microsomal and cytosol fractions, 
and the sp -reductase was found only in the cytosol fraction.
Further experiments failed to confirm the existence of a cytoplasmic 
5« -reductase (Ofncr et al*© 1970)® Some of theoa enzymes had 
been detected by earlier incubation studies of testosterone with 
human hyperplastic prostatic tissue® Wotiz and Lemon (1954) 
and Kinson (1962) showed 17p -hydroxysteroid activity; Farnsworth 
and Brown (1963) and Acevedo and Goldzieher (1965) showed 
3a -hydroxysteroid activity® Farnsworth and Brown (1963) also made 
the original discovery that a 5 a-reductase was present in this tissue*
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In vivo perfusion studies in a human subject with 
prostatic hyperplasia have confirmed the existence of all 
these enzymes except for the s p —reductase (Morfin at al®, 1970)#
In a further study, Ofner et al® (1970) were also unable to 
confirm their earlier reports of a soluble 5 a-reductase#
Many more recent incubation studies (Shimazaki et al*, 1965;
Gloyna and Wilson, 1969; Siiteri and Wilson, 1970; Pecker at al..
1972; Harper et al., 1974 and Jenkins and McCaffory, 1974)
have confirmed the existence of an extremely active 5 a-reductase
with an obligatory requirement for NADPH as cofactor in human
prostatic tissue. Siiteri and Wilson (1970) demonstrated that,
although the concentration of testosterone and androstenedione do
not differ between normal and hyperplastic human prostate glands,
there is a five-fold increase in the concentration of dihydrotestosterone
in the hyperplastic as compared with the normal gland. Furthermore,
the concentration of dihydrotestosterone in the peripheral areas
of both noimal and early hyperplastic glands were two and three
times greater than the levels found in the outer regions of these
glands. A comparison of the ability of prostatic slices to
convert testosterone to dihydrotestosterone showed that normal
and hyperplastic tissue behaved similarly. Identical results
were obtained from dog prostates (Gloyna et al., 1970). These
findings suggest a relationship between dihydrotestosterone and
benign hyperplasia, but it has not yet been established whether
dihydrotestosterone accumulation is a cause or an effect of the
disease.
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Jenkins and McCaffery (1974) found that although no 
definite relationship exists between 5a -reductase activity and 
the histology of prostatic samples, the ability of adenocarcinomatous 
tissue to reduce testosterone decreased as differentiation 
decreased# In contrast, Becker et al. (1972) reported that 
in hyperplastic tissue the amount of 5a -reductase was dependent 
upon the proportion of epithelial elements in the tissue. 
Dihydrotestosterone, while of major importance, is nut the only 
testosterone metabolite present in human hyperplastic tissue.
It has been demonstrated that testosterone and androstenedione 
are interconvertible (Wotiz and Lemon, 1954; Farnsworth et al..
1962; Acevedo and Goldzieher, 1964 and 1965; Ofner et al., 1965).
Human prostatic tissue can also demethylate testosterone to 
compounds of the 19-nor series and form 2-methoxyestrone 
(Farnsworth, 1965 and 1966). Further reduction of dihydrotestosterone 
has been studied by Jenkins and McCaffery (1974). They observed 
that the ratio of the Isomers of ahdrostanediol are abnormal in 
prostatic disease. The 3a /3p ratio, which in a normal gland 
is 2.0/1, becomes 4.8/1 in hyperplastic tissue. The 3a - and 3p - 
androstanediols can be further hydroxylated at the 6 and 7 positions 
(Ofner, 1974). Other hydroxylations occurring in C-19 steroids 
are 2i^  -hydroxylation which was detected in minced normal human 
prostatic tissue (Acevedo and Goldzieher, 1964) and 6(3 - and 2p - 
hydroxylations of androstenedione which were detected in minced 
preparations of hyperplastic and adenocarcinomatous human prostatic 
tissue (Acevedo and Goldzieher, 1965). The relationship of
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minor steroid metabolites to prostatic disease, however, remains 
uncertain®
Steroids of aorenal origin may also be metabolised by
hyperplastic prostatic tissue. For example, dehyoroepiandrosterone
(DHA) and DMA sulphate can be converted to dihydrotestosterone and 
androstanediols in vitro* Radioactive DHA sulphate infused 
into patients undergoing prostatectomy has bean shown to be taken 
up by the hyperplastic tissue (Harper et al,, 1974)® Collins at aXo
(1970) detected C-19 steroid sulphatase activity in human prostatic 
tissue by isolating DHA from incubations with. DHA sulphate, and 
by isolating testosterone from incubations with testosterone 
sulphate© They also found that androstenedione was metabolised 
to androstanedione and androsteroma.
A number of studies (Shimazaki et al,, 1955; Farnsworth, 1970;
and Jenkins and McCaffery, 1974) have shown that estrogens at
very high concentrations can inhibit human prostatic 5a —reductase 
activity in vitro. Giorgi et al* (I972a) have, however, shown
• «hts*«Brt4aï*h**<v4iT«»ra»<ja*fl «wnaaMwaatna ’  f
that at much lower concentrations estradiol«17p may affect the 
uptake of androgens by human prostatic tissue® Of more interest 
is the demonstration by Jenkins and McCaffery (1974) that progesterone 
ia a strong Inhibitor of 5 «—reductase activity in vitro® They 
suggest tnat this steroid could have a marked effect on the 
metabolism testosterone if it were administered in vivo®
Giorgi et al® (1971, 1972a and b, 1973 and 1974) have used 
a suporfusion technique to study androgen metabolism in both human 
ano dog prostatic tissue® This type of experimental procedure
creates an artificial environment nearer to the in vivo situation 
than doss the standard in vitro incubation method. Results 
from these superfusion studies confirmed that dihydrotestosterone 
is the major metabolite of testosterone, and indicated that 
androgen uptake is higher in hyperplastic than in normal 
prostatic tissue® She suggests that this difference may be 
explained by an excessive number of non-specific binding sites 
in hypsrplastic tissue which might reduce the steroid available 
for metabolism and release® At the same time the amount of 
androgen reaching the specific receptors might be affected® 
Although the former conclusion seems logical, it is probably 
unlikely that binding to non-specific receptors would have any 
effect on binding to specific receptors, since these proteins , 
have an affinity for steroids of the order of 10^ times greater 
than storage receptors® In adenocarcinomatous prostatic 
tissue decreased levels of non-specific binding sites and 
5 «-reductase activity were detected during superfusion©
Specific receptors have been known for some time to be 
of great importance in the mechanism of action of steroid 
hormones® Now that methods to study specific steroid 
binding have been established, many researchers have located 
specific receptors in c whole range of target tissues of many 
species® Using Sephodex-gel chromatography, Hansson and Tveter
(1971) have shown that components in human hyperplastic prostatic 
cytosol fractions are able to bind dihydrotestosterone and this 
binding can be reduced by the anti-androgens cyproterone and SK
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and F 7690® Androphilic macromolecules were also detected in
nuclear 1M NaCl extracts* Mainwaring and Milroy (1973) used
a more sensitive technique for the detection of specific
receptors in human hyperplastic prostatic tissue® The cytosol
fraction was pre-incubated with labelled steroid at 0°C and
then subjected to isopycnic centrifugation in a B% - 20/ sucrose
gradient* This method allows the separation of binding
components with different sedimentation coefficients* Specific 
3
binding of H—dihydrctestostorono to a protein of sedimentation
3coefficient 83 was detected® Other h-steroids including 
estradiol-17p , cortisol, androstenedione, and testosterone were 
not bound to the 83 protein to any significant extent, but 
non-specific low affinity binding was observed® At high 
concentrations, cyproterone acetate suppressed the specific
3
binding of H-dihydrotestosterone.
Although the specific androgen receptor in the rat prostate
has been extensively studied (Liao, 1974) the same is not true for
the human gland® This bias may be due both to the difficulty
in obtaining normal human prostatic tissue and the experimental
difficulties involved in working with human hyperplastic prostatic
tissue® Mainwaring and Milroy (1973) were unable to detect
receptors in all the samples of human hyperplastic prostate glands
they studied- They offer two explanations for this variation®
Human hyperplastic prostatic tissue is very difficult to homogenise,
and the receptors may have been destroyed during homogenisation®
3
Secondly dilution of the trace amounts of "H-dihydrotestosterone 
may be caused by the,high level of dihydrotestosterone in the tissue ©
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The possible presence of contamination from plasma sex 
steroid globulin, which has characteristics almost identical 
with the specific prostatic androgen receptor (Varnieulen and 
Verdonckj 1960) further complicates the study of androgen 
receptors in the human prostate gland© Steins et al. (1974) 
and Cowan et al* (1975) have bean unable to determine whether 
specific dihydrotestosterone binding in cytosols isolated from 
hyperplastic prostatic tissue was due to sex steroid binding 
globulin or to a specific receptor. Recently a specific 
receptor for 5 a-androstane-Sa ,17a «diol has been identified 
in both normal and hyperplastic dog prostatic tissue (Evans and 
Pierrepoint, 1975). In the dog prostate 5a -androstane-3 a , 
17a -diol may therefore be the active androgen*
4* Testosterone 5 a-Reductase and its Significance in 
Androgen Action
i~TTi1~nTrTr*iiiTii-irr ni~n-tTmiirrim'iilTi i*mi ATTrr I'lTrmf ‘r"~'r
The first evidence which indicated the importance of
dihydrotestosterone in androgen action came as a result of studies
3on tho intracellular localisation of ri-testosterone after its
in vivo perfusion in male ducks. Wilson and Loeb (1965)
3found that radioactivity originating from H-testosterone was 
bound to a protein component of nuclei isolated from the duck 
preen gland© Extending this study to the rat prostate gland,
Bruchovsky and Wilson (1968) showed that prior to entering the
3 3nucleus H-testosterone had been converted to H-dihydrotestcsterone©
This finding was confirmed independently by Anderson and Liao (1958).
The conversion of testosterone tu dihydrotestosterone is outlined
17.
in Figure 3*
The 5 oc-reductase enzyme responsible for the conversion 
of testosterone to dihydrotestosterone has been extensively 
studied in many androgen dependent and androgen responsive 
tissues. In androgen dependent tissues androgens initiate 
both growth and DMA synthesis, while in androgen responsive 
tissues no androgen stimulated DMA synthesis occurs (Mingeull 
and Sierralta, 1975)© Collectively these tissues are referred 
to as androgen sensitive tissues and include the liver, testes, 
adrenals, skin, epididymis, seminal vssicles, brain, kidney and 
prostate.
Fredoriksen and Wilson (1971) partially characterised 
the 5 cc «reductase from tho rat prostate gland© They reported 
that the 5 a -reductase was distributed equally between the 
nuclear and microsomal fractions, it had an absolute requirement 
for NADPH as source of reducing hydrogen, a pH optimum of 6.6, 
remained stable to freezing but became unstable upon heating at 
37°C for long periods. The enzyme was also found to be 
potentially inhibited by divalent cations * The substrate 
specificity for a variety of A ^ ““3-ketosteroids was investigated© 
Epitestosterone, 20a -hydroxy-4-pragnen-S-one, 17a «hydroxyprogesterono 
and progesterone were more effective substrates than testosterone* 
Deoxycorticosterone, cortexolone and androstenedione were of the 
same order of activity as testosterone© Androstenediol, although
a substrate, was approximately half as effective as testosterone* 
Corticosterone, cortisol and cortisone were totally inactive as
18.
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substrates for reduction over the concentration range studied*
On the bases of pH optima and it was concluded that 
the microsomal and nuclear Sa^reduutase activities belonged 
to a single enzymic entity* This may tie contrasted with the 
situation in the liver where at least five 5 a-^reductase enzymes 
have been detected, each having a limited substrate specificity 
(McGuire and Tomkins, 1960; McGuire et al». 1950)*
The rat prostatic nuclear 5 cc «^reductase has been located
on the nuclear membrane (Moore and Wilson, 1972). As the
result of chemical analysis, light microscopy, and examination 
of the subcellular distribution of several marker enzymes, it 
was concluded that the nuclear fraction used in this study was 
free from major contamination from other cytoplasmic constituents. 
The pure nuclear fraction was subjected to sonication followed 
by density gradient centrifugation. On the bases of buoyant 
density, the chemical composition of the fraction end detection 
of a flotation pattern similar to that of NADH^cytochrome c 
reductase, a known enzyme of tho nuclear membrane, it was 
concluded that tho 5# -reductase in prostatic nuclei is located
on the nuclear membrane. The enzyme is partially inhibited
by Triton X-*10D (Liao, 1974), a detergent known to remove the 
outer nuclear membrane (Blodel and Potter, 1966; Sadowski and 
Steiner, 1968). It is not yet known whether the location of 
the 5 a ■'“reductase on the outer nuclear membrane serves any 
physiological function. The Sa^reductase from rat prostate 
has been further purified after uigitonin and potassium chloride
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extraction (Moore and Wilson, 1974). In this study, the
5 o£ —reductase in both the nuclear and microsomal extracts had
an apparent molecular weight in the order of 250,000 —  350,000
as estimated by gel filtration and a sedimentation coefficient
of 13.55 -» 135, The localisation of rat prostatic 5ct -reductaso
in nuclear and microsomal fractions has been confirmed by Nozu
and Tamaoki (1973). They also observed that cytosol caused 
3inhibition of H«testosterone reduction in microsomal incubations 
but not in nuclear incubations. This appears to be the only 
detachable difference between microsomal and nuclear rat 
prostatic 5a -reductase. In both these fractions the 5 a^reductase 
has been sliown to carry out the stereospecific transfer of the 
4-pro-S-proton of NADPH to the double bond at C4 - C5 of 
testosterone (Nozu and Tamaoki, 1974)<>
Although there must be an intimate relationship between 
the specific androgen receptor and the 5 ^-reductase these 
functions belong to different proteins. The specific receptor 
and the 5a -reductase are located in different suboellular 
fractions (Mainwaring, 1970) and the anti-androgens cyproterone 
acetate and BOMT selectively block high affinity binding to 
dihydrotestosterone without impairment of 5 cx-reductase activity 
(Mainwaring, 1972)*
The 5 a-reductase of the rat prostate is androgen 
dependent. It decreases following castration and is 
subsequently Increased after testosterone treatment (Moore and 
Wilson, 1973; Gustafsson and Pousatte, 1974), Different types
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of regulation appear to exist in liver and kidney tissue. In 
the liver, 5« -reductase markedly increased after castration of 
maleso This is not unexpected since a higher rate of 5 a- 
reduction occurs in liver nuclei in female rats than in males*
In kidney nuclei, the enzyme was found to be almost unaffected 
by age, sex, castration and treatment with testosterone, but a 
marked change occurred after treatment with estrad-* jI-17 p 
(Gustafsson and Pousette, 1974).
It is possible that androgens exert their control by 
different mechanisms in androgen dependent tissues, such as 
prostate, and in androgen responsive tissues, such as liver 
(Tomkins, 1357) and kidney (l/erhoeven and He Moore, 1971).
This may account for the different constraints imposed upon the 
5 a-reductase in different tissues. Furthermore, in vitro 
measurements in liver and kidney revealed high levels of 
5 a-reductase whereas in vivo determinations showeo a much lower 
production of dihydrotestosterone. In the rat prostate, 
however, high activity of the 5a -reductase can be observed 
both in vitro and in vivo (King and Mainwaring, 1974).
Verhoevan et al, (1974) studied 5 a^reductrse activity in 
fractions isolated from prostate, submaxillary gland, lung, kidney and 
midbrain. The total 5a —reductase activity varied as followss™
lung%>pro8tatG%>kidney)>submaxillary gland%>uidbrain.
The particulate fractions were the major sites of 5a -reductase 
activity in all tissues except the submaxillary gland* The 
nuclear fractions contributed 19^ of the total 5 a^reductase
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activity in kidney and 15% in prostate. Verhoeven et al. (1974) 
are of the opinion that 5 a—reductase activity found in prostatic 
nuclear fractions by other workers may be overestimated because 
nuclear enzyme activity may be dependent, to some extent, upon 
nuclear purity.
There is considerable evidence to substantiate the 
hypothesis that dihydrotestosterone is the active androgen 
which maintains certain androgen sensitive tissues. In some 
bioassays this hormone has a more potent androgenic activity 
than testosterone (Dorfman and Shipley, 1956; Hilgar and Hummel,
1964). Moreover, dihydrotestosterone was found to be selectively 
retained in rat prostatic nuclei, where it stimulated specific 
RNA synthesis (Da\d.ee j 1972; Anderson ot al,, 1972).
Dihydrotestosterone stimulated RNA synthesis has also beon observed 
in nuclei isolated from human hyperplastic prostatic tissue 
(Davies and Griffiths, 1973). In many, but not all, androgen 
sensitive tissues, specific high affinity receptors have been 
detected for dihydrotestosterone, but not for testosterone 
(Mainwaring and Mangan, 1973).
The complex situation concerning androgen action in target 
organs has recently been clarified in a study by Imperato-McGinley 
et_^lc (1974), who have located a group of human male pseudohermaphrodites 
in a village in the Dominican Republic. These subjects are born 
with ambiguity of the external genitalia and have marked 
virilisation at puberty* Biochemical data revealed abnormally
low levels of 5k -reductase activity. By studying the clinical
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details linked to this deficiency, it has been possible to 
distinguish between organs that are sensitive to testosterone 
and, others that are sensitive to dihydrotestosterone* The 
authors hypothesise that during embryogenesis and again at 
puberty, both testosterone and dihydrotestosterone are necessary 
for complete male external differentiation and development. 
Testosterone, secreted in utero by the testes, acts directly on 
the Wolfian ducts to cause differentiation to tho vas deferens, 
epididymis and seminal vesicles, whereas testosterone acts as a 
pre-hormone in the urogenital sinus and urogenital tubercle, 
where its conversion to dihydrotestosterone results in differentiation 
of the external genitalia and prostate© The androgen induced 
changes at puberty, in particular, increase in muscle mass, 
the growth of phallus and scrotum and deepening of the voice 
appear to be mediated by testosterone and occur in the affected 
subjects. Development of tho prostate gland, increasu in 
facial hair, temporal recession of the hair line and acne do not 
occur and appear to be mediated by dihydrotestosterone*
Postpubertal psychosexual orientation is male, indicating that 
testosterone and not dihydrotestosterone is the important messenger.
Although the conversion of testosterone to dihydrotestosterone 
is of ultimate importance in target tissues such as the prostate, 
the above study indicates that this conversion is net ubiquitous 
for androgen action in man, and a complex interplay exists between 
testosterone and dihydrotestosterone* Androgen metabolism 
within a target tissue may play an elaborate role in the control
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of different cellular functions. For example5 it has been 
shown that in prostatic organ culture dihydrotestoaternne 
stimulates cell division, whereas 3 p-androstanediol stimulates 
cellular secretions (Baulieu et al., 1968; Lasnitzki, 1970).
Dihydrotestosterone is not the only active hormone 
synthesised from a pre-hormone in a target tissue. Progesterone 
is metabolised, by a 5 a ""reductase enzyme, to 5 o:"Oregnane'-3,20-dlone 
in chick oviduct, and this product binds tc a specific 8S receptor 
enabling it to stimulate the synthesis of avidin (Strott, 1974)»
In the kidney, 25-hydroxycholGcalciferol is activated by a 
25(0H)D^"»1-hydroxylasa enzyme converting it to 1,25-dihydroxy™ 
cholecalciferol (Fraser and Kodicek, 1970)»
5» Zinc and the Prostate
Zinc, the twenty fifth most abundant element, was first 
shown to have biological significance in 1D69 when it was found 
to bo required for the growth of the mould, Aspergillus nlger 
(Raulin, 1869)@ It is known to be ar, integral part of a number 
of enzymes of key metabolic importance (l/allee, 1959; 0* Doll and 
Campbell, 1971), and is found in high concentration in the male 
reproductive tract, especially in the prostate gland, where it 
may have a more specific function (Gunn and Gould, 1970)» The 
original discovery that an extremely high concentration of zinc 
occurred in the human prostate gland was made by Bertrand and 
VladescD in 1921» The rat prostate gland also contains a high 
concentration of zinc (flawson anj Fischer, 1952b and 1953;
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Fischer et al», 1955), The capacity to accumulate zinc is not 
a function of the complete rat gland, but occurs in the lateral 
portion of the dorso-lateral lobe (Gunn and Gould, 1956a; Rixon 
and Uhitefieldj 1959; Fischer et al., 1955; Millor nt al», 1951; 
and Webb et al,, 1973). Prostatic zinc concentrations are 
similar in dogs and man (Woitzel et al®, 1956; Lo bc al,, 1960; 
Whitemore* 15o3 and I'cbb et al,, 1973)* The prostate glands 
from bulls (Bertrand and V/ladesco, 1921), cats (Aughey, 1970), 
rhesus monkeys (Kar and Chowdhury, 1966), baboons (Muntzing «• »
1974), and rabbits (Mauison and Fischer, 1952b) also contain high 
levels of zinc. The boar, howouer^' concentrates zinc in the 
seminal vesicles and not in the prostate gland. (Boursnell et al,, 
1972), In other mammalian tissues such as muscle, liver, heart, 
intestine, pancreas, ovary and adrenals, much lower levels of zinc
have been observed (Tipton and Cook, 1963).
Results from a number of analytical studies which confirm 
the existence of a high concentration of zinc in the human prostate 
gland are summarised in Table 1 * To allow comparisons between 
these results, a conversion of values from pg zinc/g wet wt* to 
;jg zinc/g dry wt* was carried out for the cases indicated, making 
use of tho finding of Kerr et al® (1966) that moisture accounted 
for 80/i of the wet weight of prostatic tissue®
It appears from the analytical results presented in Table 1 
that prostatic zinc becomes depleted during adenocarcinoma.
This finding has been verified by histological studies in which zinc 
was detected by specific staining techniques using dithizone and
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silver sulphate (Gyorkey et al», 1967; Maquinay et al,, 1963)®
A lowered prostatic uptake of zinc-55 has been observed during 
in vivo perfusions of this isotope into patients suffering from 
prostatic carcinoma (Prout et al,& 1959; Rosoff arr^  Spencer, 1965)* 
Clincial studies have been performed to discover whether prostatic 
zinc-65 uptake can be related to the response of prostatic 
carcinoma to therapy (Boddy et ale, 1970; Unisholn, at al®, 1974),
The results of these studies, however, were rather inconclusive* 
Maquinay st al. (1963) made the observation that in areas 
of glandular epithelium which proliferate prior to the 
de-differentiation of adenocarcinoma, the accumulation of 
prostatic ^ secretion cauaod a rise in the zinc level* Subsequent 
loss of differentiation was accompanied by a f^ll in the zinc 
content of the tumour* This observation may explain the wide 
range of zinc levels found in prostatic adenocarcinomatous tissue* 
Gyorkey et al* (1967) showed that the decrease in zinc during 
adenocarcinoma occurred mainly in the cytoplasm, but zinc still 
remained detectable in the nucleus, particularly in the nucleolus*
The studies of Mawson and Fischer (1952a) and Hoare et al* 
(1956) showed that in hyperplastic samples the zinc content was 
lower than in normal prostatic tissue samples. This, however, 
was in contrast to the studies of Shrodt et al* (1964); Gyorkey et al, 
(1968); Gonick et- al, (1969) and Dhar et al* (1973), and the 
histological findings of Voigt (1958) and Gyorkey et al* (1967)*
A possible explanation for those differences was offered in the 
careful study of Shrodt et ^1 * (1964), who suggested that the
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discrepancy may be due to variations in the loss of prostatic 
fluid from the specimen prior to the zinc determination*
This fluid contains a high concentration of zinc (iiackenzie 
ot ale, 1952a)« Shrodt et al*, 1964 resorted that if pieces 
of prostatic tissue were squeezed to remove prostatic fluid 
prior to analysis, the tissue zinc level was depressed* The 
mass of published evidence therefore suggests that zinc levels are 
slightly greater than normal in hyperplastic glands but 
substantially lower than normal in adenocarcinomatous glands*
Dhar et_al. (1973), found unusually high prostatic zinc levels 
in normal and diseased prostates when their results are compared 
to those from other studies (see Table 1 )* This may be explained 
by tho fact that no attempt was made by Dhar gt al* (1973) to 
protect against or monitor for zinc contamination®
Zinc is not distributed uniformly throughout different 
areas of the human prostate gland, and the variations which occur, 
summarised in Table 1 , do not correlate well with anatomical 
divisions of the gland (Kerr et al., 1960; Gyorkey at al.t 1967).
In addition, in some investigations no correlation has been shown 
between the prostatic tissue zinc level and the content of 
epithelium within the tissue (Kerr et al*, 1960; Hoare et al., 1956)9 9 anjxwcircuMisun ' '
Gyorkey et al* (1967), however, chowed that in the normal prostate• / «rumTttwasiKiusa  ^ 9 9 r «
the acini, epithelial cells and cell nuclei of various zones 
stained for zinc, whereas in hyperplastic tissue, intense staining 
occurred in the epithelial cells and secretions* These findings 
are similar to those of Voigt (1958), and of the radioautographic
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study of Daniel et al® (1956).
The presence of cytoplasmic granules has been detected 
in the epithelial cells which stain for zinc (Maquinay 1®,
1953). These granules occupy the basal and apical poles within 
the cells* The authors suggest that zinc complexes are secreted 
into the lumen from the apical region and that zinc is accumulated 
from the peripheral plasma into the basal region. It is 
interesting that zinc is also associated with granules in 
leucocytes (Thiers and Vallee, 1957).
A more biochemical approach to the problem concerning the 
histological distribution of prostatic zinc has been attempted by 
Muntzing et al. (1974)* Zinc content was compared with 
P -glucuronidase since the concentration of this enzyme is related 
to the amount of epithelium in human prostatic tissue (Muntzing and 
Nilsson* 1972). A strong correlation was found between zinc and 
P -glucuronidase activity in non-cancerous, but not in cancerous 
tissue. High levels of zinc wore also detected in epithelial 
cells and glandular lumen in the prostate glands of rat (Rixon 
and Whitefield, 1959; Logothetopoulus, I960), cat (Aughey* 1970) 
and dog (Mackenzie et al., 1962b).
The prostate gland is known to be androgen dependent and 
there is considerable evidence tiiat the accumulation of prostatic 
zinc along with other specialised functions is under androgenic 
control. Administration of suitable doses of androgen to 
castrated mature male rats prevented the striking fall in zinc-65 
uptake by the dorso-lateral prostate* which should follow castration
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(Gunn and Gould, 1956b and 1957; Mirand and Bender, 1956).
Zinc accumulation in the rat testes is similar to that in the 
prostate and may be under hormonal control (Gunn and Gould* 1970).
In the dog pre-pubertal zinc levels are low. A lO/ decrease 
in prostatic zinc occurs following castration and a restoration 
of normal zinc levels in the prostates of castrated animals may 
be achieved by administration of testosterone (Whitmore* 1963)*
Zinc accumulation may also be under androgenic control in the 
baboon (Muntzing et al®, 1974).
In man, although prostatic zinc concentration is probably 
under androgenic control, reliable evidence on this point is still 
lacking® It has, however, been shown that in the human hyperplastic 
prostate gland zinc and testosterone accumulation are carried out 
by the binding of these compounds to different proteins (Reod 
and Stitch, 1973)* There is evidence that, in addition to a 
specialised role in the human prostate, zinc may play a more general 
role in male sexual development (Sandstead et^l*, 1967; Caggiano 
et al., 1969; Prasad et al®, 1963)*
«MMawHMMon * ^ teotrr ii*i> ■iw’g.ua f  '
Testosterone may not be the only endocrine factor controlling 
zinc uptake. Testosterone and prolactin have been shown to 
increase zinc uptake synergistically in the rat prostate (Gunn et al», 
1965; Moger and Geschwind, 1972)  ^ Prulactin has also been shown 
to stimulate zinc uptake in the absence oT testosterone (Moger and 
Geschwind, 1972).
In the female, zinc accumulation may also be under steroidal 
control but here, progesterone may be the controlling influence.
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For example, in women (Hagenfelclt et alo, 1973) and in female 
rabbits (Lutwak-Mann and McIntoshj 1959) endometrial zinc 
increases during the progestational phase of the menstrual cycle* 
Serious interference with reproductive performance has been detected 
in zinc deficient female rats (Mann? 1964)o
The function of a high concentration of zinc in the 
prostate gland is uncertain, but cannot be accounted for by 
the incorporation of this cation into metalloenzyrnes (Fischer et al s^
1955)* In a variety of species much of the prostatio zinc is 
located within the epithelium and cellular lumen* Human sperm 
cells (Mauson and Fischer, 1953), seminal plasma (Mawson end Fischer,
1956) and especially prostatic secretion (Mackenzie 1962a)
contain high levels of zinc, implying a special, as yet undiscovered, 
physiological role in reproduction, perhaps in the female reproductive 
tract* In support of this hypothesis, it has been demonstrated
that in the roe deer, the endometrial zinc concentration remains
high after coitus and throughout delayed implantation (Aitken, 1974)* 
Contrary evidence to this role in the case of the rat, however, was 
produced by Gunn and Gould (1958) who showed, by ligation oT the 
dorso“*lateral prostate, that prostatic fluid,presumably of high 
zinc concentration, is superfluous for rat fertility* In this 
species, nowever, zinc may be supplied to semen from the testes 
(Uetterdal, 1958; Birnhaum et al** 1961),leaving open the possibility 
of a role for high concentrations of zinc in fertility* It is 
interesting that in rat semen little of the zinc is extractable 
(Saito 1968), and zinc is probably complexed to thiol groups
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in the keratin-llke structures of sperm tails (Calvin and Bleau, 
1974)* In man (Cliasson et el*, 1971) and dog fSai^o et al*,• *  ^ kUVÿSUO»XKWl»M9 *
1967), on the other hand^a large proportion of zinc is extractable 
and is probably protein bound (Ekbom ana Wetterdal, 1951; Johnson 
et al0, 1969)* Zinc binding in seminal plasma may be of some 
importance, since free zinc is toxic to spermatozoa (Lindholmer, 
1974)» This might explain the suppression of fertility causea
by intra^uterine devices containing zinc (Zipper et al*, 1969)*
It has been suggested that one possible role of zinc in 
semen might bo to inhibit sperm mobility, thus holding the 
energy system in check until the actual time that fertilization 
is to take place* If spermatozoa are washed in vitro, an 
increase in respiratory activity occurs and this may ho associated 
with the concomitant loss of zinc (Eliasson ot al*, 1971)» 
Conversely a decrease in sperm mobility may be related to an 
increase in the concentration of zinc in the epiaidyrnis following 
administration of monochlorhydrin, a male antifertility drug 
(Gunn and Gould, 1972)» The fact that, the sperm of some marine 
species do not become motile until the zinc concentration has 
become diminished suggests that an inactivating rule for zinc may 
also occur in primitive forms with external means of fertilization 
(Fujii et al.e 1955),
6c Outline of Research
The present study Is concerned with some aspects of 
androgen metabolism in the human prostate gland» Initial findings
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by Grant at a.l* (1971) suggested that the nuclear 5 a^reductase
* eiaieeirmknKMii ' ' mJ ^
of the human hyperplastic prostate was modified by zinc* Since 
zinc is present in high concentration in the human prostate gland, 
interactions of this oloment with testosterone 5 (X«-reductase may 
have physiological implications* This study therefore set 
out to learn more about the general chaiacteristico of the 
5 a-reductasG present in the human hyperplastic prostate and, 
more specifically, to study the effect of zinc on this enzyme.
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Bo MATERIALS AND METHODS
11, £hem^j|l8_
Non-’Iabelled steroids were obtained from Kooh-Light 
Laboratories Ltd*, Colnsbrookr U*Ko and Steroloido, Croydon^ U*K*
Bovine serum albumin, DMA from calf thyn.js type 1 (highly polymerised), 
gluco3Q->6«~phoophatGp glucose^G^phocphate dehydrogenase (from Torula 
yeast type X1), o^phenanthroline and nucleotides were from Sigma 
Chemical Co.* Ltd., Kingston™upon™Thames, UcK» Zinc chloride 
(Specpure) and copper chloride (Specpure) were from Johnson end 
Matthey, London, UcK* All other chemicals were obtained from 
British Drug Houses Ltd*, Poole, U«K* unless otherwise stated*
2c Solvents
Ethanol and methanol (Burroughs, AoR* Grade) were used 
without further purification@ Benzene, obtained from British 
Drug Houses Ltd., was passed through a column containing silica gel 
and concentrated sulphuric acid, washed with water, dried and 
distilled twice before use* All other solvents ware also obtained 
from British Drug Houses Ltd*, unless otherwise stated, and were 
used without further treatment*
3c Distilled Deionised Water
All solutions were prepared with water which had been 
distilled and deionised in an Aquator 60E (Anderman and Co* Ltd*, 
London, U.K.) water purifier*
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4o Radioactive Steroids
[i ,2-^h] Testosterone (specific radioactivity 5G Ci/mmol) and 
] testosterone (spocific radioactivity 58*2mCi/mmol) were purchased
from the Radiochemical Centre, Amershamp U*Ko 3a «-Androstonediol
[ 14 Ï4<™ C J testosterone 
(specific radioactivity 56Ci/mmoi) were the products of New England 
Nuclear, Frankfurt, Germany«. Although these radioactive steroids 
should be pure on leaving the manufacturer, some decomposition may have 
occurred during transit end storage* They were therefore purified and 
radiochemical purity was established before they were used in experiments* 
Purification was accomplished by paper chromatography in light 
petroleum (boPoBO^^IOC^CÏ^benzeno^methanol-watGr (4:1s4s1 by vol*)-»
The sample, [ ^ 1 3 testosterone (25/jCi), [l j  3a-androatanediol
(ZS/jCi), 3 testosterone (JyjCi) or dihydro {testosterone
(5/JCi) was spotted on Whatman No* 1 paper (50cm x 5cm), equilihriated 
overnight in a tank saturated with the above solvent system, and than 
developed in a descending manner for 2-^ h in the supernatant ("mobilo") 
phase, light petroleum (b<.pe8O^ -*1OÜ°C)“benz0ne (4s1 v/v)* The radio™ 
active steroids were detected on a radiochromatogram scanner (Model 2700; 
Packard Instrument Co* Ltd,, Wembley, U*K«) and the area located on the 
paper was cut into small squares (lcm x 1cm), placed in a flask (50ml) 
and eluted overnight with 95^ aqueous ethanol (iQml), The supernatant 
was then decanted and the flask rinsed with ethanol (5ml)* The pooleo 
extracts were placed in a glass tube in a water baih (40°C) and the 
solvent evaporated under a stream of nitrogen* Benzene (4ml) was
added and a sample (OoOSml) counted* This stock solution of purified
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steroid was scored at 4 C, Bsnzane was used aa storaga solvent as 
suggested by Bayly and Evans (1968), In the case of ]
testosterone the specific radioactivity was decreased to 14Ci/mmol 
by the addition of cold steroid.
To provide proof of radiochemical homogeneity, carrier steroid 
(20mg) was added to a sample (0,0Sml) of stock solution and the 
radioactive and carrier steroids Ir the mixture crystallised from 
acetono/hexano (5:1 v/v)* If the specific radioactivity of both 
crystals and mother liquor in successive crystallisations were constant 
to within 5% of the specific radioactivity before crystallisation, 
then radiochemical purity had been achieved (Axelrod et al,, 1965),
In all cases the method just described produced radiochemically pure 
steroid*
5, Tissue
•auteaemaeecKiceESi
(a) Rat Ventral Prostatic Tissue
^ * »BraOavaii»a.*«rw>awat«»i.'t»cMinB n
Sprague-Dawley rats were reared in an animal house on a 
recommended diet (Diet 41, Bruce and Parkes, 1949), Adult males 
weighing between 200g and 400g were killed fay decapitation, and the 
ventral prostate gland, located at the base of the bladder, removed 
from each rat. The gland was separated from its surrounding capsule 
of connective tissue with forceps and placed in a plastic bag in 
crushed ice* Since the average weight of the rat ventral prostate 
gland is around OeSg, six glands were used for each experiment. No 
longer than 20min elapsed between removal of the glands end the start 
of an experiment.
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(b) Human Prostatic Tissue
Fresh human prostatic tissue was made available by the Urology 
Departments of three Glasgow hospitals Glasgow Royal Infirmary* the 
Western Infirmary, and on occasions Stobhill General Hospital® Surgical 
removal of the prostate gland from elderly males suffering from symptoms 
of benign hyperplasia was carried out by either the retropubic or the 
suprapubic route (see Figure 2 )« The rarnoved gland was transferred 
immediately to a plastic bag, placed on crushed ice* and taken without 
delay to the Pathology Department of Glasgow Royal Infirmary* There 
it was weighed, examined, and large sections cut for histological 
investigation. The remaining tissue, which varied in weight from 
5g to 70g depending on the size of the benign growth^was taken to the 
laboratory© The period between removal of the gland and the start of 
an experiment was usually less than 30min* However, in some cases 
when the samples were obtained from hospitals other than the Royal 
Infirmary, this period may have been longer, but n^ver exceeded 90min©
In experiments using this fresh tissue, samples exceeding 10g were not 
required© Any remaining tissue was stored for subsequent experimentation 
by the method outlined in the following section®
(c) Freezing of Human Prostatic Tissue
Prostatic tissue (I0g) was placed on a plastic dish in crushed 
iCB, cut into small squares (0*5am x 0*5cm approximately) with a razor 
blade), and dropped into liquid nitrogen (~196°C)© After 10min the 
pieces wore transferred to a plastic bog by a wooden spoon and stored 
in a refrigerator at ™70°C® When required tissue was thawed rapidly 
to minimise ice crystal formation (Mazur et al», 1970)© The frozen
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tissue squares were placed on a plastic dish partially immersed In 
warm water maintained at 30°C© To increase the surface area of 
the. tissue exposed to this heat it t‘aa continually chopped with a 
razor blade* Thawing was complete after 5min when? to prevent 
enzymatic degradation* the warm water surrounding the dish was 
replaced by ice* The chopping procedure was continued until a 
fine mince was obtained, after which the tissue was ready for 
homogenisation *
6* Fractionation of Human Prostatic Tissue
The method used was based on that of Kowarski et al* (1969), 
but considerable modification was required to accommodate the 
peculiarities of human benign hyperplastic prostatic tissue© A
major problem was its extreme toughness * due to ® high concentration 
of fibromuscular and connective tissue elements* All opérations 
were carried out at or as near as possible to 0°C by keeping vessels 
end solutions in crushsd ice© A cold room was not available*
An outline of the method used is shown in Figure 4*
(a) Homogénisation
* ' •w*ei!u.vidvA4it»wtiB$**w>«T’wrtai*mKBu»7isai
Prostatic tissue (lOg) was placed on a plastic dish partially 
immersed in crushed ice and finely minced with a razor blade© To 
remove blood contamination, extracellular fluid and cell debris* the 
minced tissue was transferred to a flask (50ml), anu mixed with a 
buffered 0.15M NaCl pH 7®0 solution for 10min at O^C with a magnetic 
stirrer* The supernatant was decanted, fresh buffered 0* 15M NaCl 
pH 7oO solution (20ml) added, and the washing procedure repeated©
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The pooled washes were filtered through nylon bolting cloth (K’ybolt
25T 45^ pore; John Stan5er and Co©, Manchester, UoK«)o The resulting
filtrate was termed the extracellular fraction*
The washed minced tissue was separated into three equal
batches and suspended in a solution (20ml) of 0*25M sucrose, OoOEiM
Tris-HCl (pH 7*0 at 20°C), 0,025M KCl and 5 x MgCl^ (0,2EM
sucros0“-ToKoM. solution)* Each hatch was placed in a polycarbonate
tube (I00ml)o An Ultra-Turrax homogeniser (Jank© and Kungol, Dreslov,
Poland; UoKo agents The Scientific Instrument Centre Ltd** London),
which uses steel blades, was found to be most effective for the
further disintegration of this tough .tissue, and was operated at
setting No© 4 with throe periods of 10s and intervals of 10s*
Homogenisation was completed with a Thomas homogeniser (size Cf.
A.H. Thomas Company, Philadelphia, UcScAo)© This is a Pottor-type
homogeniser with a teflon pestle and glass vessel and a clearance of
0»006in “ OoOOSin© The pestle was operated at 600 r©p*m« with two
vertical movements of the vessel© During homogenisation with both
types of apparatus the vessel containing the suspension was surrounded
by crushed ice in order to minimise the effect of a rise in temperature
due to friction* The honiogenate was filtered through two layers of
nylon bolting cloth (Nybolt 2ST 45jj pore) end the filtrate volume made
M
up to ?OmjL with Oo25^sugros8-T©K«Ma solution© During this filtration 
some material was unable to pass through the 45j.i pores of the nylon 
bolting cloth* Since this mesh size is about twice the diameter of 
whole cells, the retained material must bo resistant to the extreme 
homogenisation procedure* Under the light microscope the filtrate 
was found to consist of many broken cells, occasional epithelial
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whole cells, and clumps of stromal tissue; while the fraction held 
back by the filter contained a conglomerate of homogenisation 
resilient stromal and connective tissue© The filtrate thus 
constituted an enriched epithelial homoger.ate fraction*
(b) Isolation of the Nuclear Fraction
The method suggested by Blodel and Potter (1966) resulted 
in an extremely low nuclear yield when applied to human hyperplastic 
prostatic tissue# In order to effect some increase in this yield, 
the method was modified by isolating a crude nuclear pellet prior to 
further purification* The enriched epithelial homogenate fraction 
(see previous Section) was placed in MoS«E« polycarbonate tubes (100ml) 
which were fitted to the swing-out head of an M«S*F* Mistral 4L 
centrifuge (Measurement and Scientific Equipment Ltd®, London, U*K*), 
operated at 600 g for 15min at 4°C* (All "g" values reported in 
this study were calculated from the average radius of rotation of the 
column of liquid in the rotor tubes)* The pellet obtained was 
suspended in 0.25M sucros0"-T«K*M* solution (lOml) and the centrifugation 
procedure repeated twice# Supernatants from the three precipitations 
were pooled and the final crude nuclear pellet was gently suspended 
in 1*8M sucrose-TeK,M* solution by repeated passaoo through the tip 
of a Pasteur pipette,
Volumes (3ml) of 2*0M sucrose-T.K*Mo solution were added to 
three M.S.E. polycarbonate tubes (23ml)* Crude nuclear suspension 
(20ml to each tube) was gently layered on top of the 2«0M sucrose'-ToKoM* 
solution and the interphase betweui, the two layers gently disturbed 
with a glass rod* The tubes ware centrifuged for 120min ot 96,000 g
42.
^^ B\t 3e70cm) in fche 3 x 23ml aluminium swing-out rotor of an
Suparspeed 65 centrifuge^ The température control was sot at 5°C, 
since if centrifugation is carried out at below 4°C, the resulting 
change in tho viscosity of concentrated sucrosio produced poor nuclear 
yields (jouan et al©. 1973).
On completion of centrifugation a white slightly opalescent 
pellet in the shape of a thin disc was deposited at the bottom of the 
centrifuge tube. The supernatant sucrose solution was carefully 
removed by suction and the sides of the tube cleaned with Kleenex 
medical wipes. The pellet was resuspnnded in 0.25M sucrose^T.KcMo 
solution (15ml) and washed twice by precipitation for lOrnin at 600 g 
(r^v 15em)o The final nuclear pellet was carefully suspended in 
the solution used for incubation* This consisted of Tris buffer? 
pH 7.0 et 20^C (0.01M:) containing MgClg (5 x 10"^M), NaCl (0.05M), 
and* in specified instances* EDTA (5 x 10"'’^ M) and dithiothreitol 
(5 X 10 ^M)c a smooth suspension waa achieved by gentle stirring 
with a loose-fitting glass pestle followed by repeated passage through 
the tip of a Pasteur pipette. To remove any clumps of nuclear 
material which might remain* the suspension was finally filtered 
through nylon boltino cloth (Nybolt 2ST 4^j)© In most expérimenta 
this final "pure" nuclear fraction was made up to 15ml with 
incubation solution.
(c) isolation Other Cellular Constituents 
Other cellular constituents wore isolated in M.S.E. 
polycarbonate tubes {10ml) by centrifugation in the 10 x 10ml 
aluminium angle rotor of an M.S.E. Superspoed SO centrifuge©
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The pooled post-nuclear supernatant (80ml approximately) was 
centrifuged at 9,000 g (r^^ 2*55cm) for 10mir* The precipitated
material was resuspended by agitation on a vortex mixer in 0*25M 
sucrose-T.KtMo solution (lOml) and again centrifuged at 9,000 g 
for lOmiho The final pellet was termed the mitochondrial fraction.
The supernatants were pooled and centrifuged at 105,000 g 2©55cm)
for oOmin® In some experiments this 105,000 £  pellet was again 
suspended in 0©25M sucrose-TvKcMo solution (20ml) and centrifuged 
once more at 105,000 ^  for 30min* The final pellet and supernatant 
were termed the microsomal and cytosol fractions respectively» The 
mitochondrial and microsomal pellets were suspended in incubation 
solution by gentle stirring with a loose-fitting glass pestle followed 
by repeated passage through the tip of a Pasteur pipette. Incubation 
solution was added to make up a final volume of cytosol (100ml), 
microsomal (50ml) and mitochondrial (15ml) fractions*
7» Isolation of Nuclear Fraction from Rat Ventral Prostatic Tissue
r7V—“iTr-*-riTr~— -— -r—' i ——— - ' —a -f—r—TiT—rTnfTTra‘irrrrrnin ■ in i i ii i n  Trirmunn i n i~rT—rr^ TiiA -i r; un mi-r n ~~ >r "i
In a few experiments nuclear fractions from ret ventral prostatic 
tissue were isolated using th« method of Blodel and Potter (1966) without 
further modification* Prostatic tissue from six rets (total weight 
2*5g — 3o5g) was used for each nuclear isolation® This tissue was 
washed with 0®25M NaCl in the manner described for human prostatic 
tissue® The washed mince was suspended in 0.25M sucrose-T*K*M* 
solution (20ml) and homogenised with the Thomas homogeniser already 
described in 6 (a)® The homogenate was filtered through nyl'^ n bolting 
cloth (Nybolt 25T 45^ j) and the filtrate volume made up to 20ml with
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0.25M sucrosa-T.K.Mo solution© In the case of rat ventral prostatic 
tissue, little material was held back during filtration© In order 
to raise the sucrose concentration to I06M, 2.3M sucrose^ToKcM. 
solution (35ml) was added to the filtrate© Volumes (6ml) of 2,3M 
sucrose-TftKcMo solution were added to ? % 23ml M.S.E. polycarbonate 
tubes. Homogenate (I7ml to each tube) was then carefully layered
on top of thfej 2o3M ct'croso ooluticn, the interphaso between the two 
layers gently disturbed with a glass rod* and the tubes centrifuged 
for 90min at 96«000 9 (r 3®70om) in the 3 x 23ml aluminium swing-out
a V e
rotor of an M.S.E* Superspeed 65 centrifuge© The nuclear fraction 
was suspended in incubation solution (I5ml) in the manner described 
for human prostatio nuclear fractions©
8# Incubation Procedure
jj1 *2™^H3 Testosterone in benzene was placed in a glass tube 
and the solvent evaporated in a water bath (40^C) under a stream of 
nitrogen® NsN-dimethylacetamide (10pl) was added to aid solubilisation 
of the steroid* If the assay system contained largo amounts of protein
the steroid might bind to this, and tho observed rate of reaction would 
then be due to the rate of dissociation of the ste^'oid protein complex
rather than to the rate of the enzyme catalysed reaction. This type
of effect can be eliminated by the use of a solubilisation agent such
as NsN-dimethylacetamido (Engel* 1959)©
A known volume of incubation fluid containing nicotinamide
(0®4M) and NADPH (2 x 10 ^M) was added to the solubilised j[l,2-^H J
testosterone© In order to allow the final concentration of components
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in the complete incubation (total volume, 1ml) to correspond to the
values shown in Table 2, volumes (0.1ml) of t!iis solution wore added
to each incubation© The final concentration of subcellular
fractions in each incubation is shown in Tabla 3© To quantitate 
3the amount of H^tostosterone added* duplicate samples (0.1ml) of 
3H-testosterone, with the addition of absolute alcohol (3ml) to aid
evaporation, were placed in plastic scintillation ''ials (Packard
Instrument Co©), evaporated to drynuss under a stream of air, and
counted at the same time as the purified radioactive metabolites©
Incubations (1ml) were carried out in air in stoppered "Exelo" 0
test tubes in a shaking water bath (37^C) for 20min. The tubes
were then transferred to an ice bath and the reaction terminated by
the addition of chloroform s methanol 3:1 ; v/v (2ml) » Methanol
3 r 1A T(OtTml) containing 2. x 10 Ccpotn» [A- C J testosterone* methanol (0©1ml)
containing 2 x 10^c.p«m* dihydro ^testosterone, and methanol
(0#1ml) containing 3 a^androstanediol (200/jg) were added to permit
determination of procedural losses in subsequent purifications© To
1Aquantitate the amount of C steroids added, duplicate samples (Oo1ml) 
of testosterone and dihydro [A^^^c] testosterone were placed
in plastic counting vials, evaporated to dryness under a stream of air, 
and counted at the same time as the purified radioactive metabolites© 
Steroids were extracted after incubation by a method similar 
to that used by Folch et al© (1957) to isolate lipids from animal 
tissues© Incubation tubes were stoppered, shaken by hand, and the 
contents transferred to Quickfit’14/23 test tubes (15ml)« The 
incubation tubes were rinsed with chloroform i methanol 3:1; v/v (5ml)
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TABLE 2®
eea frettKâiŒKsierBWwaâive»
qç w i-i I» I n~. tr» -tm hrwjjFinal Concantration of Components of the 
5 a-Reduntase Assay
Component Concentration .
3
H-Testosterone 7 X 10"^M (2ng/ml) 
(approx© 2 x 10^d.p.m,/ml)
MgClg 5 X 10™^M
NaCl 0.05M
Nicotinamide 0,04M
NADPH 2 X 10™^M
EDTA^ 5 X lO^^M
1"
Dithiothreitol 5 X 1CT*M
Buffer = Tris - HCl (O.OIM) pH 7.0 at 20°C, 
1” Only present in specified instances©
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TABLE 3,
Final Concentration of Subcellular Fractions in the 
5 a-Reductase Assay SystemriHTiw w wnMrini Iii i«ffiii-rii irni ri rrrrT»ririrmwriirri-rri--riW-TniT'-rTn--Ti—T~*—mr
Subcellular Fraction '% Protein Concentration 
(|jg/ml)
Homogenate 100
Nuclear 200
Mitochondrial lUO
Microsomal 100
Cytosol 400
Usually only one fraction per incubation.
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to wash out any remaining steroid, and this wash added to the 
extraction tubes» The tubes were then fixed with Terry clips 
to a plats which was rotated by an electric motor in a vertical 
plane at 80 rop.m. for 10min to extract steroids# Following 
extraction the tubes were centrifuged in an M.S.E. bench centrifuge 
operated at speed setting No© 6 for lOmin© The upper aqueous 
phase was siphoned off and the lower solvent phase containing the 
extracted steroids placed in a water bath (40°C) and evaporated to 
drynes© under a stream of air©
9© Purification of the Radioactive Steroids from the Incubation
(a) Method A.
The steroids present in each incubation extract were purified 
by paper chromatography in light petroleum (b»p© B0*^-100°C)™benzene- 
methanol-water (4s1s4s1 by vol)« The sample was spotted on Whatman 
No» 1 paper (50cm x 5cm)* equilihriated overnight in a tank saturated 
with the solvent system just described, and developed for 2^ h in 
descending manner in the supernatant "mobile" phase light petroleum 
(b.p» 80°—100°C)—benzene (4s1* v/v) © The radioactive steroids were 
located by detection on a radiochromatogram scanner (Model 2700; Packard 
Instrument Co.)© This system yielded an of 0©39 for testosterone 
and Do64 for dihydrotestosterone» The detected areas on the paper 
were cut into small■squares (1cm x 1cm), and each area thus cut placed 
in a flask (50ml) and ©luted overnight with 95^ aqueous ethanol (lOml)»
The supernatant was decanted into a Quickfit 14/23 test tube (I5ml),
the flask rinsed with ethanol (5ml) and this wash added to the supernatant©
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Volumes (20D;jg) of either testosterone or dihydrotestosterone were 
added to the supernatant, and the test tube placed in a water bath 
(40°C) and evaporated to dryness under a stream of air*
The steroids were further purified on thin layers (Oc4mm) of 
silica gel (Kiesel Gel E© Merck, Darmstadt, Germany)@
In order to solubilise any lipids present* acetone (10 drops) was 
added down the sides of the test tube containing the evaporated paper 
extract© The resulting solution was carefully spotted ot the origin 
of the tol.Co plate with a Pasteur pipette© An interval of several 
minutes was allowed to elapse between applications to permit evaporation 
of the solvent® This procedure was repeated with ether (10 drops)®
The t.loCo plate was developed three times in acetone to a height of 
4cm to concentrate the spotted extract into a thin lino. Final 
development was carried out in ascending manner in a chloroform s 
acetone (7:1 ; v/v) mixture for 40 min# Tlie steroids wera detecteo 
by an ultra-violet lamp (Camlab Ltd., Cambridge, U.K.)# Testosterone 
(R^ ™ 0o41) was detected at 254nm, and dihydrotestosterone (R^ 0o50)
at 350nm* The silica gel in the detected area was loosened with a 
razor blade and sucked into a shortened Pasteur pipette which was 
blocked at the narrow end with a cotton wool plug and attached to a 
water suction pump© The Pasteur pipette was then placed in a- 
scintillation vial and the steroids adsorbed to the silica eluted into 
this vial by the addition of ether (2ml) into the t<^ p of the pipette®
The vial was placed in a water bath (40°C) and the solvent evaporated 
under a stream of air.
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(b) Method 8©
The steroids present in each incubation extract were purified 
by taloCo of acetyiated derivatives* Testosterone (200^g) and 
dihydrotestosterone (2D0^ jg) were added to the incubation extract in 
a Quickfit 14/23 test tube (l5mi)o The test tube was placed in a 
water bath (40°C) and the solvents evaporated to dryness under a stream 
of air© Pyridine (Odml) and acetic anhydrioe (0«1ml) ''ere added 
down the sides of the tube, which was then stoppered and shaken briefly 
on a vortex mixer* Acétylation then proceeded in darkness either at 
60°C for 1h or at room temperature overnight® Volumes (5ml) of 
chloroform s methanol 3:1;(v/v) and distilled deionised water (2ml) 
were then added* the water was present to facilitate partition© The 
steroids were extracted into the solvent layer and evaporated to dryness 
as described for the extraction of steroids after incubation (Section 8)© 
The acetyiated steroid extract was spotted onto thin layers (0*3mm) of 
alumina (Kiesel Gel *^^254*366 60) and developed in acetone to a
height of 4cm in the manner described for Method A* Final development 
was carried out in ascending manner in a cyclohexane ; ethyl acetate 
(4;1; v/v) mixture for 90min© The steroids were located under 
ultra-violet light* Testosterone acetate (R^ ss 0.28) was detected 
at 254nm and both dihydrotestosterone acetate (R^ s 0*44) end 
3 oc-’^ androstanediacetate (R^ %= 0.75) at 350nm« Elution from the 
alumina into plastic counting vials was carried out in the manner 
described for Method A®
In the case of 3a -androstanediacetate, only half the sample 
was transferred to the vial* the remainder being used to calculate
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procedural losses of the steroid by gas liquid chromatography#
10® Gas Liquid Chromatography of 5a -Androstane-3a .17B-Diol
A Series 104 gas chromatogram (Pya-Unicam; York St®, Cambridge,
U.K®) was ficted with a glass column (210cm) packed with 1% SE*^ '30 on
Gas'-Chrom Q (Applied Sciences Inc*, State College, Pennsylvania, U.S.A.)
0 2' and maintained at a temperature of 230 C* Nitrogen (2o'iKg/cm ) was
used as carrier gas and* after passage over the stationary phase* the
sample was detected by a flame ionisation detector® Hydrogen (1oOKg/cm )
was used as fuel, and air (0«7Kg/crn ) as oxidant* An Autolab 6300
digital integrator with a 6300 Accessory module (Spectra-Physics,
Marpandala, UcK*) monitored the detector output® This calculates,
electronically, the peak area of the amplified signal from the flame
ionisation detector®
Absolute alcohol (Oelrnl) was added to dried samples containing 
3oc «androstanediacetatsc A sample (2pl) of this solution was injected 
into the t'-'p of the gas liquid chromatogram with a graduated Hamilton 
syringe (10^j1)*
During each experiment the gas liquid chromatogram was calibrated 
by injection of 3a -androstanediacetate between osch batch of five 
injections of unknown samples© This steroid had a retention time 
of 340s® The integration delay, which controls an adjustable delay 
period before the integrated output is recorded, was set at 2Q0s ao 
that the area of the solvent peak, which had a retention time of less 
than 200s, should not be calculated® The concentration of 
3a -endrostanediacetate in the unknown sample was then calculated by
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comparison of its peak area with the peak area obtained from the 
known 3 oc-androstanediacetate sample (2;jg)«.
11* Countinnof Radioactivity
Sar.ples which had previously been d;;ied in plastic vials were 
counted after addition of scintillation fluid |^(lOml) N.E.233, Nuclear 
Enterprises Ltd,, Edinburgh, UcKaJ* This scintillation fluid 
contains highly purified toluene, 2,5 diphenyloxazole (P.P.O.) activator, 
naphthalene for reduction of chemical quenching, and 1,4 di f 2-(5-phenyl- 
cxazolyl)J-benzene (P*0,P#0*P.) spectrum shifter* It was chosen for 
USB in these experiments because the samples to be counted were 
completely soluble in toluene* counting efficiency was high, and 
minimal quenching occurred® Double isotope counting was performed 
in two channels (green and blue) of a Tri-Carb liquid scintillation 
spectrometer (Model 3380; Packard Instrument Co#), The width of the 
window in the green channel was adjusted to allow the detection of 
carbon-14 alone, while in the blue channel tritium and carbon-14 were 
counted* To obtain a sufficiently high efficiency of carbon-14 
detection, about one-fifth of the counts due to this isotope in the 
green channel overlapped into the blue channel. The exact degree of 
overlap under the experimental counting conditions was determined by 
the inclusion of a carbon-14 standard in each sot of samples* The 
carbon-14 overlap value, when subtracted from the total counts in the 
blue channel, produced the counts due to tritium in the blue channel*
The channel selection controls were set as follows:- 
Green C-D and Blue E-r *»
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This allowed a counting efficiency of 33%-35^ for tritium in the 
blue channel, and 42^45% for carbon-14 in the green channel*
Counts were accumulated in each channel to give an S.E.M* of less 
than one percent, whicn in most samples required counting for lOrnin*
The degree of quench in each sample was monitored by uso of the 
automatic external standard (A.E*S*) ratio* Tritium counting 
efficiency was calculated by the inclusion with each set of samples 
of vials containing ^H-toluene (Packard Instrument Co.) of known .
3
d.p.m* With this knowledge, H-Copom* could be converted to dop^m®
All calculations were performed on a desk computer (Programma 101;
British Olivetti, London, U.K.) by means of specially prepared 
programmes*
12o Analytical Methods
(a) Preparation of Protein, RNA and DNA Fractions 
The method used was adapted from that of Schmidt and 
Thannhauser (1945), recommended by Munro and Fleck (1966) in a 
detailed review as the most satisfactory method of nucleic acid 
purification prior to estimation* Ice-cold 10^ (w/v) trichloroacetic 
acid (5ml) was added to samples to be analysed* These usually 
consisted of homoganato (lml) or nuclear suspension (lml). The 
tost tuba (lDml) containing this solution was placed on ice for lOmin 
prior to centrifugation* Nucleic acids and proteins were procipitatao 
by centrifugation in an M*SoE. Mistral 4L centrifuge at 500 g (r^^ 17cm)
for lOmin at 0°C* The supernatant (the acid soluble fraction containing
low molecular weight components) was discarded and the precipitate washed
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with 5j^ (w/v) trichloroacetic acid (5ml)© The precipitate was then 
dehydrated with 95/ aqueous ethanol (3ml) and the lipids extracted 
by washing with ethanol s ether 3;l(v/v) (Zml)o This procedure 
also helped to remove trichloroacetic acid, which may interfere with 
subsequent DNA determinations, from the precipitate© The remaining 
precipitate was dried under a stream of air and digested overnight 
in a slowly shaking water bath (37°C) after addition of 0o3M KOH(lml)o 
A sample (0©2ml) was taken for analysis of protein, and to the 
remaining digest ice-cold 1*2M perchloric acid (0.5ml) was added, 
and the mixture allowed to stand on ice for lOmiru The supernatant 
(RNA fraction) was decanted and the precipitate washed with 0.2M 
perchloric acid (OoSml)© This wash was added to the RNA fraction 
which was then made up to 3ml with distilled water© The precipitate 
(DNA fraction) was made up to 4rnl with 0©5M perchloric acid and 
maintained at 70°C for 30min to solubilise DNA©
(b) Protein Determination
The method used for protein determination was that of 
Lowry et al© (1951). Reagents used were:-
2/(w/v) Oo1M NaOH;
1/(w/v) CuSO^  ^ solution;
2/(w/v) Na tartrate;
normal Folin Dslcalteau reagent;
working alkaline Cu reagent; (This was prepared immediately 
prior to use by adding 1/ CuSO^  ^solution (1ml) and 2% Na 
tartrate (1ml) to the 2% Na^CO^ solution (98ml), and 
standard bovine serum albumin (lOOpg/ml) in 0©03M KDH©
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This alkaline digest sample was diluted to 2ml with distilled 
water* Aliquots (lml) of this protein solution and aliquots (5ml) 
of the freshly prepared alkaline Cu reagent were placed in a test tubs 
(I0ml), mixed thoroughly and left for 10min» Folin Coicalteau 
reagent (C*5ml) was added and the solution mixed immediately and left 
to stand for exactly lOmin at room temperature* The optical density 
was determined in a Uvichem C*P* 600 spectrophotometer at 625nm* A 
standard curve in a linear range (lOjug - 100pg) of bovine serum albumin 
was prepared for every sot of determinations©
(c) RNA Determination*  *  lim<lcuaJcm>iÉiT'ilr'itrinia.'w^umCTOT»V %w^>fU3U.rc>'<sflt
The method used for RNA determination was a modification of 
the orcinol reaction used by Kerr and Seradiadarian (1945)* This 
method depends on the conversion, in the presence of hot acid, of 
pentose to furfural, a product which reacts with orcinol to yield a 
green colour* Reagents used were:-
20/(w/v) orcinol in 95/ aqueous ethanol; (This solution 
was prepared daily)*
0*03/(w/v) FeClg in concentrated HCl; and 
standard RNA solution (50;jg/ml) in 0*05M NaOH*
Aliquots of the RNA fraction ^1*5ml; prepared as described in 
12 (a)J, 0e03/(w/v) FeCl^ (1 *4ml) and 2.0/ orcinol (0*2ml) were pipetted 
into a test tubs (I0ml) and left in a vigorously boiling water bath 
for 3Dmin© The solution was then cooled under a stream of cold 
water and the optical density determined in a Uvichem S*P* 600 
.spectrophotometor at 565nm* A standard curve in the linear rangs 
10pg - 5ÜJJQ was prepared for every sot of determinations*
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(cl) DNA Determination
The method used for DNA determination was that of Burton 
(1956 and 1968), which depends on the reaction betwean deoxyriboss 
and diphenylaminoc Reagents used werex™
1o6%(w/v) aqueous acetaldehydej
diphenyiamine reagent; (This was prepared by dissolving 
diphenylamine (l«5g) in glacial CH^ COOH (lOOml), and 
adding concentrated (l^5ml) to this solution); and
standard DNA solution (lOO/jg/ml) in OoSfl HCIO^; (This 
was heated at 70^C for 15min before use*)
To each sample (lml) of the DNA fraction j^prspared as 
described in 12 (a)j an aliquot (2ml) of freshly prepared acotelclshyde % 
diphenylamine reagent [l*6% aqueous acetaldehyds (0*1ml) s diph.enylawine 
reagent (20ml)] was added* The solution was then mixed in a test 
tube (lOnil) and left in a water bath (30°C) for 18h@ The optical 
densities ware then determined in a Uvichem S*Pe 6C0 spsctrophottimeter 
at 665nme. A standard curve in the linear range 0/jg •=• 100/jg was 
prepared for every set of determinations®
(e) Preparation of Glassware for Zinc Determination 
Since glass has a high affinity for zincp all glassware used 
in zinc analysis was thoroughly washed to eliminate the risk of zinc 
contamination* Glassware was eoaked overnight in a solution of 
Decon 90 (Docon Laboratories Ltdoj Brighton, UoK®)* rinsed in distilled 
deionised water, and immersed in 5M HCl for 24ho It was then rinsed 
four times in distilled deionised water and dried in an overu During 
each experiment control samples wore analysed to monitor for zinc
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contamination©
(f) Zinc Determination 
. Zinc was determined by atomic absorption spectrophotometry on 
an absorption spectrophotometer (Model 403; Perkin-Elrner, Beaconsfield, 
UeKc) equipped with a "Boling" triple slot burner head which required 
acetylene as fuel and air as oxidant© The analysis was performed 
in a iion-»lumiriou9 flame at a wavelength of 213©8nm© The instrument 
was set to zero with a solution of 0©3M HCl and standardised against 
solutions of ?o69/jM (50)jg/1Ü0ml) and 'I3»36^M (lOO^g/lOOml) ZnCl^ in 
0c.3M HCle The standard zinc solutions were prepared by diluting a 
reference solution of certified atomic absorption standard (Fisher 
Scientific Co©, New Jersey, U*S©A«) containing 1©538 x 10 ^M(10 pg 
Zn/inOiT)l) ZnClg with 0«.3M HCl* The sample to be analysed wea- 
aspirated through a PTFE tube into the spectrophotometer flamo and 
the zinc concentration determined fay manual control on the 100 average 
scale© (The sample is counted 100 times and the calculated average 
appears on an electronic display)* Samples were read in the range 
where absorbance bore a linear relationship to concentration© This 
occurred up to 10*5pM (120jug/l00ml) for concentrations of zinc.
To eliminate rrosQ™contamination of zinc between samples, the 
PTFE tube was washed with 0©3M HCl after each sample aspiration©
The atomic absorption spectrophotometer was also restandardis&d after 
each batch of ten samples was determined to correct for minor electronin 
fluctuations©
Zinc determination on biological samples was performed after 
destruction of the organic material by dry oxidation© The samples,
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together with suitable reagent controls, wore placed in "Exelo" C-1G 
test tubes (1cm in diameter; 8cm in height) which were sealed with 
aluminium foil and placed in a stainless steel test tube rack© It 
was discovered that if samples which had been prepared in 0©25M sucrose* 
T*K«Mo solution were heated rapidly to a high temperature (470^8), 
spitting of sucrose solution occurred causing loss of sample© Thesw 
tubes were therefore placed in an oven at 110°C for 4h prior to the 
ashing piocoss®
Duplicate prostatic tissue samples (approximately SOmg wet 
weight) were also pra*»heatcd at 110°C for 4h so that the dry weight 
of the sample could be calculated© During this process the sample 
lost about 80^ of its original weight through evaporation© To 
monitor for contamination zinc was also determined in blank tubas • 
and the low value obtained subtracted from the zinc concentration 
measured in the tubes containing the prostatic sample» After pre­
heating, samples to be analysed were transferred tu a muffle furnace 
and heated at 475^0 overnight or until only a white ash remained©
The sample was then allowed to cool, 0©3M HCl, (3ml) added, the tube 
stoppered, and the solution shaken for 10s on a vortex mixer. The 
0*3M HCl solution containing the extracted zinc was aspirated into 
the atomic absorption spectrophotometer for zinc analysis© Samples 
were analysed initially on tho 18 average scale to determine whether 
the zinc concentration was greater than 1*94GpM (l2Dyjg/l00ml), in 
which case the sample was diluted with 0©3M HCl and determined finally 
on the 100 average scale©
13© Solubilisation of p-Chloromercuribenzoate
Since this thiol group blocking reagent is insoluble at neutral
pH, the method suggested by Gunsalus and Razzel (1957) was used to
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produce a soluble stock solution (10 M)' p-Chloromercuribenzoate 
(35o6mg) was dissolved in 0*2M KOH (2©0ml) and diluted to 80ml with 
incubation solution. The pH was adjusted to 7©0 with 1©OM HCl, the 
sample transferred to a volumetric flask, and diluted to 100ml with 
incubation solution#
14c Preparation of 5of. -Androstane-3a «17 B-diacetate
3 oc«endrostanediacetate was required for use in some experiments.
This steroid was unavailable commercially, and was produced chemically 
in the laboratory by acétylation of 3a -androstanediol, 3a -androstanediol 
(lOOmg), pyridine (0o5ml), and acetic anhydride (0o5ml) were placed in 
a test tube (I0ml) and left overnight to acetylate in darkness# After 
acétylation, the sample was extracted end purified on thin layers of 
alumina (2umg/taloC« plate) and detected as described in 9 (b)« The 
purified 3a -androstanediacetate fraction from five t.loC, plates was 
pooled and crystallised from an absolute alcohol/water (20:1; v/v) 
mixture* The supernatant was discarded and the crystals dried under 
vacuum. During this procedure 60% of the initial 3 a-androstanediol 
was recovered as 3 a-androstanediacetate in the final crystals#
15, Determination of Glucose-6-Phosphate Dehydrogenase Activity
GlüCüse-6-phosphate dehydrogenase catalyses the conversion of 
glucose-6-phosphate to 6-phosophogluconate, reducing the coenzyme NADP
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to NADPH in the process * The rate of production of NADPH thus
provides a measurement cf glucose-G-phosphato dehydrogonase activity.
The production rate of NADPH at room temperature was measured
by monitoring the increase in absorption at 360nm 5n a Uvichem SoP«
800 spectrophotometer© In the standard assay a sample (2ml) of a
«•3
solution containing 2 x 10 M NADP and G*01M gluco^e-G-phosphats was 
placed in a glass spectrophotometer cuvette (2,5ml; 1cm in diameter)© 
Glucoso-6-phoaphatB dehydrogenase (0*1 ml containing 0.1 unit, where 
unit is defined as the enzyme concentration which can convert 1;jmolo 
Qluco3G-5-phosphat0 to 6“phosphogluconcit8 per min in NADP at pH 7©4 
at 25^C) was added and the cuvette contents mixed and placed immediately 
in tho light path of the spectrophotometer® The rate of production 
of NADPH was equivalent to the rate of increase in optical density at 
36pnm, this value being automatically traced out on a chart recorder 
attached to the spectrophotometer©
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EXPERIMENTAL
***# *
1o Development of Analytical Methods
(a) Reliability and Practicability 
(j) Reliability
Without reliable analytical methods, results are of little 
value© Certain criteria of reliability are now generally accepted. 
These are specificity, accuracy, precision and sensitivity, (BcSth, 1952; 
Anastassidis and Common, 196B and Lorraine and Bell, 1966)* These 
criteria may be defined as followss-
Specificity is the ability to determine a chemical compoundfe'atliW'3'*«SaiVKn^NreT*c?imKSiKW'e«nBt 'f *
to the exclusion of all others.
Accuracy provides a reference point against which anâlvtical 
results can be reliably assessed® In a situation in which the true 
value cannot be determined, it represents the degree to which a given 
result approximates to tho most probable or "true" value, for example, 
accuracy may be assessed by a comparison of determinations made on the 
material under assay both before and after the addition of known amounts 
of the substance under investigation©
Precision is the concurrence of a series of measurements of 
the same quantity, and is expressed as the standard deviation of a 
series of replicate determinations, orecision may also be determined 
by using the standard deviation calculated from the difference between
duplicate results through a series of assays (Snedacor, 1952), That is
22 d
estimate of variance “ (standard deviation) = where d is the 
difference between two results in a duplicate determination and N
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(which should be greater than 20) is the number of duplicate 
determinations» This method is useful because it takes into 
account the precision obtained in a number of samples at different 
levels of measurement over a period of time*
Sensitivity is the smallest value which can be accurately 
determined. Its numerical value is often taken to be that of the 
smallest result where the fiducial level (at the 95% confidence level) 
does not involve zero* The sensitivity of a given method is also 
approximately equal to twice the standard deviation of replicate 
determinations provided that the standard deviation is based on at 
least twenty such determinations *
(ii) Practicability
In any biochemical study the practicability of the methods 
used is of utmost importance* Such factors as speed, cost, skill, 
availability of equipment and, in this case, of tissue, must be borne 
in mind* Ultimately reliability will be related to practicability*
For example, in the present study the activity of testosterone 
5 a-reductase is determined after chromatographic separation of 
radioactive substrate and product* By identification of purified 
radioactive steroids which co-crystallised with cold steroids (20mg) 
known to have similar values, the method was found to be satisfactory© 
However, to show that the assay was 100% specific, recrystalli^ation 
would have to be carried out for individual incubations in all experiments* 
This is not practical, in a study of this type, and it must bs assumed 
that since the conditions used were identical to those in the 
recrystallisation studies undertaken, the compounds were pure after
uchromatographic separation in all samples©
(b) Evaluation of DNA, RNA and Protein Determinations
DNA, RNA and protein were determined by well-established
spectrophotometric methods which depend on the production of coloured 
compounds by specific chemical reactions* These were assumed to be 
specific for the compounds under measurement © Ail methods gave a 
reproducible linear standard curve in the stated range, precision being 
determined in the following manners™
A 10%(w/v) rat prostatic homogenate was prepared in D©25M 
sucrose-T.KoMe solution* DNA, RNA and protein were determined on
OoBml and 1©0ml volumes© The remainder of the homogenate was stored
at —20°C for one week and the determinations repeated© Results are 
shown in Table 4* To ensure that the precision of analyses did not 
decrease as the limit of sensitivity was approached, no sample containing 
5)jg or less of DNA, RNA or protein were judged to give results sufficiently 
accurate for use in calculations*
(c) Evaluation of Zinc Determination
Zinc was determined by atomic absorption spectrophotometry, 
an extremely sensitive quantitative technique for the determination of 
elements* Analytical samples .are heated to a high temperature* usually 
by burning in a flame which breaks up the chemical bonds between the 
molecules; enabling individual atoms to float freely in the sample 
area. In this condition the atoms can absorb ultra-violet or visible 
radiation of a specific wavelength* This phenomenon is quantitative, 
the degree of absorption being proportional to the mass of the element 
absorbing at that wavelength©
64,
TABLE 4
Evaluation of DNA, RNA and Protein Determinations
Sample DNA # RNA * Protein *
jjJaek 1
0©5ml 1.72 i 3,1% (10) 2.50 - 7.4% (10) 92,03 1 4,3% (7)
1.0ml 1.83 t 3.8% (10) 2,72 ™ 3.5% (9) 05.75 - 3.1% (10)
Week 2
OoSml 1.00 - 3.2% (10) 2.64 - 3.2% (10) 08.03 1 2,0% (10).
1 «0ml 1,86 1 2.0% (9) 2,70 - 3.7% (10) 89.53 - 4.2% (8)
mean amount per sample (mg per g wet weight tissue)
+
» coefficient of variation 
( ) number of determinations
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A linear standard curve for zinc at a wavelength of 213c8nm 
was found in the range 0-18«46^M (0-120^g/l00mi) (Figure 5 )© Since 
this curve was reproducible, the spectrophotometer was sot against 
two standard zinc solutions^ 7«69pM (50j.jg/lOOrnl) 15©30 j^M 
(100)jg/lD0ml) during the standard assay© By means of a computer 
unit connected to the spectrophotometer, (Model 403; Perkin-Elmer) 
the zinc concentration of an unknown sample could he electronically 
calculated by comparison with these standards®
The complex organic matter in a biological sample may interfere 
with trace metal analysis during atomic absorption spectrophotometry©
Some procedure* such as wet or dry oxidation, must be developed to 
eliminate or reduce this interference (Gorsuch, 1970)© During wet 
oxidationj the sample is heated, usually to 100^-2D0°C, with a mixture 
of oxidising agents such as sulphuric acid* nitric acid, perchloric 
acid or hydrogen peroxide; whereas in dry oxidation, which requires 
rather higher temperatures* the organic material is oxidised by gaseous 
oxygen, usually by heating in air®
The atomic absorption method may be further complicated by a 
number of possible sources of error. A high concentration of inorganic 
ions, for example, are known to depress absorption (Dean and Rains, 1969)© 
The extent of this phenomenon, termed matrix interference, was evaluated 
in tho following manner;-
A standard curve for zinc was determined in both 0«3M HCl and in 
OoDSM Tris buffer containing 0.15M NaCl, 5 x MgCl^ and 0*025M KCj*
The concentration of components in the latter solution was similar to 
or in excess of what might ba expected in the unknown biological samples*
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Results obtained (Figure 5 ) indicate that matrix interference did 
not occur at these concentrations of salts and that absorbs nee boro 
a linear relationship to zinc concentration up to a concentration of 
18o5pM Zn (I20^g/I00ml)*
In the determination of zinc, sources of error include 
contamination of the sample by extraneous zinc, loss of zinc by 
volatilisation during the ashing process, and incomplete extraction 
of zinc from the tubes after ashing© In order to establish a satisfactory 
method for zinc analysis it was necessary to take these factors into 
consideration©
The measurement of zinc in prostatic samples was first attempted 
by a wet oxidation method® The sample was placed in a 5rnl pyrex 
volumetric flask to which was added concentrated HNO^ (lml) and. 
concentrated HClO^(lml)* The flask was transferred to a sand bath 
on a hot plate in a fume cupboard and maintained at 110°C for 3-4h©
After cooling the sample was diluted to 5ml with distilled water and 
zinc measured by atomic absorption spectrophotometry. It was found 
that this method led to incomplete oxidation of prostatic tissue and 
unacceptably high levels of zinc contamination© In subsequent 
experiments, therefore, use was made of dry oxidation techniques®
The first method attempted involved ignition of samples in 
"Uitreosil" silica crucibles (lOml) (Gallenkamp/t, London, U,l<«) by 
heating overnight at 475^C© The sample was then extracted by addition 
of 0©3M HCl and the final extract made up to a known volume in 0.3M HCl 
and analysed for zinc by atomic absorption© This method proved to 
bo unsatisfactory dus to incomplete extraction of zinc from the crucibles,
FIGURE 5.
Standard Gurva for Zinc Determination
A standard curve for zinc was determined in a solution 
of either G«3fl HCl or 0.05M Tris buffer containing 
0.15M NaCl, 5 x 10~^M MgCïg and 0*025M KCl.
O  in 0.314 HCl
^  in 0.05M Tris buffer containing 
0.15M NaCl, 5 x 10”^M MgCl^ and 
0,02514 KCl.
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leading to low recoveries and decreased preclslono For example* 
in an experiment in which zinc (23.1g) was added to each of 9 crucibles* 
the recovered zinc was 1@68^ g "■ 9^5%o
The method finally adopted involved dry oxidation of samples 
in borosilicate glass tubes and is described in detail in the methods 
Section 0* 12 (e)* It was evaluated in tho following manner;-
(a) To monitor contaminatiof'^ 10 blahk tubes were ashed and 
any zinc present extracted with Oo3M HCl and zinc assayed by atomic 
absorption spectrophotometry®
(b) To assess accuracy* ZnCl^ (Ppocpure) was dissolved jn 
distilled doionised water at a concentration of 1pg/10Dml (Zn Solution A)« 
Samples (Odml) were pipetted into 10 tubes and assayed for zinc*
Control samples (Odml) of distilled deionised water were pipetted
into 5 blank tubes and assayed in the same manner^ The results shown 
in Table 5 were corrected for these controls®
(c) Determinations on 10 x lml aliquots of n®25M sucrose^T.K.M* 
solution were carried out to monitor zinc contamination®
■(d) To establish whether 0®25M sucroae^ToK.M, solution interfered 
with the accuracy of the zinc determination* aliquots (lml) of this 
solution and aliquots (Odml containing 1pgZn) of 7n Solution A were 
added to each of 10 tubes® Zinc analysis was then carried out and 
results were corrected in the light of the results from the control 
experiment (c) above.
(e) To assess precision* one 20^®(w/v) human prostatic homogenate 
was prepared in 0.25M sucrose-T.K®n® solution and diluted 1 in 6 with 
this same solution. To ensure the concentration of zinc fell below
6-9<
TABLE 5o
Validation of Method foi o,3tormininq Zincvn>T.y*gfin<Mn7j»fleyw»3arjtx«a.^%ags»rsj!i»eAi-M<«»*ai*
Sample Amount of Zinc Found %'
a) Blank tubes 0*024 "  7%
b ) 1;jg ZnClg 1*020 1 4*3%
c) 1 ml 0.25M suci'ose-TeKeMo 
solution
0*055 t 1^0%
d ) 1|.ig ZnCl^ in ') ml
sucrose-ToK.Mo solution 0*983 t  3,1^
g ) Week 1
1ml pro^tatlc homogenate 1.844 -  6*3%
OoSml prostatic homogenate 0*898 t  6*0%
Weak 2mnsrtnrwrftaur.farm^t
1 ml prostatic homogenate 1*721 t 5%
0,5ml prostatic homogenate 0*840 1 3*9%
f ) 1^ jg 2nCl^ in 0*5ml 
prostatic homogenate
w I.................................... r~nn ni---------- ~ ilml i nrr^U ri»* ■ in i
1*010 i 3.4%
mean amount per sample (jjg)
•Î-- coefficient of variation.
Each sample was analysed ten times*
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I00pg/l00mlp zinc was determined in samples (10 x 1ml and 10 x 0o5ml) 
of this homogenate solution* Control samples (5 x 1ml and 5 x 0*5ml) 
of 0.25M sucrose^ToKoMa solution were’also determined? and the results 
presented have been corrected for these controls® The homogenate 
solution WPS then stored for one week at ‘-20*^C and the experiment 
repeated.
(f) To establish whether prostatic homogenato interfered with 
tho accuracy of the zinc determination? samples (lml) of this homogenato 
plus samples (0*1ml containing 13.1g Zn) of Zn Solution A wero pipetted 
into each nf 10 tubes which wore assayed for zinc. Results (Table 5 ) 
were corrected for prostatic homogenate zinc concentration and indicate 
that (a) tho precision and accuracy of the method was acceptable at 
the required level of sensitivity; (b) zinc contamination was . 
negligible; (c) the sucrose-T.KoMo solution did not "mask" or 
interfere with the determination; and (d) volatilisation of zinc 
did not occur to any appreciable extent® Since zinc chloride is the 
most volatile zinc salt? with a molting point of 210°C and a vapour 
pressure of 1mm Hg at 428°C (Gorsuch? 1970)? this lack of volatilisation 
suggests that either zinc chloride was converted to a less volatile 
compound? such as zinc oxide? or that volatilisation was prevented by 
the degree of pressure maintained within, the muffle furnace during 
ashing.
(d) Radiochemical Assay for tho Determination of 5 a-reductstso
The low physiological substrate concentrations at which steroid 
metabolising enzymes operate may give rise to experimental difficulties
71'
The availability? within the last decada? of labelled steroid 
substrates of high specific activity has made It possible to assess 
the activity of these enzymes* Hovjover? when radioactive steroid 
metabolites are identified consideration must be gi^an to tho largo 
number and low concentration of closely related compounds which may 
be present (Brooks et al®? 1970). In order to use radiochemical
*  ^ —HkhmfArn I I il ILl * *
determination to assess the activity of testosterone' 5cx -reductase
it was felt important to show that the radioactivity of tho label was
due to a single chemical entity* Since the primary interest of
this study was the activity of the Sex ^ reductase and not tho
3
identification of all H-tastostorono metabolites? only two of thosQ?
3 3H^dihydrot&stostorone and H™3a ^androstanediol were considered®
In order to determine whether any other major pathway of testosterone
3
metabolism was involved the amount of H-testosterone disappearing was
3 3compared with the amount of H-dihydrotestosterone plus H™3 a^androstanediol
formed® .
Two methods were used to purify steroids present in incubation 
extracts* Method A involved two chromatographic separation stops of 
^H-testosterone and H^dihydrotestosterone? one on paper and the other 
on silica and was used initially* When it became necessary to monitor 
for other suspected products? method B? which involved separation of 
acetylated derivatives, was developed and used in all subsequent 
experiments. Hence this method was subjected to the more rigorous 
evaluation,
(i) Radioactive Counting Efficiency
It is important in the counting of radiochemical samples
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to determine whether the efficiency of counting remains constant®
Variation in counting efficiency between samples may hn caused by 
either chemical or colour quenching and leads to artifactual results*.
The automatic external standard (A.E.S®) ratio as determined on the 
Packard Tri-farb liquid scintillation spectrometer (Model 3380) is 
a measure of the degree of quench * Where no quenching occurs, 
the A.E.So ratio is 1*0000; with infinite quenching the A.E.S: 
ratio is DcOOOOo
In all samples counted the A.E.S* ratio ranged from 0*8100 to 
0*9100* Using a quench curve, on which the degree of quench is 
plotted against the efficiency of radioactive counting of a range of 
varying quenched standards, those A*E*S. values corresponded to a 
counting efficiency in the range 33% 35% for tritium and 42% 45%
for carbon-14e Within a given experiment the range of the A,E*S* 
ratio was considerably smaller* For example, in an experiment in 
which n == 34, the coefficient of variation for the A,E.3* ratio was 
1*14%. In all samples counted, therefore, quenching was minimal, 
with little variation between samples*
(ii) Specificity
* ' KW&ve*. MPIwrxiriXtw
Definitive evidence for the purity of radioactive steroid
metabolites was provided by recrystallisation studies on purified
3steroids from incubation extracts* Purity of H-tustosterone,
3'
H-dihydrotestosterone and their acetates was monitored in relation 
to steroids of known purity, while that of ^H-3cx «androstanediacetato 
was monitored in relation to cold 3a -androstanediacotate* This 
latter steroid was unavailable commercially in tho carbon™14 labelled form,
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To evaluate the specificity of method A, recrystallisation
studies were performed follows?™
Metabolites formed after incubations of H-testosterone
with rat prostatic nuclei were purified by paper arJ thin layer
chromatographya ^^C^Testosterune,  ^^ C-dihydrotastosteronfâ,
testosterone (20mg) and dihydrote.stostorone (20mg) were added to
fractions designated testosterone and dihydrotestosterone respectively
according to their chromatographic mobilities * The solvent systems
used for recrystallisation are presented? with results? in Table 6®
To evaluate the specificity of method B, metabolites formed 
3after incubations of H-testosterone with rat prostatic hornogenates
were purified by derivative formation and tol.c* on alumina®
14 14[^Testosterone acetate, C-dihydrotestosterone acetate? testosterone
acetate (20rng), dihydrotestosterone acetate (20mg) and 3 a-androstanediacetate 
(20rng) were added to fractions designated testosterone acetate? 
dihydrotestosterone acetate and 3 amandrostanediacetate respectively 
according to their chromatographic mobilities® The solvent systems
used for recrystallisations are presented? with results, in Table 7*
Axelrod et al* (1956) have carried out a mathematical analysis 
of the errors involved in recrystallisation studies. They calculate 
that three successive crystallisations which yield values for specific 
activity fequivalent to isotopic ratio) within ™ 5% of the average of 
these three values is definitive proof of purity. Applying this 
reasoning to the results in Tables 6 and 7p\ it can be seen that the 
steroids are essentially pure after chromatographic separation by both 
methods A and B.
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TABLE 6*
Recrystallisation Study — Method A®
    ij» h i#jwnaMawi
14M/ [^Testosterone
Before
crystallisation
1. Acetone/hexane 
5:1(v/v)
2c Acetone/hexane 
5:1(v/v)
3. Acetone/hexane 
5:1(v/v)
Mother
Crystals Liquor
3*98
4*02
3*90
3*99
3*99
4*01
4*00
T ' 14
'“d/ C^Dihydrostestosterone
Mother
Crystals Liquor
1*07
1*04
1*06
1*07
loOa
1*00
1*08
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TABLE 7,
Recrystallisatxon Study ™ Mathod Bo
Testosterone
Acetate
Dihydrotestosterone
Acetate
Androstanediacetate
Mother 
Crystals Liquor
Mother 
rystalu Liquor Crysta
Before
crystallisation 2325
1e Ethanol/ 
water 
20:1 (v/v) 7.39 7.83 0.90 1.01 2212 2326
2# Methanol/ 
water 
20:1(v/v) 7.43 7.75 0.92 2544
3» Acetone/ 
water 
20:1(v/v) 7.74 7.67 2318 2426
7.50 7.43 0.90 2232Hexane 2522
# S.A. Specific Activity (cp.m/mg)
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(iii) Precision
The overall precision of tha assay system was determined
by usa of tha Snedacor equation for tha calculation of standard
deviation (SD). Purification of metabolites after H—testosterons
incubation with rat prostatic hornogenates by method A resulted in a
SD of 6o09 (n =: 22) tor H-tastosterone and 8.1 (n ss 23) for 
3H-Jiiiydrotestosterone. Purification of metabolites after
3H'^testosterone incubation with human prostatic homogenate by method
B resulted in a SD of 6.96 (n e- 29) for H-^-testostsrone and 6.51 
2
(n 25) for H-’dihydrotestoateroneo In experiments with human
prostatic hornogenates there was only very small conversion to
3 a—androstanediol. In incubations of human prostatic cytosol 
2
with H'-dihydrofcestosteronoj, however? 3 a-androstanodiol was formed 
and upon purification a SD of 7.01 (n ~ 22) was obtained, 
fiv) Accuracy
* * UuvrrMih. vfemg ja « mfa-tsla
(a) Method A
The accuracy of analysis of radioactive steroid metabolites
3
by method A was determined by addition of H^testostorone and 
3
Hmdihydrotestosterone to incubation solutions (lml) at the 
concentration expected at the end of a rat prostatic nuclear incubation. 
The samples were purified and analysed.by method A and the results are 
shown in Table B.
(b) Method B
Tho accuracy of analysis of radioactive steroid metabolites 
by method B was more rigorously determined. Human prostatic hornogenates 
wore diluted with incubation solution to s concentration of 100|jg protein
77*
TABLE 8.
Evaluation of Accuracy - Method A
Sample 
Theoretical
3
H Calculated 
After Method A
Testosterone#
65418
62625
63511
Dihydrotestosterone#
11809
11774
11591
# Values expressed as c.p.m®
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TABLE 9o
Evaluation of Accuracy - Method B
ng Steroid 2ng H Steroid After Analysis by Method B
Added to 
Incubation Tube
Testosterone
—  “ "
DihydrotestosLernne 3 oc^Androstanediol
2*000 1*972 2*174 2*105
2*014 1,934 1*940
1*000 0*975 1*070 0*936
0*964 1*050 1*034
0*500 0.483 0,489 0*524
0,479 0,488 0,507
0*250 0.247 0,250 0*255
0,230 0*241 0*249
0*100 0*099 0.095 0,112
0*094 0,088 0,102
0*050 0,052 0*049 0*053
0,045 0*046 0*068
0*010 0*010 0*010 0,018
0*009 •«=5=8^  Q . oo<\.
0*023
0*000 0.000 0*000 0*000
0*000 0*000 0,000
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in a total volume of 1ml? and placed in incubation tubes in crushed
3
ice. These tubes already contained known amounts of H-’testosterone?
3 3 ■H-dihydrotestosterone and H™3 a^androstanediol in a range similar to
that which might be expected after incubation with ‘H^testosterono,
The samples were purified and analysed by method E5 and the results are
shown in Table 9*
The accuracy of tne gol.c, determination? which was used
in metnod 0 to determine recoveries of 3 «^androstanediol? was assessed
by analysis of known concentrations of 3 cx^androstanediacatate*
Results for a range of 3a -androstanediacetate concentrations similar
to those which might be expected in assessment of procedural losses
of 3 cc-androstanediol in method B are shown in Figure 6* These
indicate that 3 a-'androstanediacetate concentrations measured were
similar to the theoretical concentrations.
It may be assumed? therefore, that both methods A and B
were adequately accurate for the analysis of steroid metabolites
present in incubation extracts*
2o Addition of Cofactors to Incubations
Human hyperplrstic prostatic testosterone 5 'X-reductase, 
like similar enzymes present in many other androgen dependent 
tissues (King and Mainwaring, 1974) has a cofactor requirement for 
NADPH.(Farnsworth and Brown, 1963)* Since the ability to produce 
sufficient NADPH is diminished during cell-free incubations, it is 
imperative, in a study in which the only limiting factor should be 
enzyme activity, that NADPH should be artificially maintained at
FIGURE 6.
Accuracy of Oo.l >c« Determination for 
5 a *-AndrostanQ“3a_p 17 B -Oiacetato
The accuracy of the g.l*o. determination? which 
was used in method B to determine recoveries of 
3 pc-**androstanediol? was assessed by analysis of 
known concentrations of 3 fx «-androstanediacetate*
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saturation levolo This may be done by adding to the 5 a-reductase 
incubation WADPj, glucose-6-phüsphate dehydrogenase or some other 
enzyme known to reduce NADP to NADPH, and a suitable substrate©
This system has the advantage of reproducing in vitro the probable» *-# I w  c »i‘n .iifcin r*aa  *
situation in vivo where oxidised NAOPH may be continually reduced©
A generating system based on glucose-ô-phosphate dehydrogenase 
has been used both in the study of rat proatatic 5 a —reductase 
(Bruchovsky and Wilson, 1968) and the Ba-reductasa of human 
prostatic nuclei (Grant 1971)© Attempts to utilise such
a system in the present study raised the possibility that factors 
modifying the 5 a^reductasa activity may do so as an effect secondary 
to the primary effect on the glucose-G-phosphate dehydrogenase 
activity© Since divalent cations are known to modify the activities 
of many enzymes, it was important to determine whether the divalent 
cations with which part of this study is concerned modified the 
production of NAOPH within this generating system©
Results for zinc inhibition, shown in a double reciprocal 
plot in Figure 7 indicate that zinc, at a low concentration, 
inhibits glucose^G-phosphate dehydrogenase in a non™competitive 
manner with respect to NADPH concentration* (A full outline of 
the double reciprocal method used to analyse the type of inhibition 
exerted by an enzyme inhibitor is given in Section 4, d©) Further 
studies indicated that a range of divalent cations inhibit the enzyma 
activity in the following order of effectiveness;™
Hg^^ = Cd^’^ >  Mn^^
To avoid modification of the 5 a^reductase activity by secondary
FIGURE 7o
Double-Raciprocal Plot of Inhibition of
  — — r I ■PIIIMUIII I I I II r 11 ■■ ■ I M I I I II !■ I III I I I IITI ~|T I r~1 I 1 M ll|l I n ■■■■!■
GlucosQ™6-Phogphat0 Dehydroaenase by Zinc
Low concentrations of zinc wero added to incubations 
of glucos0-6™phoaphat0 and NADPH with q1ucoqs-6«" 
phosphate dohydrogenaso (G~6-»PeDH)© G*^ 6«P.DH
activity was monitored by measurement of the rate of 
NADPH formation®
#  Control ZnClg
□  Control ZnClg
A  Control ZnCl^
O Control
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effects on glucose^G^phosphato dehydrogenasej the generating system 
was omitted from incubations* In its place NADPH was added at 
saturation level ( 2 x 1 0  Vi) and any possible enzymatic degradation 
prevented by addition of nicotinamide (0*04M) ( Handler and Klein, 
1942),
3. Chemical Composition nf Nuclear Fraction
The cytological homogeneity, subsequently loosely referred to 
as the purity of the nuclear fraction isolated from human hyperplastic 
prostatic tissue, was determined by comparison of its chemical 
composition with the same fraction isolated from rat prostatic 
tissue® A comparison (Table 10) was also made with published 
values obtained from guinea pig liver nuclear fraction (Maggio G^^a]L$, 
1963),
An explanation is required for the extremely low DNA content 
of human prostatic samples when this is expressed as mg/g wet weight 
equivalent of filtered homogenate. In the preparation of homogenatc 
fractions from human prostatic tissue a large amount of material was 
held back; probably due to the presence of a high proportion of 
homogenisation résistent stromal and connective tissue. Therefore, 
although for guinea pig liver and rat prostatic tissue fractions the 
DNA content expressed as mg/g wet weight equivalent of filtered 
homogenate uus approximately the same as mg DNA/g wet weight of 
tissue (after correction for nuclear recovery) this was not the 
case for human tissue.
The purity of the nuclear fraction isolated from rat prostatic 
tissue compared very favourably with that from guinea pig liver
84.
TABLE 10.
**aSUHtiCi.»Wrl.ïT<BlHaot3}XS»
Chemical Composition of Nuclear Fraction
No, of Experiments
^ Recovery ^
DNA mg/g 
% DNA*"
RNA mg/g 
% RNA*
Protein mg/g 
% Protein*^
dna/rna
Rat
Prostate
44
0.539
37.9
0.102
7o2
0.78
55
5.27
Human
Prostate
14.3
0.092
7.7
0.033
2.76
1.069
89.5
2.8
f
Guinea Pig 
Liver
25
0.468
22.3
0.100
4*7
1.22
73*6
4.7
^ - Maqgio et al. (1963)
■î’ % Recovery ^ of homogenate DNA recovered in nuclear fraction
mg/g = mg/g wet weight equivalent of filtered homogenate - 
. see text
where DNA -J- RNA 4 Protein = 100%
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tissue in that it contained loss protein and a higher DNA/RNA 
ratio. The DNA/RNA ratio is a useful index of nuclear purity 
since, within limits, the proportion of RNA in the nuclear fraction 
will correspond to cytoplasmic contamination, the hulk of the 
cellular RNA being present in the cytoplasm.
Nuclear fraction isolated from hu..ian hyperplastic prostatic 
tissue had a lower y^eld, less DNA-, and considerably more protein 
than rat prostatic nuclear fraction. The DNA/RNA ratio was 
lower, indicating that cytoplasmic contamination was greater. 
Examination under the light microscope indicated that the nuclear 
fraction prepared from rat prostatic tissue contained nuclei with 
little cytoplasmic contamination and few cytoplasmic attachments©
The corresponding fraction prepared from human tissue contained, 
clumps of non-nuclear material and occasional cytoplasmic attachments© 
In initial experiments this non-nuclear material predominated5 
filtration of the homogenate prior to subcollular fractionation 
improved the situation. Attempts to isolate a. purer nuclear 
fraction from human hyperplastic prostatic tissue by centrifugation 
through 2*3M and 2.2(1 sucrose resulted in even lower recoveries.
The results obtained highlight the problems involved in the 
isolation of nuclei from human hyperplastic prostatic tissue,
4o Testosterone Reduction by Human Prostate
(a) Effect of Freezing on 5 a-Reductase Activity
The irregular supply of human prostate glands, particularly 
during summer months, made the planning of experiments extremely
86,
difficult. To overcome this practical problem, a method was 
developed to store tissue without altering 5 «'^'reductaSQ activity.
Freezing of biological samples has become a viable 
proposition in many branches of biochemistry, I^s successful 
USB in the storage of mammalian sperm was first outlined by 
Polge et al, (1949) and has greatly aided the technique of 
artificial insemination. Many authors have suggested that cgcnta 
such as dimethylsulphoxide and glycerol greatly reduce tissue 
damage during freezing (Moryman, 1956), Lasnitzki (1955), 
however, has shown that Ehrlich ascites tumour cell suspensions 
will survive unprotected freezing at -79°C sufficiently well to 
produce takss in transplantation. Freezing injury in rapidly 
cooled cells may be decreased by quick thawing (Mazur et al*» 1970),
In the development of a method for storage of human 
prostatic tissue, factors such as those outlined above ware taken 
into consideration* - Two freezing methods were investigated.
Method A involved freezing small squares (0.5cm x 0.5cm) of fresh 
prostatic tissue by placing them in a glass tube and immersing in 
a mixture of solid CO^/acetone, Subsequent storage was carried 
out at «*20 Co In method B tissue squares were immersed directly 
into liquid nitrogen (-496°C) and stored at -70°C* Method 8 is 
described in full in the methods section 5 (c).
Experiments wore performed to evaluate the effect of 
freezing, storing and thawing on Sa -reductase activity. Fresh 
prostatic tissue was cut into small squares(0.5cm x 0.5cm) which 
were thoroughly mixed prior to freezing and storage by msthods A and B,
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In both methods samples (lg) were thawed and homogenised prior to 
and at different periods after freezing* The tissue was homogenised
in 0,25M sucrose-ToK.Mo solution (10ml)* Reductase activity was
determined in these homogenates and the results are shown in 
Table 11«
Method A resulted in a 55% loss of 5 a-reductase 
activity during freezing and a subsequent 50% reduction after 
storage at -20°C for 16 days© Method B resulted in no loss of 
5 «^reductase activity during freezing but an approximate reduction 
of 30% occurred after the first few days of storage at 
followed by a much more gradual decline until day 30, after which 
the activity remained constant. Method B was, therefore, used in
subsequent experiments.
It is possible that slight improvements in Method D 
could have resulted from the use cf protective agents such as 
dimethylsulphoxidor. Such a procedure, however, introduces new 
parameters which might modify 5 oc-reductase activity, and it was 
therefore felt that the complications involved would outweigh the 
improvements gained*
(b) Subccllular Distribution of 5 « -Roductaso Activity
Human prostatic tissue was minced and homogenised, and 
subcellular fractions isolated© Protein and Sa-reductase activity
wore determined, in duplicate, on the homogenate, nuclear, mitochondrial 
and cytosol fractions. To provide an indication of nuclear 
recovery DNA was also analysed, in duplicate, on both the nuclear 
and homogenate fractionsc On the assumption that all the cellular
88,
TABLE 11.
Effect of Freezing on the Sa^Reductase Activity 
of Human Prostatic Homoqenatea
Treatment
Before Freezing 
After Freezing 
After 2 days 
After 4 days 
After 8 days 
After 16 days 
After 32 days 
After 64 days
Method A
S.A % *
5.42 100
2.45 45.2
1.43 26*4
Method B 
S.Ac % %'
15.43 100
15.59 101
10*79 70
11.64 75
11.48 75
10.27 67
9.28 60
9.23 60
S.A* ss Specific Activity e= pmol/h per mg protein.
% K5 Percentage of 5 a-roductaoo activity in
samples before freezing.
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DNA is located in the nucleus, the percentage of homogenate DNA in 
the nuclear fraction should be approximately equivalent to the 
nuclear recovery© Mitochondrial DNA, which represents a vary 
small proportion of cellular DNA, was ignored in this calculation* 
(Goodenough end Levina, 1970)®
The standard 5a -reductase assay was performed with the 
addition of dithiothreitol (5 x 1D™^M) and EDTA (5 x 10 ‘^M>* inese 
reagents were present to counteract any divalent cation inhibition 
so that the maximum 5a ^ reductase activity should be measured®
The experiment was carried out three times, once with fresh and 
twice with frozen tissue* Results are shown in Table 12 and 
Figure 8*
h
In order to reduce the errors introduced: by defective
recoveries of cellular constituents, the results represented in
Table 12 were rocalculated on the basis of a 100% overall recovery®
In Figure 8 the relative specific activity (percentage of homogenate
activity in a specific fraction/percentage of homogenate protein in
that fraction) is plotted against the percentage protein in the
fraction® The area of each block is proportional to the percentage
of the total activity recovered in the corresponding fraction, and
its height proportional to the degree of purification achieved over
the homogenate® This method of representation was first suggested
by deDuve (1955)*
Further purification of the nuclear and microsomal
fractions (those containing the hulk of the 5a-reductase activity)
wore carried out in the following manner® The 600 g (r 17cm)
—' av o
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TABLE 12,
Subcellular Distribution of 5 a^Reductase Activity
Fraction 5 ^ -Reductase Protein
Relative
Specific
Activity*
Total Activity in 
Filtered Homogenate 1502 pmol/h 165 mg
600 g Pollet 
Suspension^ (Nuclear) 47*7 31.7 1©5
9,000 g Pellet
Suspension
(Mitochondrial) 13*4 4©3 2c7
105,000 g Pellet 
Suspensioin (Microsomal) 26o2 10.8 2,3
105,000 g Supernatant 
(Cytosol*)’ 1o9 45 0,05
Total % Recovery in 
Subcellular Fractions 69*2 91.0
1
Results expressed as % of homogenate activity unless otherwise stated* 
Results erg the average of three experiments®
■3^  ^— corrected for DNA recovery (on average 70% of homogenate DNA was 
recovered in the 600 _g pellet).
t “ relative specific activity - % of the homogenate activity in a 
specific fraction/% of homogenate protein in that fraction*
FIGURE 8.
Subcellular Distribution of 5 ps-Reductase
«miimi ^ttg^'ig^rT<nr***v<iC»T»w'i*irii.>gBt.iCT—.crwBC3sPwa>*3tK.i* iwrnmmir ■ n»asact.*»a*SEacgg
Results presented are recalculated from Table 12 
on the basis of a 100% overall recovery©
Relative Specific Activity:^ percentage of 
homogenate activity in a specific fraction/ 
percentage of homogenate protein in that fraction»
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TABLE 13,
Activity nf the 5or -Reductase in 
Nuclear and Microscma.u Fractions after Further Purification
Nuclear Fraction
g-argWOi^AiyUlJtMiCMm^U'afcl il»l T»‘H»
600 9 
Pellet Suspension
Specific % DNA 
Activity Recovery
96
poll et
Specific
Activity
,000 9 
Suspension
% DNA 
Recovery
Puiification 
Factor
14*4 70 27 15 1*87
13.02 65 16.26 13 1.24
Microsomal^Fraction
105,000 9 
Pellet Suspension
105,000 g Wash 
Pellet Suspension
Purification
Factor
13*2 22*6 1*72
22*0 26,0 1*18
— % DNA recovery ~ % of homogenate DNA present in nuclear
fraction*
« Specific Activity = pmol/h par mg protein*
- Purification Factor ~ Specific Activity in fraction after 
further purification/specific activity prior to further purification*
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nuclear pellet suspension was centrifuged through a layer of 2oOM
sucrose-ToK®f'l« solution at 96gOCJO g (r^^ 3«692cm) for 2h® The
microsomal pellet was resuspended in 0«25M sucros8-T«K»Mo solution
and re-cenfrifuged at 105,000 g (r 2c55cm) for 30rnin* Results
 ^ ' avo
are shown in Table 13* The purification factor, shown in this 
table, is defined as the figure obtained by dividing the spocific 
enzyme activity in a fraction affer further purification by the 
specific enzyme activity prior to further purification* This 
factor allows comparison of results frorti different experiments* 
Further purification of both the nuclear and microsomal fractions 
resulted in an increase in the specific enzyme activity©
In subsequent experiments further purification of the 
nuclear and microsomal fractions was performed prior to analysis 
of 5 a-reductase activity*
(c) Cofactor Requirement for Reduction
A study was performed to assess the cofactor requirement 
of human prostatic 5 ^ ^reductase under the present experimental 
conditions. The standard 5 a-reductase assay was used with the 
addition of dithiothreitol (5 x 10"^M) and EDTA (5 x lO^^M), The 
effects of increasing the concentration .of NADPH and NADH on 
testosterone reduction by nuclear and microsomal fractions are 
illustrated in Figure Q and results for the homogenate fraction 
are illustrated in Figure 10. In all three cases reduction of 
testosterone was completely dependent on NADPH; NADH was incapable 
of supplying the reducing equivalents. In nuclear and microsomal
FIGURES 9 AND 10*
Addition of Cofactors to Nuclear,
Microsomal and Homogenate Fraction 5 a-Reductase Incubations
Cellular fractions were assayed for 5 ««reductase activity 
in the presence of increasing concentrations of NADPH and 
NADH.
O  NADPH (supplied by NADPH generating system). 
Ë1 NADPH (direct addition).
A  NADH (direct addition).
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incubationsç NADPH waa supplied either by a generating system, in
which NADP is continually reduced to NADPH by glucose-b^-phosphate
dehydrogenasej or by direct addition* When a generating system
was used reduction proceeded at a slightly higher rate, probably
because a relatively higher concentration of NADPH is maintained
by continued regeneration of the NADP produced during testosterone
reduction* In all three fractions NADPH limits reduction if it
“5is present in concentrations lower than 5 x 10 M* The initial 
hypothesis that in the standard 5 a ««reductase assay a concentration 
of 2 X 10 NADPH should not limit reduction was therefore proved
correct,
3After all incubations the sum of Hktestosterone and
3
H^dihydrotestosterone accounted for over 95^ of all the radioactivity*
No significant production of 3a «-androstanediol was jJetected*
(d) Time Course of Reduction and the Effect of Trypsin
• rr*-!—i-|-ii>~rHTi-Ti~i-niiir- • n mmi-mrfrm -rrrr ^rm uTir i'tt iT-irrriM n ■•~iiTTTitiiitiTrnncfxfrtTir~i«ivi~~iTn~‘n n  i m n m m  ## i mtn nrrrmr^ n  'U irn'<>iw nn n r »i~>
InhibitorQ
Incubations of nuclear, microsomal and homogenate fractions, 
with ^H-testosterone,dithiothreitol (5 x 10™^M) and EDTA (5 x 10™^M) 
were performed for varying time periods with and without soya bean 
trypsin inhibitor (0,02%; w/v)o Results for nuclear and microsomal
incubation are shown in Figure 11 and for homogenate incubation in
3 3Figure 12® In all experiments H™testostercne and H-dihydrotestosterone
accounted for over 95^ of the radioactivity present at the end of the
3
incubation. No H-3a androstanediol was detected*
In all three fractions the 5a ^reductase activity increased 
linearly with time for 40min when a decrease occurred®■ The enzyme
FIGURES 11 AND 12.
Time Course of Nuclear, flicrosonicl and Homaqanato 
Fraction 5 ««---RGductasQ.
Incubations were performed for different time periods in 
the presence and absence of 0#02% trypsin inhibitor®
3
0  H^tostosterone control.
3
H-tostosterone 4 0*02% trypsin inhibitor.
3
O  H“dihydrotestosterone control.
3
[J H“dihydrotestosterone-f 0*02% trypsin 
Inhibitor,
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was totally inactive aftor BOmin^ It was found that addition 
of extra NADPH (? x 10 ^M) to a microsomal incubation after BOmin 
did not stimulate reductions These results provide evidence 
that in the standard 5 a-reductase assay, which was carried out 
for 20min, velocities similar to initial reaction velocities ware 
being rneasuredo The inclusion of trypsin inhibitor in 
incubations did not alter the rate of testosterone reduction©
(q ) Effect of Divalent Cations
(!) Effect of a Ranqe of Divalent Cations on 
5a -Reductase Activity^
lua «AI III'lull II IB ■ I III II) : *  in« <i~i iinnniTi n*. M ia ïm vu u as v iu w b  onss
The 5 a-’reductase activity of rat prostatic nuclear 
fraction i» sensitive to a range of divalent cations (Prederiksen 
and Wilson, 1971)© Modification of human prostatic nuclear ■ 
fraction 5oc ^ reductase activity by zinc has also been reported 
(Grant et al#, 1971)a An investigation was carried out on the 
affect of a range of divalent cations on 5a «reductase activity 
from both nuclear and microsomal fractions isolated from human 
hyperplastic prostatic tissue. The standard 5a -reductase assay 
was carried out without the addition of dithiothreitol (5 x 10*^M) 
or EDTA (5 x 10 ^M) since these agents may interfere with certain 
divalent cation effects©
To allow direct comparisons between the effects of 
different cations, all incubations wore performed simultaneously©
To provide sufficient nuclear fraction for the largo number of 
incubations involved, pooled nuclear fractions from two isolations 
were necessary© A single microsomal isolation, however, provided
100,
ample microsomal fraction for tho experimenco
Results for nuclear and microsomal fractions aro
shown in Figures 13 and 14 respectively* In aj,l incubations
3 3H^testosterone and 'H^dihydrotostosterone accounted for 9S% of
3
the radioactivityo No dx-androstansdiol was detected*
The results were similar for both fractions in that 5cx «reduction 
was inhibited by low concentrations (approximately ‘10 ^M) of 
divalent cations in the following order of effectivenesss- 
Cu^ '*' ^ >  Zn^ '*' == Mn^^\
(ii) Effect of Zinc on Testosterone Rsduction by 
Nuclear Fraction Isolated From Human and Rat 
Prostatic Tissue
ei»5*i*inb.i«eruaeirw«ee6K«TW*î»^ rieie-<vfl
In the previous experiment, although zinc caused a 
marked inhibition of 5a ^reductase activity above a concentration 
of 10™^Me no stimulation was observed at lower concentrations* One
of the initial objectives of this study was to confirm that tho 
5 (%«reductase activity of human prostatic nuclear fraction was 
stimulated by zinc at a concentration of 5 x 10™^M as shown by 
Grant et al* (1971)© The experiment in which zinc was added to 
nuclear fraction 5 a^reductase incubations was therefore repeated© 
Similar experiments using rat prostatic nuclear fraction wore also 
performed*
The resultsÿ shown in Figure 15^ confirm that zinc 
inhibits 5 a-reductase activity at concentrations above 10"”^ H,. while 
no stimulation of activity was observed at lower levels* Testosterone 
5 a-»reductase was slightly more sensitive to zinc in rat than in 
human prostatic nuclear fraction© The activity of nuclear
FIGURE 13*
Effect of Divalent Cations on Nuclear Fraction 
Î5cx "Reductase Activity
Incubations ware performed in the presence of different 
concentrations of a range of divalent cations* Two 
nuclear isolations were pooled to provide sufficient 
nuclear fraction for the exoeriment*
a  ccf+
A
©
'-V
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FIUURE 14.
Effect of Divalent Cations on Microsomal Fraction 
5 «"Reductase Activity
Incubations were performed in the presence of different 
concentrations of a range of divalent cations#
O
102,
q;
3
O)
Lu
<
g
0
1
I
alO
i
§
y
îs:
O
S
g
<
u
%
5
g
Eî
o
f-(
o
w
È
M
C M
O
OCD O OC M
g
g
K
M
$
â
NmLLOHd 3LU J3cl q/ioiud
FIGURE 15,
Effect of Added Zinc on 5 a “Reductase Activity
Incubations of nuclear fraction isolated from human 
hyperplastic and rat prostatic tissue were performed 
with different concentrations of zinc*
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5 a-'-rsductasB in rat prostatic tissuej hcuever, was considerably 
lower, measured on e prc'ooin basis, than that in human prostatic 
tissue*
(iii) Effect of Zinc nn 5 oc-Reductase Activity of 
Nuclear Fractions 'Jashad with Triton X-100
Comparison of the methods Used in the present study
and in the study carried out by Grant et al* (1971) revealed the
difference that in the latter, but not the former, Triton X*«100 
had been used to wash nuclei* Since this difference may explain 
the inability, in previous experiments, to detect a stimulation of 
5 a'“reductase activity in the presence of 5 x 10 M zinc, the 
experiment was repeated using Triton X™1Q0 washed nuclei *
A nuclear fraction was isolated from fresh human 
hyperplastic prostatic tissue and divided into three equal batches* 
Two of these batches were washed by suspension in 0,25M sucros0'»ToKoPT 
Triton X-100 solutions containing Triton X™100 at a concentration of 
either 0«1%(w/v) or 0*001%(w/v)* . The suspension was centrifuged
at 600 £  17cm) for lOmin^ The pellet was then rewashed
with 0«25h sucrose*'’?eKoH* solution to remove traces of detergent*
Incubations of all three fractions (unwashed 0*1Xo(w/v) 
Triton X-100 washed and 0c001^b(w/v) Triton X^dOO washed) wore 
performed by the standard procedure with and without 5 x 1U"^M zinc* 
Tho experiment was repeated with a nuclear fraction from a different 
batch of prostatic tissue*
Results obtained are shown in Table 14* To allow 
comparison of results between the two experiments, 5a “•reductase 
activity is represented as the percentage of the activity present in 
tho unwashed control to which no zinc had been added*
105,
TABLE 14,
Effect of Zinc on Nuclear Fraction 
5pf -Reductase Activity after Washing with Triton X‘^ 100»,KiTr*(a*mioPM;*^»h,)@^.;AT=«4qtHaovC%^ZAnïg«5%Mt«L$«*pnwa±afw*a'ÆrB*afmMr=«»m?jw#jm-pR3r ^  vi^«uB4wia.Hn»c9-VK«tvxii»rn*»ne--»/Ka*.**?#**
Sample Control
Oc1%
Triton
0,001%
Triton
•aLBinBlà**'aeer3orMi™eatŒ««eaFu»c»>reeeit
No Zinc 100 54,8 92,6
100 56.9 91,8
+ 5 X 10™^M Zinc 102 54,7 96,8
104 55,0 93,2
Results are expressed as % of the 5a •"reductase activity 
present in the unwashed nuclei.
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5, Nature of Divalent Cation Inhibition of 5a «-Reductase
Aptivity
(a) Addition of Thiol Blocking Reagents ano Thiol Groups ^ « C w t w g ^ O M » w ^ j f c i . w w 3 C T * a i —r’ l wipwirittuj yrwmn w’ t^- <g y iji«cf»mTttwKKiA.atMjia'ija«CTitta3rgri fk r*%G$
There are many chemical compounds capable of forming a
covalent complex with thiol groups. In certain instances those
reagents cause inhibition of enzymes requiring free thiol groups
for activity. It was considered that a study of the effects of
a range of such compounds on enzyme activity could provide valuable
information concerning the role of thiol groups in catalysis*
lodoacetamidep iudoacetic acid, N-ethylmaleimide and
p«“Chloromercuribenzoat0 ware used as thiol comploxing reagents*
These reagents complex with thiol groups in the following manner,
lodoacetamida and iodoacetic acid react relatively specifically
with thiol groups by alkyl substitution. The univalent organic
mercurial, p^chloromercuribonzoate, reacts stoichometrically and
also extremely specifically with thiol groups to form a merceptida,
while N-ethylnialeimide forms a complex derivative with thiol groups.
Those reagents were added to incubation tubes containing nuclear
and microsomal fractions*. The tubes were shaken, placed in an
3icB-bath for 5min followed by addition of H—testosterone and NADPH, 
The 5 «^reductase assay was then performed in the usual manner at 
3?'°Co The concentration of thiol group blocking reagents in the 
final incubation was either or 1 0 To some incubations
a freshly prepared solution of dithiothreitol was added to a final 
concentration of 10 Tio This water soluble compound contains 
many free thiol groups which ensoie it to reduce disulphide groups*
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The results of these incubations are shown in Table 15*
3These are expressed as the percentage of H-dlhydrotcatosterone
produced in a control incubation where no additive was present.
Each value is the average of at least two experiments « In one
series of exoeriments fractions were isolated from frozen tissuo*
Results were obtained identical to those from fresh tissue* In
3all cases the increase in H^dihydrotestosrerone v'Zb equivalent
3 3to a decrease in H-testosterone, No H“3 a-androstanediol
was detected.
The results indicate that the 5 a-reductaso activity in both
nuclear and microsomal fractions is sensitive to compounds known
to form complexes with thiol groups. The most effective agent
was p^chloromercuribenzoate which inhibited completely at a
concentration of 5 x 10™^M* lodoacetamide caused marked inhibition
at 10 Mp but not at 10” M* Iodoacetic acid and N-ethylmaleimide
were the least effective agents, causing approximately 60% inhibition
—2at a concentration of 10 fl* Dithiothreitol at the relatively high
—2
concentration of 10 M caused slight stimulation of reduction.
Results obtained in this series of experiments wore similar for 
incubations with nuclear and microsomal fractions:
(b) Effect of Chelating Aoents.  rririwninr»|iriiTMnrrTiri ii»i mo i iir «it ■■i,»rnnmn I 'lrmi iinm~i,ri“t rnm iiiT i r mfii itrjffpt i ,
Testosterone reduction has been shown to be sensitive to 
divalent cations in Section 2, (e). It was, therefore, of interest 
to study the effect of chelating agents on the 5 oc-reductase activity 
in nuclear and microsomal fractions isolated from human hyperplastic
108 «
TABLE 15,
Effect of Thiol Group Blocking Reagents 
and Thiol Groups on Testosterone Reduction«■ * i»ior*fcxiWBJuiJ»»«a*><Wflg*sgTtT.K>p^ u<ro>^ n.nar » h» »*» *»*#ihKWStirat*no6Wre
Reagent No* of
Nuclear Traction Microsomal Fraction
Experiments 5 a-Reductase ^ 5 a-Reductase '%
lodoacetamide
10"^M 2 13.2 6.1
lO-^M 2 102.0 99,6
Iodoacetic Acid
10“ f^1 2 57.9 39.7
10 M 2 97.8 102.4
N*»Bthylmaleirnid0
io"^n 2 58.3 52.4
icT^n 2 85.6 85.0
p-chloromercuri™
benzoate 
5 X io“^n 5 0,8 0.7
Dithiothreitol
•*•2 116,010 M 6 123.0
^ Results expressed as percentage of H^ ’dihydrotestosterone produced 
in a control incubation where no additive was present*
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prostatic tissue* Three chelating agents, EDTA, c-phenanthroline
and citrate were used. The results are shown in Table 16. Each
value is the average of at least two experiments* Results
obtained from fractions isolated from frozen prost^tic tissue were
again identical to those for fresh tissue* Results are expressed
3as the percentage of H'^dihydrotestosterone produced in a control
incubation where no additive was present* In all cases the 
3
increase in H-dlhydrotestosterone was equivalent to a decrease in
3 3H—testosterone. No H«3 a-androstanediol was detected*
The results show that in both nuclear and microsomal fractions
EDTA produced a slight stimulation, o-phenanthroline a slight
inhibition, and citrate no effect on 5a -reductase activity.
(c) Reversal of Inhibition
Inhibition of the activity of an enzyme may be either 
reversible or irreversible. If inhibition is reversible, the 
enzyme activity will be restored upon elimination of the inhibitor; 
for irreversible inhibition to occur, a fundamental change within 
the protein structure of the enzyme (i.e. a dénaturation) may have 
taken place* Experiments were performed to determine whether 
inhibition of the 5a -reductase activity by zinc and 
p-chloromercuribenzoate could be reversed.
The experiments were designed in such a mann^'r that the 
reversal agent was added 1Omin after the beginning of the incubation. 
At this point, therefore, the enzyme was known to be under inhibition, 
ensuring that a true reversal was be:ng observed® If inhibition
110,
TABLE 16,
Effect of Chelating Agents on Testosterone Reduction
Chelating No* of Nuclear Fraction Microsomal Fraction
Agent Experiments . 5 (X-Reductase ^ 5 o:-Reductase #
EDTA
10^^M 5 117 125
o-phenanthroline
io”^n 4 86 90
Citrate
1 2 94 101
-3
10 fl 4 100 103
Results expressed as percentage of H-dihydrotestosterone in a 
control incubation where no additive was present*
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and reversal agents were added at the sarno time it would be 
impossible to determine whether the observed effect was due to 
true reversal or to deactivation of the inhibitor© Incubations 
were terminated 15min after the addition of the reversal agent*
To quantitate the effect that a reversal agent had on 
inhibited enzyme activity the percentage release of inhibition 
was determined* This valuo was calculated by subtraction of the
3
H—dihydrotestostorone produced in a 25min incubation with inhibitor 
3
from the H~dihyrlrotestosteron© produced in a 25min incubation to 
which a reversal agent was added after lOmin* The mathematical 
basis for this calculation is outlined as follows
3
H"“dihydrotestosterona produced in the inhibited enzyme after a 
25min incubation y ng«
3
H-dihydrotestosterone produced by the inhibited enzyme during 
the first 10min of incubation x ng.
3
H-dihydrotestosterone produced by the inhibited enzyme after a 
25min incubation to which a releasing agent had been added after 
the first 1Omin of the incubation - z ng.
3
The 'H-dihydrotestosterone produced by release of inhibition in 
the last 15min of incubation (z - x)-(y-x) ng* - z - y ng*
This value was divided by the enzyme activity of a control 
incubation containing releasing agent clone and then multiplied by 
100 to give the percentage release of inhibition*
Since previous results indicate that 5 a-reductase inhibition 
involves thiol groups it is possible that if these groups were added
112.
in excess to an inhibited enzyme this may cause some reversal of
inhibitionc Experiments wero therefore performed in which
—2dithiothreitol (10 M) was added to the nuclear and microsomal 
fraction incubations under inhibition by p-chloromcrcuribenzoate 
(5 X or by zinc (1D™^M). The results obtained are shown
in Table 17 and Figure 16©
Two experiments were performed with fractions from fresh 
prostatic tissue while in the others fractions were isolated from
frozen tissue* In all incubations tho only detected metabolite
3 3
of "H™tostosterone was H-dihydrotestosterone.
Results show that reversal of zinc or p-chloromercuribenzoate
inhibition occurred if dithiothreitol was added 10min after the
beginning of the incubation* Dithiothreitol was most effective
in reversing inhibition by D-chloromercuribenzoate. The extent
of reversal was approximately the same in nuclear and microsomal
fractions.
It is possible that chelating agents with a high affinity 
for zinc may reverse zinc inhibition* Reversal experiments were 
therefore performed with two such chelating agents, EDTA and 
o-phenanthroline and also the naturally occurring r-helating agent 
citrate* The procedure was exactly similar to that used in the
previous experimont* Incubations were performed in duplicate and
3 3the only detected metabolite of "H-^teatosterone was H-dihydrotastosterone,
The results, shown in Table 18 and Figure 16^ indicate that
inhibition of 5 a-reductase activity by 10 zinc can be reversed
by EDTA and o-phenanthroline* No significant difference could ba
115. 
TABLE 17.
Reversal of p-chloromercux’ibenzoate and 
Zina Inhibition by Dithiothreitoi (10 '^Tl)
Inhibitor
p-c h lo r 0 me r c u ri» 
benzoate
5 X 10^^M
;inc
1 üT%
No* of 
Experiments
Nuclear
Fraction
51
34
Microsomal 
Fraction #
64
Results expressed as percentage release of inhibition - see text©
TABLE 18c
■tmTHTiHU »,1i.>W#'.IAaMUlÆ4J
Reversal of Zinc Inhibition by Chelatinq Agents
Chelating
Agent
No. of 
Experiments
Nuclear 
Fraction ^
Microsomal 
Fraction *
EDTA » 
lO-^M 2 39 47
o-phenanthroline
10*”^ M 2 42 30
Citrate
10“’^ M 2 25 9
10“^M 2 1.9 1.2
Results expressed as percentage release of inhibition - see text*
FIGURE 16.
Reversal of 5 a«Reductase Inhibition
Nuclear and microsomal fractions were incubated with 
inhibitor for lOmins before addition of reversal 
agent. Incubations were terminated 15min after 
the addition of the reversal agent©
% Rolease of inhibition is an index of the increase of 
5 a-reductasB activity after the addition of the 
reversal agent. The method for calculation of the 
% release of inhibition is outlined in the text.
C] Nuclear Fraction 
Microsomal Fraction. 
P.CMB p-chloromercuribenzoate
DTT Dithiothreitol
0-P • o-phenanthroline
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detected betfjeen nuclear and microsomal fractions in this respoct©
High concentrations of citrate (10 *71) also caused reversal which 
was most marked in the nuclear fraction.
(ri) Kinetic Study of Zinc Inhibition
Since the inhibition of 5 a-reductass activity by zinc 
was found to be reversible, information concerning the mechanism 
of inhibition could be gained by a Michaelis-Menten type analysis 
(flichaelis and Menton, 1913).
All enzyme activities increase linearly with time as 
the concentration of substrate (or cofactor) is increased up to 
saturating level. The velocity of the enzyme reaction at 
saturation is termed Umax and the substrate concentration when the 
enzyme activity is half of that at saturation is termed The
relationship between the enzyme's initial reaction rate (v), the 
substrate concentration [s j ,  Vmax and |<^  is given by the Michaelis— 
Menten equations-
Umax [s]
+ [S]
The concepts Umax and K^, are dependent on the affinity
of the substrate (or cofactor) for the enzyme and the efficiency of
catalysis 0 They are useful parameters for the comparison of enzyme
activities© A plot of v against [s] gives a hyperbolic curv‘d from
which Umax and can be determined© Since this plot is an asymptote
it is extremely difficult to determine tho exact point at which tho
reaction has reached saturation* To determine Umax and K more
m
precisely the Michaslis-Menten equation can bo rearranged to tue form;-
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1 1 , 1ju *nMMKsne»««
v Umax [SJ Umax 
This is called the Lineweaver-Burk equation (Lineweaver and Burk, 
1934)o
If l/v is plotted against 1/[S] (a double reciprocal plot), 
a straight line should result, the intercept with the ordinate being 
equal to 1/Umax while that with the abscissa being equal to l/Km.
If an inhibitor combines at or near to the substrate (or
cofactor) binding sito, or is structurally sufficiently similar to
the substrate (or cofactor) to compete with it for its binding site
the effect will be reflected by an increase in the substrate (or
cofactor) concentration required to attain half the maximum
velocity© The maximum velocity, however, should not bo altered*
(K is increased and now termed K ,« but Umax is unaltered)© This 
' m mi
type of inhibition is called competitive inhibition.
If, on the other hand, an inhibitor combines with a site far 
removed from the substrate (or cofactor) binding site the effect 
will be reflected by a decrease in the maximum velocity of the 
reactiono The substrate concentration at which half the maximum
velocity is attained should be the same in the inhibited and 
uninhibited enzymes (Umax is decreased and now termed Umaxi, 
is unaltered)® This type of inhibition is called non-competitive 
inhibition.
The present series of experiments ware designed to determine 
what type of inhibition was exerted by zinc on the 5 oc-reductase 
activity present in the nuclear and microsomal fractions of the human 
hyperplastic prostate. The results obtained were analysed by
117»
double reciprocal plots. If the inhibition is competitive such 
a plot is characterised by straight lines of differing slopes 
intersecting at a common intercept oh the 1/v axis, if it is non­
competitive the lines differ in slope but do not share a common 
intercept on tho 1/v axis®
In the first series of experiments of this type nuclear 
and microsomal fractions were incubated with increasing levels 
of testosterone with and without 10 zinc. The cofactor (MADTH)
concentration was kept constant (2 x 10™^M), It was found in a
preliminary experiment that as tho substrate concentration increased,
3 3the percentage conversion of H-testosterone to "H-dihydrotestosterone
3
formed during incubations decreased® The level of H-^testosterons
5was therefore increased from 2 x 10 dUp.m* (the level in the
5standard -reductase assay) to 8 x 10 dopom© in these experiments.
3This allowed a more precise detection of H-dihydrotestosterone 
formed during these incubations©
The results (Figure 17 ) indicate that, in both nuclear and 
microsomal fractions, zinc does not competo with testosterone 
during inhibition of the 5a -reductase* The following parameters 
were calculated from the double reciprocal plotss-
Fraction app ^ Umax Umax!
Nuclear 105 12,5 1,94
Microsomal 66,7 208,3 100
X “ nM pmol/h per mg protein
In the next series of experiments nuclear and microsomal
FIGURE 17.
Plot of l/v Versus 1/I Substretel in the 
Presence and Absence of Zinc
Nuclear and Microsomal fractions were incubated with 
increasing levels of testosterone^with and without 
10"^M ZnClg. The cofactor (NADPH) concentration 
was kept constant.
O  Control
Control -V 10"°^ M ZnCl^
118.
F i q u r e  1 7. PLOT OF 1/v VERSUS 1 /  [SUBSTRATE] IN T H E P R E S E N C E  A N D  
Â B S E N Œ  O F  Z I N C .
A ) N U C L E A R  F R A C T I O N
900-
V. 6 0 0 -
300  -
5 2010 15
[t e s t o s t e r o n eB) M I C R O S O M A L  F R A C T I O N
20-
10-
5 10 1 5 20
^^ijESTOSTERON^ )
119.
fractions were incubated with increasing levels of NADPH with and 
without loT^M ziiiGo The concentration of substrste (’^H-testosterono) 
was kept constant (2 x 10^ de.p»mo)o The results (Figure 18) 
indicate that in both nuclear and microsomal fractions 5 os-reductase 
activity is inhibited in a competitive manner with respect to 
cotactoro The following parameters were calculated from the 
double reciprocal plots:-
Fraction Vmax app K app K .m mi
Nuclear 18*18 0.42 B
Microsomal 66*0 0*45 11*1
X “ pmol/h per mg protein - xIO NADPH
The later series of experiments give a positive result which 
indicated that zinc may bind at or near the cofactor binding site*
The experiment was therefore repeated? with microsomal fraction 
and low concentrations of zinc (10 and 10 '^ M) tu seek added 
confirmation of this effect* The results, presented on a 
double reciprocal plot? are shown in Figure 19* The following 
parameters wero calculated from the graphs-
Vmax = 71„4 pmol/h per mg protein
app K = 0,3 X 10“ V^l NADPH m
app K . (10™^M Zn) = 0.57 x 10"^M NADPH mi
app K . (ICT^M Zn) = 3*2 x 10"^M NADPn mi
FIGURE 18.
Plot of 1/v Versus 1/[Cofactor] in the 
Presence and Absence of Zinc
Nuclear and Microsomal fractions were incubated with 
increasing levels of NADPH, The substrate 
(testosterone) concentration was kept constant*
O Control
g- Control 4- ZnClg
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FIGURE 19,
Plot of 1/v Versus l/[Cofactor] in The 
Presence and Absence of Zinc
Microsomal fraction was incubated with increasing 
levels of NADPH, The substrate (testosterone) 
concentration was kept constant#
O Control
□  Control 10"^M ZnCl^
Control *1- ICT^M ZnClg
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Relationship between Zinc Content and 5 a-Reductase 
Activity
eavs*t»eiww*iTt*vn»»"»«i1
In the previous experiment zinc (10 ^M) was found to inhibit
3
the reduction of H™testosterone in nuclear and microsomal fractions 
isolated from human hyperplastic prostatic tissue^ This 
reversible inhibition was competitive with respect to cofactor 
and may have involved binding of zinc to a thiol croup* Although 
many enzymes are known to be sensitive to divalent cations tbs above 
observation may be of more physiological importance because of the 
high zinc content of human prostatic tissue. The objectives of 
these final experiments was to confirm that the prostate has a high 
zinc content* to discover where this zinc is located* and to search 
for evidence which might indicate that zinc controls 5 a-'•reductase 
activity in vivo.
(a) Zinc Content of Hyperplastic and Adenocarcxnomatous 
Prostatic Tissue
A study was performed to determine the zinc content of 
human prosLatic tissue* The results obtained for the zinc content 
of tissue samples from two distinct areas of thirteen hyperplastic 
prostate glands are shown in Table 19, Results for three cases of 
adenocarcinoma are presented in Table 20©
The average zinc content of hyperplastic prostatic 
tissue was 1210 - 901 (S,D*) jjg/g dry wt, (n = 26) whereas the much 
lower value of 421*6 ^ 238 (S*D©) pg/g dry wt, (n ~ 5) was determined 
in adenocarcinomatous tissue. There was an extremely large 
variation in the zinc content in both hyperplastic (450 « 4216 pg/g dry wt,)
125.
TABLE 19,
^ i n ç C g n t e ^ ^  , P ro ^ ^ lc J b L a s ^
Patient’s
Initials
Age
(Years)
Total Sample 
■Jet wt. (g)
Zinc Content 
of Sample A
Zinc Content * 
of Sample B
1 M *C 0 67 51 971 1411
GoMc. 60 77 Zl49 564
W.Mc, 73 130 4215. 2124,
AcMcG. 92 81 955 833
H oMCo 51 60 1030 805. _
T.S* 73 85 772 726.
D «L e 66 59 3462, 612
],R. V3 39 1074 , 1285
3.N. 67 03 675 905
A e G • 69 16 923 719
3.C. 72 22 988 1201
HoRe 70 50 2494 701. .
•RoMo 68 56 682 082
•î^ Expressed as jjq Zn/g dry weight
Mean = 1210 - 901 (S.Do) /jg Zn/g dry weight (n 26) 
Range 450 - 4216 yjg Zn/g dry weight
124.
TABLE 20.
Zinc Content of Adenocarcinomatous Prostatic Tissue
Patient * s 
Initials
Age
(Years)
Total Sample 
Wet wtc (g) Histology
Zinc Content ^ 
of Samples 
from two 
distinct sites
J.Qo 66 30 Moderately well 
differentiated
328,2 
244 0 4
SoP. 63 28 Well different 
tiaced
769,7
281,9.
R*S e 72 35 Well differen™ 
tiated plus 
benign hyperplasia
701 o 6 
263,5
* Expressed as /jg Zn/g dry weight
Mean ^ 431,3 - 238 (3*0*) pg Zn/g dry weight (n “ 6) 
Range ^ 244*4 - 769,7 yug Zn/g dry weight
FIGURE 20.
Prostatic Zinc Content in Relation to 
Prostatic Weight and Patient Ago
Zinc was determined in two samples from each of 
thirteen hyperplastic prostate glands and related 
to prostatic weight and patient age.
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and adenocarcinomatous tissue (244 - 759 pg/g dry wt©). Within 
individual prostate glands there was also marked variation in 
the level of zinc in samples taken from two distinct sites.
In hyperplasia this variation was most extreme in patient D*L. 
where there was a difference of 2850 pq zinc/g dry wt* between 
two sites. In adenocarcinomatous tissue a smaller difference
of 538 pg zinc/g dry wt© was observed in patient R«S* It is
important to point out that the carcinoma patients were not under 
estrogen treatment* The disease had been discovered only 
after histological examination of tissue removed for suspected 
benign hyperplasia©
Figure 20 shows that no relationship is apparent between 
the zinc content of hyperplastic prostatic samples and patient .
age or prostatic weight©
(b) Distribution of Zinc in Hyperplastic Prostatic Tissue
Since zinc is known to be a component of human prostatic 
secretion (Mackenzie et al©* 1952) an Initial experiment was conducted 
to determine whether any zinc was removed during the 0.15M NaCL 
washing procedure© Samples (5 x 1g) wore taken from different 
areas of two prostate glands. Each sample was minced and washed 
with 0.15M WaCl as described in the methods section© The washed 
tissue war homogenised in 0©25M sucrose-T.KoM© solution and duplicate 
zinc and protein analyses were performed on both the NaCl wash and 
homogenate fractions© To correct for zinc contamination during 
the zinc determination control samples of 0.25M sucrose™ToK*M.
127,
solution and ü*15M NaCl were also analysed and the value obtained 
subtracted from the relevant homogenate or NaCl wash sample 
values* Results are presented in Table 21©
The proportior'Bof the total zinc and protein found in 
the extracellular fraction are relatively high. In prostatic 
tissue for patient 34'/ of the total protein and 39/ of the
total zinc was located in the extracellular fraction* while in the 
case cf patient AoMc© 21/ of the total protein and 18/ of the total 
zinc was present in the extracellular fraction. The complete 
distribution of zinc within hyperplastic prostatic tissue was 
studied* taking into account the large proportion washed cut of 
the mince with 0*15M NaCl© Three samples (lOg) of frozen 
hyperplastic prostatic tissue were used for this purpose.
Cellular fractions were isolated as described in the methods 
section. Duplicate zinc and protein analyses were performed 
on each fraction© To correct for possible zinc contamination 
in the determination* zinc was also determined in suitable reagent 
controls and the value obtained subtracted from the sample value. 
Results (Table 22 and Figure 21 ) are represented according to 
the method suggested by de Duve (1955)» In addition* values 
for the extracellular fraction are also included in this 
presentation. It can be seen that most of the prostatic zinc 
was located in the extracellular* nuclear and supernatant fractions 
(51,0/* 24,4/ and 18/ respectively),
(c) Relationship Between Zinc and Soc -Reductase Activity
In Prostatic Hornoqenates
Tissue homogenatesj prepared from fresh prostatio tissue*
128.
TABLE 21o
Zinc and Protein Content of Extracellular Fraction
1 Concentration in 
1 Extracellular 
Fraction
P.A. Age 75 yrs. 
Prostatic wt^ — 65g
AoM^o Age 55 y 
Prostatic wt*
mg Protein/g 
original tissue 17o7 11,2
/ Total protein 33*9 22,1
).jg Zn/g original 
tissue 40o3 5,1
/ Total zinc 39.0 18,7
pg Zn/mg Protein 2,3 0,5
/ Total Zn// 
total protein 1,15 0,9
Results presented for each patient are the average of five
determinations from distinct portions (ig) of tissue from
different areas of the prostate.
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TABLE 22,
Distribution of Zinc in Human Hyperplastic Prostatic Tissue
Relative
Fraction Zinc Protein Specific
Activity!
Absolute Value 0,864mg 256,4mg -
Extracellular 51.80 33*50 1,58
Intracellular 46,55 69,70 1.50 1
600 q Pellet
Suspension'^
(Nuclear) 24,43 19,00 1.46
9*000 g Pellet
Suspension
(Mitochondrial) 0,70 3.13 0,21
105,000 g Pellet
Suspension
(Microsomal) 1,94 7.73 0,23
105,000 g
Supernatant
(Oytosol) 18.05 39*00 0.48
Total / Recovery 
in fractions 96,90 95,97
îesülts expressed as percentage of absolute value.
Results are the average of three experiments, 
f z: / Zinc in a specific fraction// protein in that fraction,
4: corrected for DNA recovery (on average 70/ of homogenate DMA 
was recovered in the 600 g pellet).
FIGURE 21
Distribution of Prostatic Zinc
Results presented are recalculated from Table 22 
on the basis of a 100/ overall recovery#
Results are the average of three experiments® 
Zinc/protein = / Zinc in a specific fraction// 
Protein in a specific fraction#
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were analysée for zinc and 5cc “-reductasQ activity© Samples
(5 X 1g) were taken from each prostate gland© These samples
were minced, washed, filtered and homogenised as described in the
methods section* The final filtrate was made up to a volume of
10ml with 0o25M sucrose-ToKoMo solution and duplicate samples
analysed for zinc and 5 a^raductase activity* To monitor for
zinc contamination during ths zinc determination control camples
of 0*25M sucrose-T©K*Mc solution were also analysed for zinc and
the value obtained subtracted from the homogenate sample value.
Results are shown in Table 23 and Figure 22©
Histological examination confirmed that four of these
glands were hyperplastic* In the case of patient R.Mco, however*
anaplastic malignant infiltration of lymphoid origin was diagnosed*
This patient was subsequently found to be suffering from leukemia.
The hyperplastic tissue results produce a coefficient of linear
correlation of - 0o54* The best straight line to fit this data
ai
is shown in Figure The student-t value was 3©099 and with a
two tail probability table the P value of <%0*01 was obtained (n ~ 19). 
These results show that a significant negative relationship exists 
between the zinc concentration and 5 a ^reductase activity of human 
hyperplastic prostatio homogenates*
(d) Effect of Added Zinc on 5 a «"Reductase Activity cf 
Prostatic Pomoqenates
An experiment was performed to determine whether zinc 
added to prostatic homogenates modified 5a -reductase activity©
An homogenate was prepared from fresh hyperplastic prostatic tissue
132.
TABLE 23c
Relationship between Prostatic Zinc 
and -Reductase Activity
Patient
and
Details
/jg Zn/mg 
Protein
SoAo i(- 
5a -Reductase
BoN. Age 67 4 o56 17.98
P.wt. 6?g 2 c 20 19.60
BoPel-U 2.04 21.27
3*94 16.31
1,62 31,45
GoC, Ago 86 3.84 16,06
Powto 135g 1.89 11.12
B 0 Pc H 0 2.55 71*85
3.62 16.42
D0P• Age /3 1,41 30.39
Powte 62g 1,34 36.25
BcP.H. 1,69 34,22
1.08 36.82
2.99 33,98
DcB, Ago 62 1.66 53,35
Pcwt© 29g 1.62 55,59
BcP.Ho 1.17 52.60
2.15 31 .60
1.38 42,15
RcMc* Ago 75 0.68 17,91
PeWto 44g 0.22 4,13 ,
B cPeH c 0.50 41,55
0,19 14,07
0.24 6,54
 ^s.A, KÎ Specific Activity = prr.ol/h per mg protein.
B.PoHo ” Benign Prostatio Hyperplasia.
PoUito r: Prostatic Weight.
FIGURE 22,
Relationship between Zinc Content 
and 5 k —Reductase Activity
Homogenates were prepared from sarnples(5 x 1g)from 
each of four hyperplastic prostates® These 
homogenates were analysed for both zinc and 
Sa-reductasGo
Patient's Initials
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89 described in the methods section* Incubations wars conducted
in duplicatej, with increasing levels of added iinc@ After all
3 3incubations the sum of H^testosterone and "H^dihydrotestosterone
accounted for at least 95^ of the radioactivity* No 
3' H—3a —androstansdiol was detected*
The results (Figure 23) indicate that zinc caused 
inhibition of 5a -reductase activity of prostatic homogenates* 
Inhibition began at a zinc concentration of and was complete
at
(e) Effect of Cholatinq Agents and Dithiothreitol on 
5 a-RoductasG Activity in Prostatic Homononates
Reversal of 5 a-reductase inhibition by zinc has previously 
been demonstrated in nuclear and microsomal fraction incubations by 
the addition of the thiol group containing reagent dithiothreitol, 
or the chelating agents EDTA or o-phenanthroline (see Section 3 ao)«> 
Since the concentration of zinc in prostatic homogenates bears an 
inverse relationship to 5 a*-*reductase activity, suggesting that the 
enzyme may in certain situations be under zinc inhibition, it was 
of. interest to discover if these reagents modified 5 a^-reductase 
activity in homogenate fractions *
Homogenates wore prepared from fresh hyperplastic prostatic 
tissue as described in the methods section* Incubations with
3
H^testosterone were performed, in duplicate, with the addition of
dithiothreitol EDTA (10™^M) and o-phenanthroline
3After all these incubations the sum of H^testosterone and
3
'H-dihydrotestosterone accounted for at least 95^ 0 of the radioactivity,
FIGURE 23,
Effect of Added Zinc on
Prostatic Homoqenste 5 a^Reductase Activity
Homogenate incubations were performed in the 
presence of increasing concentrations of zinc,
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3
No H-3 oc c»ar.drostanGciiol was detected*
Results obtained (Table 24) are expressed as percentage
3of H-dihydrotestosterone found in control incubations* 
Dithiothreitol had no effect, EDTA caused stimulation, and 
o-phananthroline caused slight inhibition of prostatic homogenate 
5a -«reductase activity* The modifications of 5a -reductase 
activity by EDTA and o-phenanthroline are, therefore, very similar 
to those seen when these reagents were added to nuclear and 
microsomal fraction incubations» Although dithiothreitol 
caused stimulation of nuclear and microsomal fraction 5 a-reductaso 
activity, in the present tissue homogenate incubations no 
stimulation occurred,
(f) Effect of Cytosol or Heated Cytosol on Microsomal 
5a «-Reductaso Activit'
The following experiments were designed to determine 
whether the cytosol fraction, which contains much of the intra-- 
cellular zinc, could inhibit 5 à-réduction when it was added to 
microsomal fraction incubations. In the first experiment, 
microsomal and cytosol fractions were isolated from fresh hyperplastic 
prostatic tissue (5g), The cytosol fraction (50ml) was divided 
into two 25ml portions and one of these portions was heated in a 
boiling water bath for 20min, cooled in an ice bath and centrifuged 
at 600 g (r^^ 17cm) for 10min to precipitate proteins. The
supernatant fraction was decanted and termed the heated cytosol 
fraction. Duplicate incubations were performed of microsomes, 
cytosol, ^microsomes plus cytosol and microsornes plus heated cytosol
137.
TABLE 24*
Effect of Dithiothreitol and Chelating Agents 
on Prostatic Homogenate Sœ-Reductase Activity
Agent % Control Activity Average
DithiothroitoX 99*2
(10^^M) 102*5 101*6
101*6
EDTA 115*8
(I0“ f^l) 126*3 124*3
130*8
a«°phenanthrolin0 95*2
(I0“‘^fl) 85*4 87*5
81*7
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3with H<“tBstostei'oneo The activity of the 5a «reductase was 
determined*
The 5oc -reductase activity detected in the cytosol
fraction incubations was subtracted from the value obtained in
incubations of microsomal fraction plus cytosol fraction, so that
in these incubations the activity of the microsomal fraction alone
could be seen. In microsomal plus cytoscl incubations there was
3also a small conversion to H™3a -androstanediol and this product 
was taken into consideration in the calculation of 5oc •«reductase 
activity* Results of this experiment (Table 25 ) show that the 
addition of cytosol to microsomal incubations caused stimulation, 
whereas addition of heated cytosol caused inhibition of Sg ^reductase 
activity*
Further experiments were developed to investigate 
these effects* Microsomal and cytosol fractions wore isolated
from fresh hyperplastic prostatic tissue (I0g), The cytosol 
fraction (I00ml) was separated into two portions (60ml and 40ml),
The first portion (60ml) was boiled and protein precipitated as 
previously described* A portion (30ml) of heated cytosol fraction 
thus formed was passed down a cation exchange column prepared as 
follows;- A glass column (0*5cm in diameter) was filled with 
washed Amberlite resin IR-120 (H) , wrdch was suspended in
distilled water to a height of Gem, Amberlite was washed before
use so as to remove fines* The resin was magnetically stirred 
in distilled water for 2min, allowed to sediment, and the supernatant 
containing finos was decanted by suction. Heated cytosol fraction
139,
TABLE 25,
Addition of Cytosol Fraction to 
Microsomal 5 a--Reductase Incubations - Initial Experiment
% Microsomal ControlSc ActivityIncubation
100Control
'Î* Cytosol 50.7
26.7 66.14- Heated Cytosol
S. Activity Specific Enzyme Activity - pmol/h per mg 
protein*
Results presented correspond to the activity of the 
microsomal Sa -reductase.
t  in this case 5a «reductase and 3 cc-hydroxysteroid 
dehydrogenase activity of the cytosol fraction were 
subtracted from the total activity*
:i40*
was passed through the cation exchange column at a flow rate of 
approximately Sml/min* To avoid dilution of the sample, the 
first 10ml of heated cytosol passed down the column was discarded. 
The following 20ml was collected and the pH carefully adjusted to 
7,0, with 1M NaOHo This was necessary since after passage of 
the cytosol fraction through the column the pH was acid because 
cations had been exchanged for hydrogen ionso This fraction
was then diluted to 30ml with 0.25M sucrose-ToK.M, solution and 
called the Amberlita heated cytosol fraction» Cytosol and
heated cytosol fractions (20ml of each) wore also diluted to 
30ml before being used in incubations to ensure all fractions 
were at the same concentration. During passage through the 
cation exchange column the heated cytosol fraction lost 96^ of . 
its zinc and 70% of its protein.
3
Incubations of microsomal fraction with H-^testosterone 
plus the fractions shown in Table 26 were performed. As before 
the results presented correspond to the activity of the microsomal 
5 a —reductase after subtraction of the 5 # -reductase and 
3 ÇC“ketosteroid dehydrogenase activities of added fractions. 
Results for two experiments are shown in Table 26. These are in 
agreement with the previous experiment.,in so far as the heated 
cytosol fraction added to microsomal incubations caused about 
30% inhibition. The pH of the heated cytosol fraction was 
checked and found to be unchanged at 7.0, This inhibition was, 
therefore, not due to a pH change,
A small activation of heated cytosol inhibition was
—3achieved by the inclusion of EDTA (10 M) with these incubations.
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TABLE 25,
Addition of Cytosol Fraction to 
Microsomal 5 cc-Reductase Incubations
Incubation S. Activity # % Microsomal Control
Control 28*9 100
38.4 100
i
4 Cytosol 34o3 119
38.5 100
4 Heated Cytosol 20,2 69
28,2 73
4 Amherlite 25c5 88
Heated Cytosol 39,2 102
4 Heated Cytosol 25 85
and 10“^M EDTA 31 81 '
* S. Activity == Specific Enzyme Activity ~ pmol/h per mg
protein*
Results presented correspond to the activity of the microsomal 
5 a-reduefase after subtraction of the 5 a-reductase activity 
of added fractions.
in this case 3 a ™hydroxysteroid dehydrogenase activity 
was also subtracted.
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This activation is no greater than the stimulation of microsomal 
5 a-reductasG activity by EDTA (Table 16 ) and therefore does 
not constitute a reversal of heated cytosol inhibition. Passage 
of the heated cytosol fraction through a cation exchange column 
almost completely reversed the heated cytosol inhibition of 
microsomal 5a -reductase (Table 2.6 ) * In experiments where 
cytosol was added to microsomal fraction a stimulation of 
approximately 20% of the 5 a-reductase activity occurred ( I'ables 
25 . and 26 )* . This may be due to a pull exerted by a 
cytoplasmic 3a -ketosteroid dehydrogenase present in these 
incubations.
Zinc was determined in the cytosol and heated cytosol 
fractions and the concentration of this cation in incubations to 
which these fractions had been added was calculated. The 
effect that this level of added zinc would have had if added to 
5a-—reductase incubations was also calculated with reference to 
earlier results (Figures 13 , 14 and 15 )* The calculated 
value was compared to the actual inhibition by these fractions 
(Table 27 ), The calculations show that, in the case of heated 
cytosol; the inhibition of microsomal 5a -reductase activity is 
similar to that expected from the concentration of cytoplasmic 
zirto in the incubations. This is not the case for unheated 
cytosol incubations. These results indicate that in cases 
where the protein is denatured by heat cytoplasmic zinc may 
become free to inhibit 5a -reductase. In normal cytosol fractions 
zinc may be largely protein bound and unable to inhibit 5 a —reductase 
activity.
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TABLE 27,
Zinc Content of Cvtosol and Heated Cytosol 
Added to Microsomal Incubations
Zinc Content
Approxo Theoretical 
5a -Reductase 
Inhibition
Actual 5 a-Reductase 
Inhibition
Cytosol
4*2 X 10 M
2o7 X 10 M
30 - 50%
20 - 40%
(19% Stimulation) 
nil
Heated Cytosol
0*98 X 10 M
0.90 X 10 M
16 - 31% 
15 - 30%
31%
27%
.144.
D. DISCUSSION
TOKa-W*.*nPt|SWalrt»cn ' î
1* General Characteristics of Testosterone Reduction b'y
Human Hyperplastic Prostatic Tissue
Certain characteristics of testosterone 5 a-reductase of tho 
human hyperplastic prostate gland were found to be similar to 
those of rat ventral prostate as described by Frederiksen and 
Wilson (1971)^ In both species the enzyme is located in 
nuclear and microsomal fractions, in both NADPH but not NADH 
is required for activity, and in both the enzyme is unstable 
upon heating for long periods at 37°C« In addition the enzyme 
from each species has a similar and is inhibited to the same 
extent by certain divalent cations. No major difference was 
detected between nuclear and microsomal fraction 5tx -reductase 
in the many experiments carried out in the present study* It 
is therefore likely that, as in the rat prostate, this activity 
in the human hyperplastic prostate belongs to a single enzyme 
entity*
It was originally intended to carry out a comparison of 
the 5a -reductase activity in normal and hyperplastic prostatic 
tissue, but this had to be abandoned because of the unavailability 
of fresh normal human prostatic tissue. Siitori and Wilson 
(1970), however, in an as yet unconfirmed report, found that, 
although dihydrotestosterona was increased during hyperplasia, 
the 5 cx-reductase activity of normal and hyperplastic prostatic 
tissues was similar*
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(a) Time Course of Reduction and tho Effect of Trypsin 
inhibitor
Time course experiments (Figures 11 and 12) revealed 
that undor the present experimental conditions, activity of the 
human hyperplastic prostatic 5 cc -reductase increased linearly 
with time for 40mino Thereafter the enzyme progressively lost 
its activity and was inactive within 80min* This inactivation 
could not be explained by lack of cofactor or substrate* It is 
known that upon homogenisation of certain exocrine organs, stored 
secretory proteases and nucleases may bo released, causing 
inactivation of cell organelles and constituents (Robinovitch
1969)* Since the prostate gland secretes proteolytic 
enzymes required for the liquefaction of coagulated semen (Mann, 1964) 
tho presence of these enzymes in a cell-free system might cause 
enzymatic degradation of 5 a «reductase. In time course 
experiments, however, no difference was observed between control 
incubations and incubations carried out in tho presence of a known 
proteolytic enzyme inhibitor (soya bean trypsin inhibitor)* This 
inhibitor eliminates some proteolytic enzymes as factors causing 
a time-related inhibition of 5oc-reductase activity* It is of 
interest to note that tho 11 p -hydroxysteroid dehydrogenase studied 
in homogenates of rat submandibular salivary glands is degraded 
by certain proteolytic enzymes, an effect which may be overcome 
by tho addition of soya bean trypsin inhibitor (McPhee, 1973).
(b) Activity of 3 a-Hydroxysteroid Debydrooanase in 
li o noQ G n a t a I nc u b a t ip n s
. A cytoplasmic 3 a “hydroxysteroid dehydrogenase has been
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found in the rat ventral prostate gland (Oruchovsky and Wilson,
1968; Nozu and Tamaoki, 1973)* In the human hyperplastic 
prostate gland, 3a -hydroxysteroid dehydrogenase activity has 
been shown in incubations with prostatic slices (Farnsworth and 
Brown, 1963; Siiteri and W i l s o n 1970), minces (Acevedo and 
Goldzieher, 1963) and homogenates (Ofnei, 1970)* The 
3 à-hydroxystcroid dehydrogenase is located in the cytoplasmic 
fraction isolated from numan prostatic tissue (Chamberlain at al*, 
1966) as it is in the rat ventral prostate*
The prostatic homogenates in the present study 
appeared devoid of 3a -hydroxysteroid.dehydrogenase activity, 
even when the concentration of cofactor or the incubation time 
was increased (Figures 10 and 12 )* Lack of 3 a-hydroxysterpid 
dehydrogenase activity may be due to sensitivity of this enzyme 
to the rather extreme homogenisation procedure used in these 
experiments* Detectable 3 a-hydroxysteroid dehydrogenase activity, 
however, was found in human prostatic cytosol incubations,which 
makes sensitivity to homogenisation a rather unlikely possibility*
It is more likely that tho dilution of the homogenato during the 
assay procedure decreases the content of the 3 a-hydroxysteroid 
dehydrogenase, but not the 5 a-reductase, to such an extent that 
enzyme activity cannot be detected. In support of this 
possibility is the finning that a high ratio of 5a -reductase to 
3“ -hydroxysteroid dehydrogenase would be expected in human 
prostatic tissue (Oenkins and McCaffery, 1974)* It is rather 
surprising that the 3 a^-hydroxysteroid dehydrogenase of the human
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hyperplastic prostate has not boon more extensively investigated 
since it is possible that a decrease in the activity of this 
enzyme may account fur the over-accumulation of dlhydrotestosterone 
during prostatic hyperplasia (Siitari and Wilson, 1070)*
(c) Subcellular Distribution of 5 a-Reductase Activity
Chamberlain et al. (1966) have found that in the human 
hyperplastic prostate much or the «-reductase activity is located
in the cytosol* Dfner et ale (1970), however, were unable to
• Mfaar» ^ f W *
confirm this finding* They suggested that microsomal S a-reductase 
may be present on slowly sedimcnting particles which were not 
completely precipitated from the cytosol fraction in the earlier 
study. Evidence from the present study would seem to confirm 
this suggestion, sinca in experiments in which microsomes were ' 
separated from the cytosol fraction by centrifugation at a high 
g force (105,000 gj 2.55cm) for 60min, little 5 «-reductase
activity was located in the cytosol.
The intramicrosomal site of the 5 «-reductase in human 
prostatic microsomes remains unknown* The intramicrosomal 
distribution of rat ventral prostatic 5 «-reductase is known to 
be similar to that of human placental enzymes related to 
steroidogenesis (leurugi et al., 1971)* In the rat ventral 
prostate, Nozu and Tamaoki (1974b) have shown an age-dependent 
shift of 5 o;-reductase from the rough surfaced to tho smooth 
surfaced microsomal fraction, and am age-dependent decrease of 
microsomal 5 a-reductase activity* The physiological explanation
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for these findings remains uncertain* It is, however, known 
that microsomaL enzymes are synthesized on the rough endoplasmic 
reticulum and transferred to the smooth endoplasmic reticulum 
where membrane catabolism takes place. The age-oependent 
shift of activity from rough to smooth microsomes may therefore 
be caused by a decrease in the degradation of the smooth membrane*
The intramicrosomal distribution of enzymes related to steroidogenesis 
are discussed in a review by Tamaoki (’1973),
The mitochondrial fraction isolated from human prostatic 
tissue was found to contain a small proportion of 5a -reductase 
activity. A similar situation has been found in the rat ventral 
prostate (Frederiksen and Wilson, 1972; Nozu and Tamaoki, 1973).
It is possible that this activity is due to contamination of the 
mitochondrial fraction by endoplasmic reticulum. Further 
purification of the mitochondrial fraction by zonal centrifugation 
linked to studies of the distribution of microsomal enzyme markers 
as performed on adrenal mitochondria (Cowan et al., 1971) may 
prove useful in confirming this hypothesis,
A major problem in subcellular fractionation of human 
hyperplastic prostatic tissue is the isolation or pure nuclei. 
Extremely low yields of DWA are obtained, and nuclear purity, as 
judged by ONA/RNA ratio (Table 10) and light microscopy, does 
not compare favourably with rat prostatic nuclear fraction, or 
with the nuclear fraction isolated from guinea pig liver (Maggîo 
et al*, 1963), flainwaring and Fllrny (1973) described similar
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problems in nuclear isolation from human hyperplastic prostatic 
tissue but Hansson and Tueter (1971) and Davies and Griffiths
(1973) make no reference to such difficulties in thoir purification 
procedure*
As a result of cytoplasmic contamination, the 
amount of 5 a-reductase activity found in the nuclear fraction 
in the present study may be overestimated* In a careful study 
by VerhoGven at al* (1974) it was shown that, within limits, 
the quantity of the 5 «-reductase present in the nuclear fraction 
isolated from various rat organs was proportional to cytoplasmic 
contamination® Upon further purification of human hyperplastic 
prostatic nuclear fraction, an increase in specific activity of 
5 a-reductase occurred (Table 13)* This finding suggests a 
proportion of the nuclear fraction 5. a-reductase was not present 
as cytoplasmic contamination* Similar results were observed 
upon further purification of the microsomal fraction (Table 13).
The problenBinvolved in the isolation of prostatic 
nuclei may be related to the high content of fibromuscular, 
stromal and connective tissue in the human hyperplastic prostato 
gland (Franks, 1954)* Filtration of the homogenate prior to 
subcellular fractionation removed much of this homogenisation 
résistent material, and resulted in higher nuclear yields*
During centrifugation of tho crude nuclear pallet through 2.DM 
sucrose some of the stromal connective tissue components still 
remaining wore able to penetrate this dense layer® Similar 
problems are associated with nuclear isolation from muscle tissue
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(de Duve, 1971)* Purer nuclear fractions may be obtained by 
the use of organic solvents (Bohrens, 1932) or citric acid 
(Higashi et al** 1966)* These methods were avoided in the
' «uurmAKiMmaniif ' *
present study since the presence of such agents may damage 
membrane structures (Kier et al*, 1967; Gurr. et al.. 1963)*
(d) Kinetics of 5cc -Reductase Activity
The apparent values, determined by Lincweaver - 
Burk analysis, for the nuclear and microsomal 5a -reductase 
activity from human hyperplastic prostatic tissue were 
0.105 X 10 M and 0*667 x 10 M respectively (Figure 17 ).
These values are of the same order as those obtained for 
5a -reductase from both rat prostatic nuclei and microsomes, 
and human skin microsomes, but are considerably lower than 
Lhose found in rat liver microsomes (Table 28 )« The 
5 oc-reductase would thus seem to be much more active in liver, 
where its function is to deactivate circulating testosterone»
In prostatic and skin tissue, where activity is lower, the 
function of the 5 a-reductase may be to activate circulating 
testosterone. The apparent of the 5 a-reductase for 
testosterone in human hyperplastic prostatic tissue is at 
least ten times that of the testosterone concentration in the 
same tissue (Siiteri and Wilson, 1971). It is possible, 
therefore, that as soon as this steroid enters the prostate 
in an unbound form it will be converted to dlhydrotestosterone*
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TABLE 28,
Apparent K of the 5« -Reductase for
Æia ui*aswg«cJ‘iVAt.^ aT7-»»P .«MWMWWWTKf «w%fwo*^ r^«m=&CR=zac»
Testosterone in Certain Tissues
Tissue 
1— — — ----- -— —
Subcellular
Fraction
Apparent K 
c rn
X 10 M
Reference
Rat Prostate Nuclear 0.62 Frederiksen and Wilson 
(1971)
Rat Prostate Nuclear 0.32 Shimazaki et; alo (1971)tnr.'itftwi;aBcoan '
Rat Prostate Nuclear
Microsomal
1 .05 
0.90
Nozu and Tamaoki (1973)
Rat Prostate Microsomal 2.50 Roy (1971)
Human Skin Microsomal 1.10 Voigt et al. (1970)ew*sct»irte.wAiu ' '
Rat Liver Nuclear 20.30 Gustafsson and Pousetto 
(1974)
Rat Liver Microsomal
... .
100 McGuire ot al. (1960)
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(a) Divalent Cation Inhibition of 5a -Roductaso Activity 
A number of enzymes are known which are both activated 
and inhibited by certain metal cations. For such enzymes 
inhibition usually occurs by cation concentrations greater than 
the optimum concentration for maximum activity (Hewitt and Nicholas 
1963). The findings of Grant et al* (1971) suggested that the 
nuclear 5a -reductase of human hyperplastic prostetic tissue was 
an enzyme of this type which was activated by low concentrations 
and inhibited by high concentrations of zinc. This hypothesis 
has not been confirmed* Results presented show that zinc 
inhibits nuclear 5 o-reductase activity at concentrations higher 
than 10 but does not cause stimulation at lower concentrations 
(Figure 13 Microsomal 5a -reductase of human hyperplastic-
prostatic tissue and nuclear 5a —reductase of rat prostate showed 
similar results (Figures 14 and 15 )<,
In an attempt to explain the difference between the 
observations of Grant et al. (1971) and those of the present 
study the experiment was repeated using nuclei washed with 
Triton X-100* This detergent was used by Grant et al* (1971)
but avoided in the present study since it is a known inhibitor 
of 5a -reductase (Liao, 1974). The inhibition of nuclear 
5 a-reductase by Triton X-10D is probably caused by disruption 
of the outer nuclear membrane on which the enzyme m'=>y be located 
(Moore and Wilson, 1972). The possibility was considered that a 
low concentration of zinc may, in some way, prevent membrane
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disruption by Triton X-100* A finding adding strength to this 
hypothesis is that zinc has been implicated in membrane stability 
(Reynolds 1972; Chvapil 1973). Unfortunately, results presented 
provide no evidence for this hypothesis; zinc was unable to reverse 
Triton X-lOO inhibition of nuclear 5 «-reductase (Table 14 )«
No further explanation for zinc stimulation of Sa -reductase 
observed by Grant et al* (19?1) can be offered*
Inhibition of both nuclear and microsomal fraction 
5 «-reductase activity of human hyperplastic prostatic tissue was 
achieved by a range of divalent cations with the following order 
of offoctivenesss-
2-t 2'f- 2 4- 24 24-
Hg * ^ Cu^^>2n ” ^ %
Frederiksen asnd Wilson (1971) observed similar results for the 
5 «-reductase of rat prostatic nuclear fraction,. .
Kinetics of zinc inhibition of tho 5 a-rsductase suggest 
that in both nuclear and microsomal fractions tha inhibition may 
be non-competitive with respect to substrate (Figure 17 ) and 
competitive with respect to cofactor (Figures 10 and 19 )* It
is, therefore, possible that zinc binds to a site at or near to the 
cofactor binding site,
A slight stimulation of human hyperplastic prostatic 
5 «-reductase occurred in the presence of EDTA (Table 16 )* This
may be due to the removal of endogenous or contaminating divalent 
cations* If this chelating agont is added to a zinc inhibited 
enzyme, reversal of inhibition occurred (Table 18 and Figure 16 ).
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A much smaller reversal is achieved if a high concentration of 
citrate is substituted fur EDTA* This phenomenon may be worthy 
of more thorough investigation since citrate, like zinc, is a 
component of seminal plasma and is found in high concentrations 
in the human prostate gland (Lutwak-Mann, 1963; Marberger ot al*,
1962).
(f) Thiol Group Involvement in 5« -Reductase Activity
Evidence presented in Section C.4. suggests that the 
5« «^reductase of human hyperplastic prostate may require an active 
thiol group for activity. The 5a -reductase of this tissue was 
extremely sensitive to the thiol group blocking reagent 
p-chloromercuribenzoata and was partially inhibited by high 
concentrations of ioduacetarnide, iodoacetic acid and N-ethylmaleirnlda 
(Table 15)* Reversal of p-chloromercurihonzoate inhibition 
was obtained by subsequent addition of ditniothreitol (Tablo 17 
and Figure 16)* High concentrations of dithiathreitol itself 
caused slight stimulation of 5a -reductase activity (Table 17).
Many enzymes which depend upon thiol groups for their 
activity are sensitive to low concentrations of some divalent 
cations (Howitt and Nicholas, 1963). Moreover, Klotz (1954) 
suggests that where free thiol groups are binding sites for metals, 
the order of affinity for this binding is reflected by the ' 
relative magnitude of the solubility products of the metal 
sulphides formed. On the other hand, if chelating reactions 
occur the stability constants of the metal chelates formed
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determine the relative affinities. The solubility products 
of metal sulphides in decreasing order are as follows;- 
. Hg - Ag^^CLT^Pb = Cd ^  Zn ;> Co = Ni Mn.
This is similar to the order of inhibition effected by some 
divalent cations on 5 a-reductaso, suggesting that these cations 
inhibit by binding tc a thiol group * Furthermore, inhibition
of 5 «-reductase can be reversed by subsequent addition of 
dithiothreitol (Table 17 and Figure 15 ). ‘Since zinc may 
bind to a site at or near to tha cofactor binding site it is 
concluded that an active thiol group may be present at this site.
It is possible that a competitive inhibition with 
respect to cofactor would be observed if zinc bound to NADPH 
thereby reducing the effective concentration of the cofactor® 
There are several sites on the cofactor where zinc could bind, 
for example, at the adenine group (Wallenfels and Sund, 1957) or 
at the pyrophosphate group (Kosower, 1962). It was shown 
earlier that the 5 «-reductase requires an active thiol groupe 
The order of divalent cation inhibition and the reversal of zinc 
inhibition by dithiothreitol suggested that these cations bind at 
a thiol group* It is, therefore, much more likely that zinc 
binds to a thiol group at, or near to, the cofactor binding site 
than to the NADPH itself. Many oxidoreductase enzymes are 
known to possess thiol groups which may play a role in catalysis 
(docelyn, 1972)® Results presented in Section C*3, and C,4. 
indicate that human prbstatic 5« -reductase may be an enzyme of
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this type. Frederiksen and Wilson (1971) present an order of 
inhibition by divalent cations of the rat prostatic nuclear 
fraction 5« -reductase consistent with that expected if these 
cations inhibit by rncrcaptide formation with thiol groups.
Roy (1971) found that rat prostatic microsomal 5a -reductase 
was strongly inhibited by 10 p-chloromercuribenzoate, but not 
by 1C iodoacatate or N-ethylmalaimide. Rat liver 5 a-reductasa 
is also strongly inhibited by p-chloromercuribenzoato and this 
inhibition can ba reversed by glutathione (5 x 1 [flcGuire 
At alo, 196o],
It is of interest to note that 5 a-reductase activity 
is slightly inhibited by o-phenanthroline (Table 16 )., a reagent 
which can also reverse zinc inhibition effected on this enzyme • 
(Table 18 and Figure 16 )* This agont forms complexes with 
metals and is widely used as a chelating agent, particularly for 
zinc and ferrous ions (l/allee, 1960). Rabbit muscle fructoso-1, 
6-diphosphate aldolase is inhibited by this chelating agent 
(Kobashi and Horecker, 1967). Fructose-1,6-diphosphate aldolase 
from rabbit muscle, however, 5s not considered to be a métallo- 
enzyme (Rutter, 19641* Kobashi and Horecker (1967) consider 
that the inhibition of fructose-1,6-diphosphate aldolaso by 
o-phenanthrolino is due to the oxidation of thiol groups to 
disulphide groups by atmospheric oxygen, catalyzed by a metal - 
o-phananthrolino complex.
Since the 5 a —reductase may require an active thiol
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group for activity, the oxidation of this group to a disulphide 
by atmospheric oxygen, catalyzed by o-phenanthroline, may explain 
why the 5 «-reductase is slightly inhibited by this chelating 
agente Furthermore, since the thiol group may be located 
at or near the NADPH binding site of the enzyme, it could 
participate in reduction by transferring hydrogen from NADPH 
to testosterone.
A possible outline of the process is shown in Figure 24* 
Glutathione reductase (Asnis, 1955)^lipoamide dehydrogenase 
(Massey et al*, 1960) and thiorcdoxin reductase (Moore et al*, 1964)
' • * ■uegajawwBm a’jfAUi * • ' . * *
are three enzymes in which proof of this type of thiol group 
involvement, with transfer of hydrogen from the cofactor to the 
substrate, has been presented* Conclusive proof of a mechanism 
of this type for Boc -reductase, however, would require the use 
of a purified enzyme preparation, and was considered to be beyond 
the scope of the present study*
2*. Zinc and Its Relationship to the 5 cc-Reductase Activity 
in ‘the Human Prostate
(a) Zinc Contont of Human Prostatic Tissue
Many reports suggest that human hyperplastic tissue has 
a high zinc content while adenocarcinomatous prostatic tissue has 
a greatly reduced zinc level (see Table 1 ). Results presented 
confirm these observations (Table 11 and 20 )*
Unfortunately it proved impossible to include a comparison 
between the zinc content of normal and hyperplastic human prostates
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in this study because of unavailability of normal tissue*
Although there are conflicting reports in the literature 
(flawson and Fischer* 1952s Hoars et al,, 1956) it would appear 
that the level of zinc, expressed as /jg of zinc per mg dry 
weight of tissue, in the hyperplastic prostate is slightly 
qrepter than the level in the normal gland (Schrodt et al,.
1964; Gyorkey et al,, 1967s Gonick et al,, i9G9; Dhar et al,,
* * /  ttlWp^gKCi^gTO'B * * *iJiilWi.ri'l,«ITmm ^ *
1973)o since prostatic weight increases dramatically during
hyperplasia a much more apparent increase will occur in the 
total zinc content of hyperplastic compared to normal prostate 
glands. The accumulation of such a high amount of zinc in
the diseased organ may cause marked changes in the ovorall 
metabolism of zinc within the body,
A marked variation in the zinc content detected in 
both benign hyperplastic and carcinomatous qlands in the present 
study was not due to lack of reliability in the experimental 
method use<^  for measuring zinco The reliability of this method 
is described in section C,1,(c), The variation in zinc content 
is more likely to be due to different amounts of zinc rich 
prostatic fluid stored in the samples analysed. The variations 
detected are in accordance with results from many other studies 
(see Table 1 ),
Since higher levels of zinc ar» found in hyperplastic 
than in normal prostate glands, a relationship may exist between 
zinc concentration and the degree of hyperplasia. No relationships
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however, was found between zinc concentration and hyperplastic 
prostate weight (Figure 20 ), Howaver, since the gland is 
rarely removed completely during surgery prostatic weight may 
not be an accurate indicator of tho extent of hyperplasia,
Likewise, patient age did not bear any relationship to the zinc 
content of the removed prostate glands,
(b) Distribution of Prostatic Zinc
While studying zinc distribution within the human 
hyperplastic prostate consideration was given to the extracellular 
fraction. This was considered important since it is likely 
that high concentrations of zinc are Stored in the extracellular 
compartment (i«G, lumen) of prostatic epithelium (Maquinay
1963)* To remove this compartment the prostatic mince was 
thoroughly washed with physiological saline prior to subcellular 
fractionation. This washing procedure may also remove small 
amounts of cell debris, blood contamination and intracellular 
fluid from damaged cells * The prostate gland,■however, is rich 
in stored secretion. If a sample of surgically removed prostate 
■is squeezed a relatively large volume of fluid can be forced out 
of the tissue. It is therefore felt that a large proportion 
of the fluid removed during the saline wash will be of extracellular 
origin. The saline wash also serves to prevent artifactual 
results obtained by the possible re-distribution of extracellular 
zinc during subcellular fractionation.
Investigation of the distribution of prostatic zinc 
within cellular fractions revealed that zinc is mainly located
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within the soluble portion (extracellular plus cytosol fraction) 
and ths crude nuclear fraction* Those findings are in partial 
agreement with the distribution of zlnc-65 in subcwliular fractions 
isolated from human hyperplastic prostatic tissue after incubation 
of tissue homogenates with zinc-65 (Reed and Stitch, 1973),
Dhar et al, (1973), however, obtained much lower values for the 
proportion of endogenous zinc in the cytosol fraction isolated 
from human hyperplastic prostatic tissue© No explanation can
be offered for the different zinc distribution obtained in the 
latter study© Endogenous zinc levels measured in subcellular 
fractions isolated from tha rat (dorso-lateral), monkey and dog 
prostates (Kar and Chowdhury, 1966; Ulabb £ t o  9 1973) are also 
consistent with the zinc distribution reported in the present 
study* No allowance was made for /.inc content of the 
extracellular fraction in any but the present study*
It is to be expected that zinc, a known component of 
prostatic secretion, should be present in the soluble portion of 
prostatic tissue* The high zinc content of prostatic nuclear 
fraction, however, requires some comment* Again it should bo
emphasised that zinc was not determined on pure nuclear 
preparations* Interpretation of results must, therefore, be 
approached with caution* Histological studios of this 
tissue have revealed that nuclei stain intensely for zinc 
(Gyorkey et si** 1967)© Another non-destructive technique, 
using an electron microscope microanalyser, has confirmed that a
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large portion of rat prostatic zinc is found within the nucleus 
(chandler et al*, 1974)* It is concluded, therefore, that 
although the proportion of zinc found in the nuclear fraction 
in the present study may be an overestimate, it is probable 
that zinc is a component of hyperplastic prostatic nuclei*
Nuclear fractions of other male reproductive tissues 
are also capable of concentrating divalent cations similar to 
zince In two studies where cadmium-109 was injected Into 
rats, approximately 40^ of the testiculai radioactivity was 
localised in the nuclear fraction (Chon et al*, 1974s Oohnson
et al * i 1970)* In tissues such as liver, which contain a much
lower level of zinc than that found in the hyperplastic prostate, 
approximately similar subcellular patterns were found with a high 
proportion of cellular zinc detected in the nuclear fraction (Thiers 
and Uallee, 1957)© There are several important zinc metalloenzymcs 
present in the cell nucleus such as DWA polymerase 1 (Springgate 
et alo, 1973), but it is unlikely that these contain much of the 
nuclear zinc#
The high zinc level in prostatic nuclei may be a 
consequence of the high concentration of zinc found in the cytoplasm* 
The accumulation of nuclear zinc may occur as a result of the uptake 
of zinc from a zinc saturated cytoplasm due to binding of zinc 
to non-specific sites© Studies, similar to those of Bryan et al©* «isAavchMvn-Mfw
(1974) on the intranuclear binding of Hg^^ in rat liver could help 
to elucidate whether nuclear zinc plays a functional role in the
16),
biochemistry uf the prostatic nucleus,
(c) Relationship Bstwocn Prostatic Zinc and 5a -Reductase
Activity
As shown jn Figure 22 a significant inverse relationship 
exists between the zinc content of fresh hyperplastic prostatic 
homogenates and 5« -reductase activity. This relationship is 
also apparent within different areas of three out of the four 
hyperplastic prostate g.lands studied, although statistical analysis 
would be invalid due to the small number of experiments performed 
on individual glands. In one prostatic sample, a negative 
relationship between zinc content and Set-reductase activity was 
not found* Histological examination revealed that this gland 
was infiltrated with an anaplastic malignancy© This is an 
extremely rare condition to be discovered in surgically removed 
prostatic tissue, A malignancy of this type is associated with 
leukemia and not with prostatic disease. Properties of this
tissue would not bo expected to bear any similarity to normal, 
hyperplastic or adenocarcinomatous prostatic tissue.
It is rather unfortunate that normal or adenocarcinomatous 
tissue was not available for a study of the relationship between 
zinc and 5 oc-reductase activity© In the latter case, however, 
results similar to those described in the case of anaplastic 
malignancy may be expected due to the lower zinc levels (Table 1 ) 
and decreased 5 a-reductase activity (Giorgi et el,© 1973) in 
.adenocarcinomatous tissue. It is regretted that, although gross 
histology was performed on proststic samples^no information was
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available as to the precise histological nature of the tissue 
sections removed for homogenisation® A more careful histological
analysis may have revealed more information such as relationship 
between zinc and 5a -«reductase activity and epithelial content of 
the tissue under examination*
Considering the high zinc concentration present in 
the prostate it must be assumed that this tissue has a high affinity 
for zinCo When zinc was added to prostatic homogenates the 
resulting inhibition of 5a -reductase activity (Figure 23 .) 
occurred in the same range of zinc concentrations as that seen 
for nuclear and microsomal incubations (Figures 13 and 14 )•
This implies that any binding components which may be present in 
the homogenato are saturated with zinc* If this was not the case 
zinc added to homogenato incubations should immediately be bound 
to non-saturated zinc binding sites present and hence probably be 
unable to inhibit the 5a ^ reductase* In this situation zinc
added to homogenate incubations should inhibit the 5a -reductase 
at a higher concentration than zinc added to nuclear and microsomal 
incubations which are unlikely to contain the zinc binding 
component responsible for the accumulation of zinc within the 
prostatic cello This explanation for -the experimental results 
reported assumes that bound zinc is unable to inhibit the 5a -reductase, 
Although this is probable no further evidence is available to 
confirm this hypothesis*
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(d) KynokhGticpl Feedback Control EF^ectod by Zinc on 
5 a "’Reductase Activity
Results of in vitro oxpcriments carried out in the 
present study show that (a) an inverse relationship occurs between 
zinc content and 5 oc-reductase activity, (b) prostatic homogenates 
may bo supersaturated with zinc and (c) prostatic 5 a-reductase
is a zinc sensitive enzyme g probably by virtue of an active thiol
group at or near the NADPH binding site* This information leads 
to the suggestion that, in vivo, prostatic 5 a-reductase activity 
may be controlled by the concentration of zinc within the tissue©
The results of an independent study by Habib et alp (1975) ere also 
consistent with this proposal. These workers showed an inverse 
relationship between prostatic zinc and the level of dihydrotastosterone,
the product of the 5a -reductase enzyme, in human prostatic tissue *
In a gland, such as the prostate, where secretory material 
is both synthesized and stored in preparation for eoisodic release 
some type of feedback control must exist. This feedback system 
must maintain secretory stores within narrow limits and must permit 
rapid accumulation of stores to follow release, A hypothesis 
involving zinc in a feedback control of prostatic secretion is 
postulated and illustrated in Figure 25, Upon entry into prostatic 
epithelial cells testosterone is rapidly converted, by the 5« -reductase, 
to dihydrotostosteroneo Dihydrotesto^terone, bound to a specific 
receptor, is transferred to the nucleus where it stimulates the 
synthesis of a specific messenger RNA, The dihydrotestosterone 
initiated message is then transferred back to the cytoplasm where
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it is translated into a protein which has a high affinity for 
zinCcj Reed and Stitch (1973) have isolated and purified such 
a protein from human hyperplastic prostatic tissue* The zinc 
binding protein may be responsible for the accumulation of zinc 
from the peripheral plasma into the epithelial cells against a 
concentration gradient © As the epithelial cells and lumen 
become saturated with zinc the 5oc ^ reductase will be inhibited 
by zinc, and this in turn wiJl reduce the amount of zinc binding 
protein synthesized and reduce zinc uptake* Upon ejaculation 
the prostatic secretion containing much of this zinc is removed 
and testosterone is again able to be reduced to dihydrotostosterone* 
This prostatic system may be somewhat analagous to that suggested 
by Larkins et ale (1974) who suggest that as calcium accumulates 
in kidney tubule cells, it inhibits the hydroxylation of 
25“»hydroxycholGcalciferol to the active 1,25-dihydraxycholBcalcif8rolfl 
The latter hormone is involved in the synthesis of a calcium 
binding protein by the tubule cells*
(e) Further Considerations
Although the hypothesis presented in Figure 25 provides 
a rather attractive explanation for the way in which prostatic 
secretion is controlled there are several considerations which 
cannot be ignored* For instance, the prostatic tissue used in 
this study was hyperplastic and not normal* Although benign 
hyperplasia is a disease which affects the size and number of 
prostatic epithelial cells and in some cases fibromuscular
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elements, the secretory processes oF the gland are not markedly 
impaired* It is therefore possible that the system involved 
in the control of prostatic secretion is similar in both normal 
and hyperplastic glands*
Artifacts may be produced by the use of tissue 
homogenates* During homogenisation considerable disruption 
of the prostatic cells occur which result in redistribution of 
cellular components* In this disrupted state prostatic zinc 
may be capable of inhibiting 5a ^reductase activity* There 
is no conclusive evidence, however, that in vivo, where there is 
no disruption or redistribution such an inhibition would take 
place*
Methods which might partially overcomo this problem
3
could involve incubations of H-tostosterohe with prostatic 
preparations which had not been as extensively disrupted^as mince 
or slice incubations* Because of the heterogeneity of human 
prostatic tissue, however, it would be extremely difficult to 
relate 5 a •■’‘reductase activity to zinc content* In homogenate 
incubations this problem is partially overcome since a homogeneous 
preparation is obtained* Much of the stromal and connective 
tissue is also removed from this preparation by filtration*
Addition of reagents (TDTA, o-phenanthroline and 
dithiothreitol) which are known to reverse zinc inhibition of 
the 5 a-reductase in nuclear and microsomal incubations, did not 
markedly stimulate reduction in prostatic homogenates* It is
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possible that; either these agents are deactivated during 
homogenate incubations before being able to act on the 
5 oc-rer'uctnse or that some other agent (the zinc binding 
protein?), which has a relationship with prostatic zinc, 
can inhibit the 5a ^reductaso* Citrate, which is related 
to zinc in the human prostate (both are components of 
prostatic aecreticn) uas been eliminated as a compound 
able to inhibit Sex -reductase (Table 16)*
Prostatic cytoplasm, which is known to contain a 
high proportion of the intracellular zinc (FigLiro 21) did not 
inhibit 5a ^reduction when added to microsomal incubations*
Heated cytosol fraction, however, was capable of inhibiting 
5a -reductase activity (Table 25 and 25)t The inhibitory 
factor present in heated cytosol could be removed by passage, 
through a cation exchange column, a process known to remove zinc*
(f) Concluding Remarks
Much future research is necessary to clarify the 
feedback control hypothesis outlined in Figure 25 and to 
explain the contradictory observations outlined in Section (o) 
above. It is assumed that in the human prostate the zinc 
binding protein is under androgenic control via the nucleus*
There is no experimental evidence presented for this, however, and 
other possibilities exist, Dihydrotestosterone could cause the 
accumulation of zinc by causing the . conversion of pre-zinc 
binding protein to an active zinc binding protein*
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The inhibition of the 5 o^Toductase by zinc may be of a more 
complex nature* Calcium inhibition of kidney 25,hydroxy- 
cholecolciferol-1-hyuroxylasej for example, may be associated 
with calcium influx into renal cells (Larkins et__al*, 1974), 
Depression of 5a —reductase activity by zinc may not be due 
to a direct effect on the 5a -reductase activity but may result 
from decreased synthesis of the enzyme* In this context
Webb et al* (1973) have shown that protein synthesis by
polyribosomes isolated from dog and rat (dorso-lateral) 
prostates may be modified by zinc*
An experiment that might provide useful information 
concerning the feedback control of zinc on 5a -reductase
activity could be performed on the dog* It is known that
pilocarpine hydrochloride will cause stimulation of prostatic 
secretion if injected into male dogs* For example, one hour
after administration as much as 60rnl fluid has been shown to be 
discharged from the gland (Huggins, 1945 and 1947)* In this 
situation 5 a-reductace activity should be greatly increased 
within the gland due to a reduced zinc level.
Perhaps some questions concerning the androgenic 
control of prostatic secretion in the human prostate gland will 
remain unanswered until a more convenient system is developed 
for the biochemical study of human prostatic tissue* Surgically 
removed hyperplastic prostatic-tissue, os used in the present 
study, is extremely heterogeneous and contains varying amounts 
of upithelial and stromal components * This leads to problems
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when comparing and interpreting results from different, experiments® 
Another problem is that most research carried out on 
human hyperplastic prostate is hampered by lack of knowledge 
as to whether the results obtained apply to normal or only to 
diseased tissue* Difficulties occur in comparing results 
with experiments with fresh normal prostatic tissue which is 
extremely difficult to obtain® The great diversity in 
reproductive biochemistry may make comparison with normal 
prostatic tissue from other mammals unhelpful® The best 
comparison, however, could be with normal dog prostatic tissue 
since the dog is the only other species known with a high 
incidancB of prostatic hyperplasia* If biochemical information_ 
is not available from normal human prostates results of experiments 
with hyperplastic tissue, although of importance in themselves, 
are unlikely to shod'much light on the nature of prostatic 
hyperplasia*
Further difficulties arise from variations in 
parameters such as age, general health, prostatic weight, 
nutritional state, drug therapy and environmental status of 
patients* Reynolds and Dingle (1970) have used an organ 
culture system to study the effects of hormones and other agents 
on the movement of calcium into and out of bone* A similar 
system has been developed for the rat prostate (Lasnitzki and 
Franklin, 1972)* It may be that the use of an organ or cell 
culture technique, which would by-pass many of the practical
172,
problems inherent in the present approach, would facilitate 
further investigations into the relationship between zinc 
and androgen metabolism in the human prostate gland*
173.
BIBLIOGRAPHY
Acevedo, H,Ft and Goldziehar, 0,W. (1964)
Acte. 82, 118-120,
Acevedo, iUF. and Goldzishor, 3®U« (1965) O.iochim* Biaphys® 
Acta. 97, 564—570,
Aitken, R,0® (1974) ' 3. Rcnrod. Peri® 40, 333-340.
» ’  ^  f;4^it.^MWMwrKtrirrn9A^ssn.nmicwcr.t®.airJfV=n
Anastassladj,8, P.A, and Common® R.Ho (1968) Anal® Siocharrio* * '  * BMVa- ftJl-P^WVIWSMKMVVfiklblblk'X. '^LjniTTtin'
22^  409-423.
Anderson, K*M, and Liao, S® (1968) Nature ii-ondon) 219, 227-279,
Anderson, KJI., Cohn, He and Samuels, S. (1972) F,E.B,S, Letters 
27, 149-152.
Andrews, G,S. (1951 ) 3. Arst. 85, 44-54«* ’ ' KWI^ <«VC4( p>rW7«*v«»V« *
Asnis, n,E, (1955) 3. Biol, Chen. 213, 77-85.
Aughey, E. (1970) 3, Rcprcd, Fort® 22, 65-68,
Axelrod, LcR®, Matthijssen, C., Go.ldzieher, 3.1;J« and Pollian,
3.E. (1965) Acta., Eodo'-'r-l.nol^  (Conanhacen) Bunol, 99,
174*
Baulieuj E-E*, Lasnitzki, I® and Robalj P® (1968) Nature 
(London) 219, 1155-1156.
Bayliss, W.M. and Starling, EoH® (1902) 3ePhysiol (London)
28, 325-353®
Bayly, R.3. and Evans, E.A. (*1968) In Storage and Stability of
• * * '  « i, i# Lu.i .w mi#  mu., ..««L ■■nm u m
Compounds Labelled with Radioisotopes Review No® 7, The 
Radiochemical Centre, Amersham, U*K«
Becker, H,, Kaufmann, 3®, Klosterhalfen, H® and Voight, K.D. (1972) 
Acta* Endocrinol. (Copenhagen) 71, 589-599.
Behrens, M. (1932) Hoppe - Seyler's. Z® Physiol. Chem* 209, 59-74®
Bertrand, G. and Vladesco, R® (1921) C.R® Acad. Sci., Paris.
173, 176-179.
Birnbaurn, D., Hall, T® and Lee, R. (1961) Proc, Soc* Exp.
Biol. Med. 108, 321-324.
Blodel, Gp and Potter, V.R. (1966) Science (New York) 254, 1662-1665
Boddy, K., East, B.W., King, P.C., Simpson, R.D. and Scott R,
(1970) Brit. 3. Urol. 42, 475-480.
^ * ■tofee**itFVxi:tta*û«»eai<eo™iM3w«Mi»5rr*a** m m k m * '
Borth, R. (1952) In CIBA Foundation Colloguia on Endocrinology 
Vole 2, p.45 LondonsChurchill
175
Baursnell, 3«C., Baronos, S®, Briggs, P.A. and Butlor, E.G. 
(1972) Go RejDrodo Pert® 29, 215-227*
Brooks, CflGcW*, Brooke, R.Vo, Potherby, K®, Grant, G,K*, 
Klcpper, Ao and Klyne, W« (1970) G. Endocrinol. 47, 263-272,
BrucR; H«M. and Parkes, A.S* (1949) G. HyOo 47, 202-208,
Bruchousky, N, and Wilson, G.D, (1968) G* Biol® Chem® 243, 
2012- 2 021.
Bryan, S.A*, Lambert, C,, Hardy, K®G* and Simons, S. (1974) 
Science (New York) 186, 832-833.
Burton, K® (1956) Biochem. G® 62, 315-323
Burton, K* (1968) In Methods in Enzymoloqy (Colowick, S.P, 
and Kaplan, N®0® eds®), Vol. 128, pp® 163-166, Academic Press, 
London and New York*
Caggiano, V®, Schnitzler, R®, Strauss, W®, Baker, R.K.,
Carter, A.C., Gosephson, A®S® and Wallach, S. (1969)
Amer, G® Med. Sci, 257, 305-319.
Calvin, H.I. and Bleau, G® (1974) Exp® Cell® Res® _86, 280-284. 
Chamberlain, G., Gagarinec, N® and Ofner, P® (1965) Biochem Go* r ^ / r«siU4ïtJ4f4<m|C>w4r*Mn«aaR"a
99, 610-616,
176,
Chandler, 3.a®. Harper, M.E* and Griffiths, K* (1974) 
3. Endocrinole 61, 1v-1vi.
Chen, R.Wo, Wagner, P.A®, Hoekstra, W.G® and Ganther, H.E
(1974) :io Reprodc Eert. 38, 293-306*
Chisholm, G.D®, Short, M.O., Guanadian, R«, McRae, C.U. and 
Glass H.I. (1974) 3, Nucl, Med. _15g 739-742.
Chvapil, M* (1973) Life Sci* 13® 1041-1049** * « m BB<u«c*b>fvuiMej»><>Kan» iaacsKra*
Collins, W.P., Koullapis, E.N., Bridges, C.E. and Sornmerville, I.E.
(1970) 3e Steroid Biochem. 1_@ 195-207.
Cowan, R.A. and Grant, 3.K. (1975) Biochem. Soc. Trans.
(In Press).
Cowan, R.A., Grant, O.K., Giles, C.A. and Biddlecombe, W.
(1971) Biochem. 3., 1971 126. 12P.
Daniel, 0., Haddad, E., Prout, G. and Whitmore, W.F. (1956)
Brit. 3. Urol. M.» 271-278.
Davies, P. and Griffiths, K« (1973) 3. Endocrinol.
59, 367-368.
177 o
Davies, Fahny, A.R®, Pierrepoint, C«G. and Griffiths, K®
(1972) Biochem®j, 129, 1167-1173.
Dean, 3.A® and Rains, T.C. (1969) In Flame Emission and 
Atomic Absorption Spectrometry Vol. 1. pp. 113-116 
Marcel Dekker, New York and London.
de Duve* C® (1971) 3. Oeil Biol* 50, 200-550*
de Duve, C®, Pressman, B.C., Gianetto, R,, Uattiaux, Ro 
and Appelmans, F® (.1955) Biochem® 3® 60, 604-517*
Dhar, N.K®, Geol, T.G®, Dube, P.C., Chowdhury, A.R. and 
Kar, A.Bo (1973) Exp* Molec* Biol* 19, 139-142*
Dorfman, R®I. and Shipley, R.A. (1956) ïn Andronons pp: 116-128 
3ohn Wiley and Sons, New York®
Dorfman, R®I® and Ungar, F* (1965) Metabolism of Steroid 
Hormones Academic Press, London and New York®
Ekbom, K® and Wetterdal, B® (1961) Scan® 3® Lab, cl;n® Invest, 
23, 396-401*
Eliasson, R®, 3ohnsen, 0® and Lindho.1 mer, C® (1971) Life Sci 
10, 1317-1320*
178*
Enqel, Le (1969) In Progress In Endocrinology (Gual, G. and 
Ebling, F.D.G.s sr^ So ) pp. 857-062 . Excerpta Meciica FoumJation, 
Amsterdam®
Evans, N« and Rabin, B.R. (1968) Eur. 3® Biochem* 548-554,
Evans, C.R. and Pierrepoint, C.G® (1975) Endocrinol.
£4, 539-543*
Farnsworth, U.E. (1965) Steroids £, 519-530*
Farnsworth, W.E. (1966) Sterolds £, B25-S44o
Farnsworth, W.E. (1970) In Some Asoocts of the Aetioloov 
and Biochemistry of Prostatic Cancer (Griffiths, K. and 
Pierrepoint, C.G., eds.) pp. 3-15*
Farnsworth* W.E., Brown, O.R., Lano, Co and Cross, A. (1962) 
Fed, Procn Fed. Aner. Soc« Exp. Biol, 21, 211*
Farnsworth, W,E. and Broun, 0»R, (1963) 0. Amor, Med. Ass
183, 436-439o
Fischer, M,I *, Tikkala, A®0. and Mawson, C.A. (1955)
Can e 3. Biochem. Physiol * 33, 181-190*
179.
Folch, D.ÿ Lees, M. and Stanley, G.fLS® (1957) Biol* £heiii! 
226, 497-509®
Franks, L«.M. (1954) ,\nn« Rqs'. Coll. Surq. Enql* 14, 92-1 OS*
Franks, L.M. (1974) In The Treatment of Prostatic Hypertrophy 
and Neoplasia (Castro, 3®E., ad* ) pp« 1-26 Medical:, and 
Technical Publishing Co. Ltd., U®K®
Fraser, C.R. and Kodicek, E. (1970) Nature (London) 228, 754-765
Frederiksen, D.W® and Wilson, 3 ®D* (1971) 3® Biol. Chem.
246, 2584-25930
Fujii, To, Ptida, 5. and Mizuno, T* (1955) Nature (London) ^ r * f f > * isM»«r*ï*rten»ewiiîe*M.'Aem»a«5*wat—tt^etaw'
176, 1068-1059.
Ge]1er® 3o (1974) In The Treatment of Prostatic Hypertrophy 
.?il£i™J^ l£££LâSi;£ (Castro, 3.E®, ed.) pp. 27-58 Medical and 
Technical Publishing Co. Ltd®, D.K®
Giorgi, E.P®, Stewart, 3.C., Grant, 3.K, and Scott, R* (1971) 
.Bipchem® 3* 123, 41-55®
Giorgi, E.P*, Stewart, 3.C®, Grant, 3JK. and Reid, 3« (1972a) 
3. Endocrinol, 55, 421-439*
180,
Giorgi, E*P*, Stewart, 3*C«, Grant, 3.K ® and Shirley, I.M*
(1972b) Biochem. 3® 12Ô, 107-121*
Giorgi, E , Shirley, Ï.Mo, Grant, 3 @K ® and Stewaju t, 3.G®
(1973) Biochem0 3* 132, 465-474*
Giorgi, E.P*, Moses, T.F'o, Grant, b « K *, Scott, R® and 
Sinclair, S® (1974) Molec® Cell* Endocrinol® 1, 271-284
^ '  #» ■B ru nm:#u UuÆ®a»ir' rT<t itt«> «n i " i « jns'
Gloyna, R®E« and Wilson, 3®D® (1969) 3, Clin® _En£oc^.ngl
Metabe 29, 970-977*
Gloyna, R ® E *, Siiteri, P*K ® and Wilson, 3.0® (1970) ■ 3. Clin* 
Invest, 49, 1746-1753*
•«nasTTiue'jfcvnbTvji) rtcssaa'
Gonick, P., Oborleas, D®, Knechtges, T. and Prasad, A®S, (1969) 
Invest a Ur olt 6, 345-347*
Goodenoughj V.W. and Levine, R.P® (1970) Scientific American 
223, No* 5, 22-29*
Gorski, 3- and Morgan, M * S. (1967) Biochem* Biorjhys* Acta* 
149, 282-287*
Gorski, 3*, Toft, Da, Shyamala, G*, Smith, D* and Notides, A, 
(1968) Recent Proqr* Horm* Res* 24, 45-80*
181*
Gorsuchc T«To (1970) In The Destruction of Organic Matter 
Inta Series of Monographs in Analytical Chemistry, Vol* 39 
Pergamon Press Ltd*, Oxford, U*K*
Grant, 3,K. (1969) In Essays in Biochemistry (Campbell, P,fvi«. 
and Greville, G.D® edsc) Vol* 5 np* 1-58 Academic Press, 
Londcn and New York*
Grant, 3*K*, Minguell, 3*, Taylor, P* and Weiss, M* (1971) 
Biochem, 3* 125, 21P*
Gunn, S*A* and Gould, T*C* (1956a) Proc^ Soc* Exp* B.iol* Med*
£2, 17-20o
Gunn, St A. and Gould, T*C* (1956b) Endocrinology* 58, 443-452*
Gunn, 5*A* and Gould, T*C* (1957) 3* Endocrinol* 16, 18-27*
Gunn, S*A* and Gould, T.C* (1958) Amer* 3* Physiol* 193, 505-508.
Gunn, ScAo and Gould, T*C* (1970) In The Testis (Oohnson, A*D*
and Gomos, W.R* eds*) Vol* III pp* 377-461 Academic Press,
London and New York*'
Gunn, S,Ao and Gould, T * C * (1972) Proc * Soc * Exo* Biol* Mod*
14J_, 639-642*
Gunn, S.A«, Gould, T*C® and Anderson, W® A n0« (1965) £*
Endocrinol® 32, 205-214,,
GunsaluSÿ j l # G .  and Razzell, W®E, (1957) In Methods in 
Enzymolnny (Colowick, 5®P. and Kaplan, N«0® eds®) Vol® III 
p® 940 Academic Press, New York and London *
Gurr; M«Io, Finean, 3.B® and Hawthorne, 3®N, (1963)
Bioch.im* Biophys., Acta. 70, 406-416®
Gustaffsson, 3-R* and Pousette, R* (9174) Biochem® 3®
£42, 273-277.
Gyorksy, F *, Min, K-W*, Huff, 3.A® and Gyorkey, P. (1967) 
Cancer Res* 27, 1348-1353.
NiWwjMfiieMiBiA'iiaafWiiMAiKvniue eeeaw ^
Habib, F,.Ke, Hammond, G.L®, Stitch, S,R® and Dawson, 3*A.
(1975) 3* Endocrinol® 65, 34P®
Hagsnfeldt, K®, Platln, L<,0® and Diczfalusy, E* (15 73)
Acta. Endocrinol® (Ccponhanen) 72, 115-126*
Handler, P. and Klein, 3.R® (1942) 3® Biol* Chem* 144, 453-454.
Han^son, U« and Ti/etar, K.3® (1971) Acta® Endocrinol, (Copenhasan) 
68, 69-78o
183,
Harper, M.E*, Pi.ke, A«, Peeling, W*B*. and Griffiths, K* (1974)
.3 E n doc r in pi a 6d, 117-125.
Hewitt, Eo3o and Nicholas, Do3®D. (1963) In Mat abolie Inhib i t ors
(t-Iochstcr, R.Mo and Quastoll, 3,H. eds*) Vol* II pp. 311-436
Academic Press, London and New York*
Higashij Ko, Narayanan, K.S®, Adams, H*R, and Busch, H® (1956)
Cancer Res. £6, 1582-1590.
Hilgar, A»G* and Hummel, 0«3, (1964) In Androgenic and 
Myopenic Endocrine Bioassay Data . Part III Nat, Cancer Inst®, 
Bethasda, U,5,Ao
Hoaro, R«, Delroy, G,E, and Pennor, 0«U, (l956) Cancer® £, 721-726,
Huggins, C, (1941) 3, Urol* 46, 997-1006.
^  # ^ »a*aaau<iniJ.I i,»j  n w tji ■smxmca''
Huggins, C. (1945) Physiol, Rev, 25, 281-295.
'  ■iMi4uqn'!4kf.v<vm>oAqm>i»>iVM3iaijnMba(s«H M'cAan*
Huggins, C* (1947) Harvey Lect. 42, 148-193,
Huggins, C, and Hodges, C«V, (1941) Cancer Res, £, 293-297
Hunter, 3® (1792) In Observations or: Certain Parts of the 
Animal Oeconomy, 2nd, edn* pp* 31-51 London*
184.
Imperaho—noLinleyj 3.  ^ Guerrero, T«, Gautier, T. and Peterson,
R*E. (1974) Science (New York) 185, 1213-1215®
Isurugi, K®, Inano, H® and Tamaoki, B* (1971) Steroidoloqia 
2, 303-32Ü,
Sacoby, M® (1923) 2. Urol. Chir® 14, 5-37,
Jenkins, 3*S« and McCaffery, U.Mo (1974) 3® Endocrinol*
£3, 517-526.
Jensen, E.V* and De Sombre, E.R. (1972) Annu® Rev* Biochem*
4£, 203-230®
Jensen, [.V®, Suzuki, To, Kawashima, T*, Stumpf, W.E.,
Jungblut, PoW® and Do Sombre, E.R, (1958) Proc* Nat* Acad® Sci* 
U.S.A. £9, 632-638.
Jocelyn, P.O. (1972) In Biochemistry of the SH Group pp. 14-22 
Academic Press, London and New York®
Johnson, A.D., Sigman, M.D. and Miller, W.3. (1970) 3. Reprod.
Fort® 23, 201-213® ,
»nnn«*« '
Johnson, 3®, Wikstrom, B® and Nylander, G® (1969) Scand. 3. Urol, 
irol® 3, 9-11.
185 o
Jouan, P., Sarnperezo S» and Thiev/lant, M*L, (1973) 3, Steroid,
Biochem. 4, 65-74*
Karg A.Bo and Chowdhury, A.R® (1966) 3® Urol® 96, 37C-371
* * * * * ■ I     ■■iniiiminiiiiiiiriii «kinvusu '
Kqîï', H*M*, Smollie, R.M»S. and Siebert, G. (1962) Nature 
(London) 196, 752-754*
Kerr, S,E. and Seradiadarian, K * (1945) 3 « Biol* Chem®
159, 211-215®
Kerr, W.K.* Korestecig A.G® and Mayoh, H® (1960) Cancer,
£3, 550-554®
King, R,3,B* and Mainuaring, W.I,P* (1974) In Steroid-Cell ^ f trPF*«»«h4<»Wft»»ta*ew<â»ïir»*«*nu,>ïî*
Interactions pp® 25-35 and pp. 41-101 Butterworths* London.
Kinson, G. (1962) Fed* Proc, Fad, Amer, Soc. Exp. Biol*
2£, 211.
Klotz, loMc (1954) In The Mechanism of Enzyme Action 
(McElroy, W,B. and Glass, 0, eds.) pp. 257-285 3ohn Hopkins 
Press, Baltimore.
K o b a s h i, K ® and H o r s c k er, B,L. (1967) Arch. Biochen* Biophys. 
121, 178-186.
186.
Kosower, E.M. (1962) Biochem. Biophys® Acta* 56. 474-479.
Kowarski, A®, Shalf, 3. and Mlgeon, C.J, (1969) 3, Biol* Chom*
£44, 5269-5272.
Larkinsj RoG®, MacAuley, S.T® and MacIntyre, I® (1974) Nature 
(London) 252, 412-4'ii.
Lasnitzki, I. (1955) In Radiobiology Syninoaiurn 1954 (Bacq, Z.M* 
and Alexander--5 P* eds*) pp® 321-330 Acsdernic Press, London and 
New York ®
Lasnitzki, I. (l970) In Some Aspects of the Aotioloqy and 
Biochemistry of Prostatic Cancer Proc. 3rd Tenovus bJorkship 
(Griffiths, K. and Pierrepoint, C.G®, eds.) pp* 68-73*
Lasnitzki, I® and Franklin, H® (1972) 3, Endocrinol. ^  ^ f ey*ew<w*c*w**Tw«»Fwwa»r»K»mej»aw*;’.ve
£4, 333-342.
Liao, S« (1974) In MoT.P* Int., Review of Science Biochemistry of 
Hormones (Rickenberg, H«V® ed.) Biochem. Series One*Vol. B pp. 154« 
185 Butterworth®
Lindholmerj C. (1974) Androloqia. 6, 7-16®
1S7«
Lineweaver® H® and Burk, D® (1934) 3* Am:r* Cham® Soc.
56; 658—666.
Lo, M-C.j Hall, Ta and Whitmore, W « F ® (1960) Cancer.
£3, 401-411o
LoQothatopoLilcs, 3. (i960) Amer® 3® Pathol* 37, 357-375
* * ' ' fr*aanmr'Mga».4^ >j.:B™mjaMJiJtatgrgga-B3j«rg» ^
Lorains, 3«Ao and Bell, F.T, (1965) In Hormone Assays and 
Clincial Applications F * and S® Livingstone, Edinburgh and 
London®
Lowry, 0*H«, Rosebrough, N®3., Farr, A.L. and Randall, R®3® 
(1951) 3® Biol® CheiTio 193, 265-275*
Lousley, 0*5, (1912) Amor® 3® Anat.. 13® 299-349
Lutwak-Mann, Co (1963) In The Biolony of the Prostate and
FT ' r  I rt -i-r-i—IT-r*Y—irf-l-Trf~T*<Tf^ - r m iimfr-ir>«r>—r--T»iTT iT.<i-"nTinnnTmiifT i imrrvrmrtri n«K iir iii
Related Tissues IMatn® Cancer Inst* Monogr. 12, pp. 307-308, 
Lut'-iak-Mann, C. and McIntosh, 3*E,A® (1969) Nature (London)
* '  * S-Htfye’.lMeeiwHnKiuejCTauseAeenaMiew^nwiojVflflHiew»
22, 1111-1114,
Mackenzie, A.R®, Hall® T, and Whitmore, W.Fo (1952a) Nature 
(Lo..don)_ 193; 72-73.
188.
Mackenzie, A.R*, Hall, T* and Whitmore, W*f-* (1962b)
3 * Urole 87; 923-929.
MaggiOg Ro, Siekevitz, P. and Polade, Got* (1963) 3. Cell,
Biol. 18, 267-291.
Mahler, H. and Douglas, 3. (1957) 3. Amer. Chem® Soc.
79, 1159-1166.
Mainwaring, W.I.P. (1970) Biochem. Biophys. Res® Commun»
40, 192-198.
Mainwaring, W.I.P. and Mangan, F.R* (1973) 3® Endocrinol.
5£, 121-139.
Mainwarlng, W.I.P. and Milroy, E.3«G* (1973) 3* Endocrinol.
57, 371-384.
Mann, T* (1954) In The Biochemistry of Semen and of the Male 
Reproductive Tract Mathuen and Co® Ltd., London.
Maquinay, C., Timmermans, L. and Gerebtzoff, M.A. (1963) 
Procès. V/erbausB Mémoires et Discussions Uu Congres Français 
D'urologie 57, 567-575.
189.
Marbergerg Marbergsr, Eo, Mann, T = and Lutuak-Hann3 Co
(1962) Brito Mad, 9. ,1^3 835-836,
Massay* V, $ Gibson « QcH* and l/eeqer« C* (i960) Biochon 0^
77, 341-331,
Mawson, C 0 A o and Fischer, Mel* (1952a) Can * 3, Med, Set,
30, 336-339o
Mawson, C.Ao and Fischer. M.I* (1952b) Arch, Biochem- Bionhys, 
36, 485-486,
Mauson, C*A* and Fischer, M,T, (1953) Blochem* Oo 55, 696-700
Mawson, C,A. and Fischer, M,!* (1956) Nature (London) 177, 190
Mazur, Pc, Loibo, 5*0*, Farrant, 0,, Chevs, ILY*, Hanna, M«G* 
and Smith, L,H* (1970) In The Frozen Cell (Uolstenholrne, G*P,li/« 
and CdConnor, M * ads,) pp, 69-35,0® and A® Churchill, London,
McGuire, 3*5* and Tomkins, G*M* (i960) ]* Biol* Chem* 235, 1634-1638,
McGuire, 3*S&; Hollis, V.W® and Tomkins, G*M* (1960) ]* Bi.nl* Chom®
235; 3112-3122.
190.
McPhee, G® (1973) In Investigation of 11G-hydroxy Steroid 
Dehydrogenase in Pal.iv/ar'- Gland PheD* Thesis (Univ® of Glasgow)*
Meryman, H« F* (1965) In Crybj^olog^ (Moryrnan, H.T® ed*)
pp* 1-114 Academic Press, London and New York®
Michaelis, L® and Men ten, M*> * (19'|3) Oidcherri, Z® 49, 333-369®
*  v  ^ ririrr-ri[-nri-.—nTirnni«'Wi>rrM**TiirT II [1 tr.nii w  '
Millar, M«3*; Vincent, N.R® and Mawson, C®A® (1961) 3® Histochem,
Cytochemo 9, 111-116®
Minguall, 3.3. and Sierralta, U.D* (1975) 3®^  Endocrinol»
6^, 287-315o
Mirand, EoA. and Bender, M« (1956) Anat* Rec© 125, 618©
Moger, U.I. and Geschwind, Id* (1972) Proc. Soc© Exp® Biol® Med,
111» 1017-1021*
Moore, R®3. and Wilson, 3,D. (1972) 3® Biol. Chem* 247, 958-967, 
Moore, R.3* and Wilson, 3,0. (1973) Endocrinol© 93, 581-592,
' * ' * »«rau.vcj'vnru«MVXkDrva'M©M.b*'dUDUia  ^ WjnAri,» *
Moore, R.3o and Wilson, 3.0, (1974) Biochemistry, 13, 450-455,
191*
Moore, E.C., Roichard, P© and Thelandor* L, (1964) 3* Biol
Chen, 239, 3445-3452,
Morfin, RoF®, Aliapoullos, M*A*, Bonnet, AoH., Harrison, 3,H* 
and Ofner, P. (1970) In Hormonal Steroids Proc© 3rd Int, 
Conoro Hormonal Steroids (Oamos, V.H/T. and Martini, L* eds©) 
pp, 337-345 Excerpta® Modica,, Amsterdam,
Moszkowicz, L, (1935) Virchows, Arch, A© 295, 211-235®
Munro, H,N, and Fleck, A, (1966) Methods Riophem, Anal,
21, 113-176.
Muntzlng, 3, and Nilsson, T, (1972) Scand® 3, Urol, Nephrol, 
£, 107,
Muntzing, 3,, Nilsson, T, and Polacek, (1974) Scand, 3,
Urol, Nephrol, B, 87-90,
Muntzing, 3.M,, Varkarakis, H,, Yarnanaka, G.P, and Sandberg, A.A,
(1974) Proc, Sac, Exp, Biol® Med* 146, 849-854©
Nozu, Ko and Tamaoki, B<^ Io (1973) Acta® Endocrinol® (Copenhagen) 
73, 585-598,
]92,
Nozu. Ko and Tamaoki, B-I© (1974a) Acta® Cndocrinol*
(Copenhagen) 76, 608-624©
Nozu, K« aiid Tamaoki, B-I* (1974b) Biochim© Biohnys* Acta®
348, 321-333.
0*DelI, B.Lo and Campbell, B.3. (19?1) In Comprehensive* * ¥  ^ ■■u.i «W ,u%a«wrai**.tmL=a
Biochemistry 21, pOo 179-252 Elsevier Publishing Co.,
New York*
Ofner, P®, Smakula, E.E., Wotiz, H.H., Lemon, H®H® and 
Moscon, Ho (1965) Biochim© Biophys® Acta® 100, 247-255®
Ofner, P®, Morfin, RoF®, Ve^a, R®Lo and Aliapoullos, M.At 
(1970) In Some Aspects of the Aetiology and Biochemistry 
of Pr0s131ir; Cancer Proc® 3rd Tenovus IJorkship (Griffiths, K® 
and Pierrepoint, C ®G ®, eds.) pp® 55-62 Alpha Omega Publishing 
Ltd®, Cardiff®
Ofner, P®, Vena, R.L© and Morfin, R.F® (1974) Steroids® 24,r ¥ * » > r «toM.it» \S3K^iKtuntxa-n ¥
261-279®
CPMalley, 3,W® and Mearns, A.R. (1974) In M.T.P® Int®
Review of Science Biochemistry of Hormones (Rickenberg. H*V® ed«) 
Biochem® Series One. Vol® 8, pp® 1B7-210- Butterworth*
193*
Polgc3, Ccj Smith, AoV® and Parkes, A*S. (1949) Nature (London) 
J H ,  6660
Prasad, A.5*, Schulert, A.P®, Miale, A*, Farid, Z« and Sandstead, 
H.Hg (1963) Amor© 3® din® Nutr® 12, 437-444®
Price, Dc (1963) In Biolony of the Prostata and Related Tissues 
Nat* Cancer© Inst* Monogr® 1_2_, pp© 1-27*
Prout, C.Re, Sierp, M® and Whitmore, U*F* (1959) 3* Amer* Med©
Assoc 0 169, 1703-1710*
Raspe, G© (ed*) (1971) Scherinq Work ship on Stero.id Hormone
Advances in the Biosciences 7; Porgarnon Press;Dxford©
Raulin, R* (1869) Ann® Soi* Nat* Botan* et* Biol * Vogetala 
11, 93-107.
Reed, 3*Mo and Stitch, S.R* (1973) 3* Endocrinol® 58, 405-419*
¥ \ / KTT"riinmn*iM*f'iriim f i r '~i*.TiH— tTTt -nf i  nrir te«aei* “
Reynolds, 3.A* (1972) Ann* N*Y, Acad. Sci, 195, 75-85®
Reynolds, 3*3* and Dingle, 3*To (1970) Calcif* Tissue Res®
4, 339-349*
Rixon, R*H* and Whitfield, 3*F, (1959) 3* Histochem® Cytochom,
7, 262-266©
194o
Robinovitch, M,Ro, SmucUler, E*A. and Sraebny, L*M® (1969)
3© Binl* Chom© 244$ 336i—5367©
Rosoff, Bo and Spencer, H© (1965) Nature (London) 207, 652-653©
“ ' f % f -iru**w*.eeevîstKwsue*aL*<i-«M«fliw. * *axlw«-Bsa *
Roy, A.8, (1971) Biochprnie* 53. 1031-1040©
* ¥ ■ '  I ■ I ^  trf, — «VW Bc n v >  '
Rutter, W*3. (1964) Fed© Proc© Fod® Amsr, Soc® Fx d * Bio}* 
23, 1248.
Sadouski, P.O. and Steiner, 3.U. (1968) 3® Cell® Biol.
147-161®
Saito, So, Ze.ttz, L«, Bush, i«M., Lee, R* and Whitmore, W.F,
(1967) Amer. 3. Physiol. 213, 749-752.
Saito, S., Zeitz, L®, Bush, I.M., Lee, R. and Whitmore, W.F.
(1968) Amer. 3. [l\/siol. 217. 1039-1043.
Sandstead, H.H., Prasad, A.S., Schulert, A.R., Farid, Z., 
Minle, A., Bassilly, S. and Darby, W.3. (1967) Amer. 3. Clin,
¥ • ¥ ¥ * * \ i 6ct»*™:*-JM--TCw**>*-rsv-«warwe.-e*rv»«a
Nutr. 20, 422-430.
Schrodt, G.R., Hall, T. and Whitmore, ILF * (1964) Cancer. 
17, 1555-1566.
195
Schmidt, G., and Thannhausor, 3 ©Da (1945) 3. Biol * Cham,
161, 83-8 9*
Shimazakiji 3*, Kurihara, H., I to, Y © ana Shida, K « (1955)
Gu/ninao 3© Med© Sole 11, 326-331 „
Shimazakij 3©, Horagushi, To, Dhki, Y© and Shi da, Ko (I97'l) 
Endocrinol* 3ap. , 179-184©
Siiteri, P.K* and Wilson, 3*0. (1970) 3© Clin. Invest *
£9, 1737-1745o
Smollio, R.MeSo (ad*) (1971) In The Biochemistry nf Steroid 
Hormone Action Biochemical Society Symposium £2, Academic Press 
London and Now York.
Springgate, C.F., MiIdvan, A.S., Abramson, R*, Engle, 3oL. and 
Loob, L.Ao (1973) 3. Biol. Chern. 248, 5987-5993.
Snedocor., GoLL (1952) Biometrics. 8, 85-86.
Steins, P., Krieg, M., Hollmann, H.3* end Voigt, K,D. (1974) 
Acta. Endocrinol; 75, 773-784.
Strott, C.A* (1974) Endocrinolo-v. 95, 826-837.
196.
Tarnaok.1, B-I© (1973) 3» Steroid* £, B9-118©
Tipton, 3*H* and Cook, M * 3 © (1963) Health Phys@ 89-101 
Tomkins, (1957) 3* Giol. Cham® 225, 13-24.
Tomkins, G*M* (1969) Science (New Yoi:k) 'i66, 147/'-1480o
Thiers, R,C. and Valise, B.L© (1957) 3* Biol, Chem. 266,
911-920.
Thiesson, C.V© (1974) Cancer© 34, 1102-1107.¥ y ¥ ■■ntsBCMnnn«Eibu»«s easeern» *
ValIee, B.L, (1959) Pliysiol, Rev© 39. 443-490.¥ * ¥ >E»*iM/tiriBt»«jmA»aaatt4Gugaaa*tCTiggta3i mr^ dr:» "
Valloe, BoLo (1950) In Thn Enzymes (Boyer, P®D*, Lardy, H. 
and Myrahack, K© eds.) Vol® 3 pp. 225-275 Academic Press, 
London and New York.
VerhoGven, G© and De Moor, P. (1971) Endocrinolory. 89,
042-8460
Vsrhosven, G*, Lamberigts, G. and De Moor, P. (1974)
30 Steroid Biochemistry® 5^  93-100.
Vermeulen, A* and Verdonck, L« (1958) Steroids© 11, 609-535©¥ ¥ y ¥ g- IrjtMeraHLsanuÿ’.m.it^ annnCBt tesxsun» *
m .
Voigt, GoE* (1958) Acta© Pathol® Microbiol* Scand. 42, 242-245©¥ ' M r7*ip,-b=*k&iü'#w " I i«fcjfaaxamii«uBa»wiai i» ««•«»■«'
Voigt, U«, Fornandez, E*P« and Hsia® S.L* (1970) 3© Biol©
Chom* 245; 5594-5599.
Uallenfels, K* and Sund, H. (1957) Biochem. Z. 329, 59-74.
¥ ¥ % ¥ a.a.' j LRr%M%3ku<i«Wj. mBWiifiATayMmAMa BH'jOACCœa '
Webb, Me, Creed, H© and Atkinson, S® (1973) Biochim® Bionhys 
Actac 324, 143-155.
Bt&QB4Ai>trs«a* tta-âw«a'xlir
WeitzGl, Go; Rooster, V., Buddocke, E‘. and Stretcker, F-3* 
(1956) Hgppp-5eylGr«s, Z® Physiol® Chen© 303, 161-175©
IdGttqrdal, 0© (1958) Acta» Radiol© Suopl® 156, 5-88* 
Whitmore, WcF* (1963) In The Biolony of the Prostate and
* SHe*wnr«oraea«*«eicua™isi»eue<T".’#4ve«siït»aamBWisi»#»«rs«iae«a*-vT<ir-*-yr--iiT3fl:'pwe»ti*i#»g3»tirin>"Wîi«rtwei»a'7i
Related Tissues Natn* Cancer Inst* Monogr* 12, 1-28*
Uotiz, H*H* and Lemon, H*M* (1954) 3® Biol* Chem* 206,
525-532,
Wilson, 3»Do and Loeb, P*M* (1965) In Development and 
Metabolic Control Mechanisms and Neoplasia pp* 375-391 
Williams and Wilkins Company, Baltimore, U,S,A*
198*
Wurtman. R©]» and Oensen, E.V, (1968) Science (New York) 
159, 1261*
Zipper, 3©, Model, Mu and Prager® R© (1969) Amnr^ 3* Qbstet, 
Gynecol© 105, 529-534©
L ;
Lîk

